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Abstract

Introduction: Distress has become so problematic in oncology that it has been
recognized as the “sixth vital sign” implying that distress monitoring should occur
as routinely as the monitoring of one’s temperature or blood pressure. The
research reported herein investigated the impact of head and neck cancer on
levels of distress, commonly reported problems, and perceptions of quality of life
in individuals with head and neck cancer and their caregivers.
Method: Two distinct studies were conducted; the first explored the patient
experience of distress and quality of life while the second assessed the caregiver
experience of these same constructs. A prospective, longitudinal research design
was employed for the patient study while a cross-sectional design was utilized for
the caregiver study. Measurement instruments included: (1) a demographic
survey; (2) the Distress Thermometer and Problem Checklist; (3) the EORTC
Quality of Life questionnaire (EORTC-QLQ-C30), and (4) the EORTC Head and
Neck module (EORTC-QLQ-H&N35), to evaluate quality of life in individuals with
head and neck cancer; and (5) the Caregiver Quality of Life-Cancer Scale
(CQOLC) to assess quality of life in caregivers.
Results: Data indicate that elevated distress can exist at any point along the
continuum of care in both individuals with head and neck cancer and their
caregivers. Relative to the patient population, distress was most prevalent at
diagnosis and length of time following diagnosis had a large effect on perceived
distress. Meanwhile 45% of caregiver participants reported clinically significant
distress; both caregiver sex and the treatment status (i.e., awaiting treatment,
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undergoing treatment, completed treatment) of the individual for whom they were
providing care influenced perceptions of distress in caregivers. Relative to quality
of life, participants in both studies reported elevated burden in three primary
domains: role fulfillment, physical functioning, and psychological well-being.
Conclusion: Data suggest that perceptions of distress are individualized and
heterogeneous in nature. Thus, routine distress screening represents a critical
first step in the identification of elevated distress in both those with head and
neck cancer and their caregivers. Through early identification and effective
management of distress, comprehensiveness of care may be enhanced and
long-term outcomes may be optimized.

Key Words
Distress, Head and Neck Cancer, Caregiver, Quality of Life, Family, Spouse,
Distress Screening, Psychosocial Oncology, Distress Thermometer, EORTC
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Epigraph

“We must embrace pain and burn it as fuel for our journey”

Kenji Miyazawa
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Chapter 1
Introduction and Review of Literature

Cancer is a disease of multiple types, sites, and etiologies. Statistics
indicate that it is the leading cause of death in economically developed countries
and the second leading cause of death in developing nations (WHO, 2008). This
prevalence translated to approximately 12.7 million diagnoses of cancer and 7.6
million cancer-related deaths in 2008 (Jemal et al., 2011). Unfortunately, the
cause for concern related to cancer extends beyond the pervasiveness of the
disease to also include the myriad consequences that stem from it. Due to the
current forms of treatment available (e.g., chemotherapy, radiotherapy, surgery,
and multimodality protocols), there are often significant consequences related to
the functioning and quality of life of individuals with cancer (Semple, Sullivan,
Dunwoody, & Kernohan, 2004) in addition to that of their caregivers.
Irrespective of anatomical site, all individuals with cancer experience some
level of distress related to their diagnosis and treatment (NCCN, 2013).
Unfortunately, this problem is amplified in those with head and neck cancer, a
population who exhibits the highest rates of anxiety, depression, and suicide
compared with other cancer sites (Kendal, 2006; Misono, Weiss, Fann, Redman,
& Yueh, 2008). While the specific reasons underlying the disproportionate rate of
suicide and depression in individuals with head and neck cancer are unknown,
researchers have speculated that the cause may be attributable to the
devastating effect of the disease and its treatment on the quality of life of
individuals with head and neck cancer (Misono et al., 2008). The impact of the
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disease and its treatment on one’s appearance and essential functions such as
breathing, swallowing and speech were also cited as possible factors contributing
to the elevated rates of depression and suicide in individuals with head and neck
cancer (Misono et al., 2008). In addition to the concerns of the person with head
and neck cancer, it is apparent that the diagnosis of cancer and its
accompanying sequelae (e.g., treatment- and disease-related consequences
such as impaired breathing, speech, and swallowing) create a crisis for family
members and significant others (Blood, Simpson, Dineen, Kauffman, &
Raimondi, 1994); these individuals are expected to grieve – or rather, respond to
the loss (Lev & McCorkle, 1998) – while simultaneously supporting the health
and psychosocial well-being of the individual with cancer. Given this level of
burden, it is not surprising that partners of those with head and neck cancer
report higher levels of anxiety than those with the disease (Vickery, Latchford,
Hewison, Bellew, & Feber, 2003). Consequently, it is apparent that elevated
distress has the potential to impact not only individuals with head and neck
cancer, but also their loved ones and caregivers.
Since the relationship between individuals with cancer and their caregivers
appears to be interrelated, with both partners experiencing negative
consequences when one is distressed (Northouse, Templin, & Mood, 2001;
Segrin, Badger, Dorros, Meek, & Lopez, 2007), efforts to develop an improved
understanding of the factors that contribute to elevated distress in both those with
head and neck cancer and their caregivers may have important implications for
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improving health-related outcomes in both caregivers and those with head and
neck cancer.
Head and Neck Cancer
Head and neck cancer refers to an extensive array of diverse tumour
types that arise from various anatomic sites located within the head and neck
region (Pai & Westra, 2009; Walden & Aygun, 2013). These sites include, but are
not limited to: craniofacial bones, skin, soft tissues, mucosal membranes, and
salivary glands (Pai & Westra, 2009). More than 90% of head and neck cancer
diagnoses may be histologically classified as squamous cell carcinomas; most of
these tumours originate in the mucosal surfaces of the head and neck such as
the nasopharynx, oropharynx, hypopharynx, larynx, and oral cavity (Marur &
Forastiere, 2008; Ragin, Modugno, & Gollin, 2007; Walden & Aygun, 2013).
Other less common forms of malignant neoplasms include adenocarcinomas,
lymphomas, melanomas and sarcomas (Semple et al., 2004).
Head and neck cancer may present as a localized disease without lymph
node involvement or it may present as regionally advanced disease with a
primary tumour and/or lymph node involvement, indicating the increased
potential for distant metastases (Marur & Forastiere, 2008; Vokes, 2012).
Treatment may consist of surgical excision, radiotherapy, chemotherapy or a
combination of these approaches (Semple et al., 2004; Vokes, 2012).
Irrespective of treatment modality, individuals diagnosed with head and neck
cancer face a distinct set of treatment-related challenges related to oral
communication, emotional expression, social interaction, and/or physical
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function. The manner in which one learns to adapt or cope with these distressing
changes may significantly influence his or her perceived quality of life and level of
distress. Collectively, one’s ability to cope with distressing changes related to the
disease and/or its treatment may impact both short- and long-term health related
outcomes (Elani & Allison, 2011; Horney et al., 2011).
Incidence of head and neck cancer and mortality. In the past 20 years,
the overall incidence of head and neck cancer has declined in Canada, the
United States, and Western Europe (Johnson-Obaseki, McDonald, Corsten, &
Rourke, 2012; Siegel, Ward, Brawley, & Jemal, 2011). Despite this decline,
international incidence rates of head and neck cancer reached an estimated
633,000 new cases in 2008 (Ferlay et al., 2010). Within Canada, findings reveal
an increased incidence in oropharyngeal cancer in both men and women but a
decreased incidence in all other head and neck sites for both sexes (JohnsonObaseki et al., 2012). Relative to mortality, international data indicate that an
estimated 355,000 individuals succumbed to their disease in 2008 (Ferlay et al.,
2010). Recent Canadian data suggest that there has been no statistically
significant improvement in survival among women for any head and neck cancer
site, however, slight improvements in survival were reported among men for all
head and neck cancer sites, with oropharyngeal sites representing the most
improved rate of survival (Johnson-Obaseki et al., 2012). The reasons for the
varying incidence and mortality rates associated with oropharyngeal cancer
versus other head and neck sites may be explained through an examination of
etiological factors.
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Etiology. The etiology of head and neck cancer stems from a variety of
risk factors that contribute to the disease both independently and collectively.
Namely, diet, oral hygiene, genetic predisposition, preexisting medical conditions,
infectious agents, and exposure to a variety of carcinogens may all contribute to
the development of head and neck cancer (Pai & Westra, 2009; Vokes, 2012;
Wynder & Bross, 1957; Wynder, Bross, & Feldman, 1961). Of these potential
carcinogens, tobacco usage is a well established risk factor for the development
of head and neck cancer (Pai & Westra, 2009; Vokes, 2012; Wynder & Bross,
1957; Wynder et al., 1961). In fact, Rodriguez and colleagues (2004) determined
that heavy smokers under the age of 46 have a 20-fold increased risk of
developing oral or pharyngeal cancer compared to individuals who do not smoke.
Not surprisingly, the risk associated with smoking tobacco products is directly
correlated with the duration and amount of smoking (Pai & Westra, 2009;
Rodriguez et al., 2004). Similar to lung cancer, environmental exposure to
tobacco smoke also has been shown to increase the risk of head and neck
cancer, even among those with no smoking history (Zhang et al., 2000). In
addition, smokeless tobacco products have been cited as an etiologic agent for
oral cancers (Cogliano et al., 2004; Cullen et al., 1986; Zhou et al., 2012).
Additionally, heavy alcohol consumption is also recognized as an
independent risk factor for head and neck cancer (Hashibe et al., 2007; Sturgis &
Cinciripini, 2007). Heavy alcohol consumption has been estimated to increase
the risk of developing oral cancer by five-fold (Rodriguez et al., 2004). Though
both alcohol and tobacco are independent risk factors for head and neck cancer,
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when the two agents are combined the risk of developing oral or pharyngeal
cancer has been reported to increase by nearly 50-fold (Rodriguez et al., 2004).
In fact, it has been reported that as many as 75% of all head and neck cancers
are attributable to the synergistic influence of this carcinogenic combination
(Hashibe et al., 2007). Although alcohol itself does not act as a direct carcinogen,
its metabolite, acetaldehyde, interferes with DNA synthesis and repair
mechanisms causing irreparable damage (Brooks & Theruvathu, 2005). Since
alcohol is a chemical solvent, it is thought to amplify the carcinogenic effects of
tobacco by prolonging and enhancing the mucous membrane exposure to the
carcinogens found within tobacco (Pai & Westra, 2009). In effect, alcohol may
increase the susceptibility of the body to the harmful carcinogens found in
tobacco.
Although alcohol consumption and tobacco exposure are well-established
risk factors, recently, there has been an epidemiologic shift towards human
papillomavirus (HPV)-related head and neck cancers (Li et al., 2012; Marur,
D'Souza, Westra, & Forastiere, 2010; Marur & Forastiere, 2008). Syrjanen,
Pyrhonen, and Syrjanen (1983) first suggested the role of HPV in head and neck
carcinogenesis (Campisi & Giovannelli, 2009). Since then, epidemiological
research has shown that the risk of developing HPV-induced head and neck
cancer is increased by sexual behaviours associated with the transmission of
high-risk HPV types (Forte, Niu, Lockwood, & Bryant, 2012; Walden & Aygun,
2013) specifically HPV-16, -18, and -31 (Marur et al., 2010; Marur & Forastiere,
2008; Pai & Westra, 2009). In effect, HPV is emerging as a preeminent and
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significant risk factor for oropharyngeal cancer and appears to be altering the
demographics of head and neck cancer toward those who are younger and
without a history of tobacco use or heavy alcohol consumption (Walden & Aygun,
2013).
In addition to tobacco, alcohol and HPV, there are several additional risk
factors for head and neck cancer that include, but are not limited to: poor oral
hygiene (Pai & Westra, 2009), diets deficient in vitamin A (Marur & Forastiere,
2008) or with low fruit and vegetable intake (Pai & Westra, 2009; Vokes, 2012),
infectious agents such as the Epstein-Barr virus (Vokes, 2012), a family history of
disease (Pai & Westra, 2009), marijuana smoke (Vokes, 2012), and occupational
exposures – particularly in nickel refining, textiles, leatherworking, woodworking,
metalworking, and any areas with exposure to asbestos, chromium, radiation or
mustard gas (Marur & Forastiere, 2008; Vokes, 2012). All of these factors, either
individually or collectively, may contribute to the development of head and neck
cancer and the associated consequences and complications of the disease and
its treatment. While the presence of a single etiologic factor may pose significant
risk for the development of head and neck cancer, the possibility of coexisting
factors must be considered in the treatment and assessment of health status and
outcomes in individuals with head and neck cancer.
Impact of disease. The diagnosis of head and neck cancer carries with it
a unique set of challenges that potentially exceed those associated with other
sites of cancer (Howren, Christensen, Karnell, & Funk, 2012; Semple, 2001).
This assertion is related to the fact that head and neck cancer treatment can be
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quite complex with potentially debilitating consequences. In essence, debilitating
side effects related to the disease and its treatment are present in all of those
diagnosed with head and neck cancer; however for some, the consequences
stemming from these side effects are more disabling than others. For instance,
side effects may include difficulties related to essential functions such as
breathing, eating, swallowing and speech production, in addition to a loss of
smell and taste, decreased sensation, sticky saliva, excessive dry mouth, pain,
swelling, and facial disfigurement (Doyle, 1994; Payakachat, Ounpraseuth, &
Suen, 2012). Further, some institutions require those individuals receiving
chemoradiation treatment to undergo prophylactic extraction of all dentition in an
effort to prevent future dental and mandibular problems (Hunter & Jolly, 2013).
Understandably, this process can be quite traumatic in and of itself. Moreover,
these myriad side effects stemming from the complex treatment regimens
required for the management of head and neck cancer often serve to impair daily
functioning and one’s ability to work.
Treatment regimens for head and neck cancer have the potential to create
a debilitating and lasting impact on an individual’s functional status, which may
consequently limit their ability to work both during and after treatment (Penner,
2009). Research examining work-related disability in those with head and neck
cancer revealed that 52% of individuals who were employed at the time of
diagnosis were unable to return to work following the completion of treatment
(Taylor et al., 2004). Likewise, other researchers have reported a similar inability
of individuals with head and neck cancer to return to their previous employment
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for extended periods of time, if at all (Shone & Yardley, 1991; Taylor et al., 2004;
Verdonck-de Leeuw, Van Bleek, Leemans, & de Bree, 2010). Even if those with
head and neck cancer are able to return to work following treatment, many have
reported having to change their jobs because of poor health and/or physical
discomfort related to treatment consequences (Liu, 2008). When compared with
other types of cancer, individuals with head and neck cancer have reported the
highest risk of quitting their jobs following treatment for their cancer (Short,
Vasey, & Tunceli, 2005). This change in employment status may have significant
implications on the financial and psychosocial well-being of these individuals
(Taylor et al., 2004).
In addition to the impact on one’s employment status, further concerns
may arise related to one’s independence and ability to participate in social
activities. To elaborate, research has shown that individuals treated for head and
neck cancer often either decrease the frequency of their driving or stop driving
altogether during and after treatment because of treatment-related impairments
(e.g., shoulder dysfunction following neck dissection) (Yuen, Gillespie, Day,
Morgan, & Burik, 2007). Consequently, daily routines and tasks such as running
errands or driving to and from work (if applicable) are disrupted, as those who
have been treated for head and neck cancer must increasingly rely on others
(e.g., caregivers) for transportation (Yuen et al., 2007). This reliance on others to
perform tasks which once symbolized independence (e.g., driving) may result in
feelings of dependence and decreased self-worth in those with head and neck
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cancer. As a result of these myriad concerns, individuals may experience
substantial problems within the context of social and family settings.
Often, these concerns are exacerbated by the very visible side effects of
head and neck cancer and its treatment including the potential for physical
disfigurement and scarring (Björklund, Sarvimäki, & Berg, 2010; Doyle, 1994).
Society tends to place more importance on the head and neck region than any
other area of the body (Semple et al., 2004). The emphasis on facial aesthetics
and cosmesis may be particularly difficult for those with head and neck cancer
because the visible signs of head and neck cancer and its treatment often cannot
easily be concealed (Semple et al., 2004). Consequences such as these often
prevent those with head and neck cancer the privacy afforded by less visible
forms of illness. As a result, those treated for head and neck cancer may
experience unwelcomed intrusions such as those associated with insensitive
comments or staring (Björklund et al., 2010). These experiences may result in
feelings of stigmatization and consequently cause additional psychological
distress. Feelings of stigmatization may result in multiple levels of social penalty
and consequently contribute to additional psychological and social distress for
individuals with head and neck cancer (Doyle, 2005; Fife & Wright, 2000; Lebel
et al., 2013). Factors such as these have led researchers to describe head and
neck cancer as the most emotionally traumatic form of cancer (Björklund et al.,
2010; Koster & Bergsma, 1990).
Given that research has demonstrated a relationship between the
emotional experiences of individuals with cancer and their caregivers (Northouse
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et al., 2001) – in essence suggesting that when one individual is distressed (e.g.,
person with head and neck cancer), that the other individual may also be
distressed (e.g., caregiver) – there appears to be a potential to experience
emotional trauma as a result of either having head and neck cancer or caring for
someone with the disease. Essentially, the emotional trauma caused by head
and neck cancer and its treatment may directly influence the emotional state of
caregivers (Hagedoorn, Sanderman, Bolks, Tuinstra, & Coyne, 2008).
Importantly, researchers have begun to acknowledge that head and neck cancer
not only has enormous consequences for the individual with the disease, but also
for their loved ones and caregivers, as the entire family dynamic may be
disrupted by the disease and its accompanying consequences (Björklund et al.,
2010). Thus, it would seem important to understand and acknowledge the
concerns of both the individual with head and neck cancer and their caregivers
since improvements in our understanding of the caregiver experience may
promote the identification of meaningful ways to support caregivers.
Caregivers
The definition and use of the term “caregiver” has been discussed in the
literature for several years (Hunt, 2003). Caregivers have been described as
unpaid individuals who participate in the experiences and activities involved in
the provision of assistance to a loved one who is unable to provide for
themselves (Pearlin, 1994). Recently, authors have suggested that a caregiver is
‘who the person says it is’ (Hodges & Humphris, 2009; Kissane & Bloch, 2002;
Stenberg, Ruland, & Miaskowski, 2010), implying that the caregiver may consist
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of a blood relative, neighbour, friend, or other individual. Regardless of how the
term caregiver is defined or who fulfills the role, providing care for another
individual who has been diagnosed with cancer is an experience, shared closely
with the recipient of care, which may affect numerous aspects of the caregiver’s
life.
It has been well established that family members of individuals with cancer
are affected by the illness throughout the trajectory of the disease (Stenberg et
al., 2010). For instance, the consequences of the disease continue to impact
family members well into the survivorship stage for those who survive the illness
and into the end of life care for those who do not (McCorkle & Pasacreta, 2001;
Stenberg et al., 2010). Family members often provide the primary source of
emotional and social support for individuals with cancer. They also serve a key
role in how effectively an individual with cancer is able to manage the impact of
their illness and its treatment (Zwahlen, Hagenbuch, Jenewein, Carley, & Buchi,
2011). Considering that hospital stays have decreased in length (Cohen, Stock,
Andersen, & Everts, 1997; Yueh et al., 2003), individuals with cancer are
increasingly left to manage their illness and its side effects at home. As a result,
the burden of responsibility for family members has increased; this in turn has
made the role of family-based caregiving ever more vital (Stenberg et al., 2010).
This shift towards family-based caregiving often requires a reorganization of
personal roles and responsibilities on the part of the caregiver in order to address
the needs of the individual with cancer and also ensure that the family is still able
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to function effectively and perform essential tasks (e.g., raising children, paying
bills, etc.).
The role of caregivers. Most often, the spouse or significant other of the
individual with cancer fulfills the role of primary caregiver (Mellon, Northouse, &
Weiss, 2006). Despite the fact that these loved ones often receive minimal or no
preparation, they are frequently tasked with many care-related responsibilities
such as the provision of physical care, medication administration, transportation,
emotional support, household management, and assistance with activities of
daily living (Northouse & McCorkle, 2010). The demand for these tasks to be
undertaken is often within a very short period of time following the diagnosis of
their loved one’s cancer. While family caregivers have historically provided
significant contributions to the care of their loved ones, the level of technical,
physical, and psychological support currently required of caregivers has reached
unparalleled levels in recent years (Given, Given, & Kozachik, 2001). This shift in
burden of care towards caregivers results from healthcare system changes which
have transferred the delivery of cancer care from an in-patient, hospital-based
setting to ambulatory and home-based settings much sooner following treatment
than in previous years (Cohen et al., 1997; Given et al., 2001; Yueh et al., 2003).
This shift in care settings has translated to an increased level of caregiver
involvement in the daily care of the individual with cancer (Given et al., 2001).
Thus, since individuals are providing care for those with cancer much sooner
following treatment (e.g., surgery), they must also deal with a more acute set of
potential issues (e.g., wound care, infection, swallowing problems).
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In addition to the disease- and treatment-related factors that caregivers
are responsible for (e.g., disease and treatment monitoring, symptom
management, medication administration, transportation to appointments), they
must also ensure that the responsibilities usually fulfilled by the individual with
cancer (e.g., errands, payment of bills, care for minor children, preparation of
meals) are addressed. Ensuring the fulfillment of responsibilities may be
particularly burdensome when the person with cancer is a spouse or family
member and the household tasks that were formerly shared between two
individuals must now be accounted for by the caregiver alone. While this effort to
preserve the normal level of family functioning is commendable, it can create
feelings of role overload for the caregiver (Northouse & McCorkle, 2010). As the
number of illness-related demands increase, caregivers experience numerous
physical, psychological and social consequences that potentially may exceed
those experienced by the individual with cancer (Mellon et al., 2006). Moreover,
research has demonstrated that as the level of demand on caregivers increases,
they are placed at an elevated risk for the development of depression (Braun,
Mikulincer, Rydall, Walsh, & Rodin, 2007). This elevated risk poses a problem
not only for the caregiver’s well-being, but also may impact their ability to provide
complex care to another when their own physical and mental health is
compromised. Thus, in order to ensure optimal caregiving, efforts to understand
and ameliorate the negative consequences of caregiving would appear to be a
reasonable area of consideration.

15
The consequences of caregiving. A recent review of the effects of
caring for an individual with cancer conducted by Stenberg and colleagues
(2010) identified more than 200 problems and burdens associated with being a
caregiver. This large range of concerns included issues related to one’s physical
health, psychological state, social activities, and practical responsibilities. While
the range of physical health concerns was indeed quite extensive, the most
commonly reported physical problems according to Stenberg et al. (2010)
consisted of pain, fatigue, sleep disturbances, loss of physical strength, loss of
appetite, and weight loss; symptoms which would appear to mirror those of
depression (Miller & Massie, 2009). These problems seem understandable given
that caregivers are often required to adjust their lifestyle (e.g., restricting leisure
activity and contact with friends and family) in order to accommodate the
increasing needs of the individual with cancer (Stenberg et al., 2010). These
lifestyle amendments often mean that during a time when the restorative benefits
of relaxation and social support are most needed, that caregivers actually have
the least amount of time and resources available for their own self-care (Bevans
& Sternberg, 2012).
Further complicating the situation, caregivers have been shown to
prioritize the needs of the individual with cancer over their own (Williams, 2007),
thus, leaving minimal time for maintaining activity and exercise, good nutrition,
and regular healthcare check-ups. Consequently, caregivers experience
increased health-related concerns such as fatigue and sleep disturbances, which
are exacerbated as symptom burden increases and functioning decreases in the
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individual with cancer (Palos et al., 2011). Symptom burden is a concept that is
comprised of both the severity of symptoms and the individual’s subjective
perception of the impact of the symptoms on their daily life and level of
functioning (Cleeland, 2007). As a result, one could infer that as the level of
symptom burden increases in individuals with head and neck cancer, so too does
the level of burden in caregivers.
In addition to physical consequences reported by caregivers, they have
also reported a diverse range of positive and negative psychological responses
to their experience as a caregiver. Specifically, caregivers have described a
spectrum of emotions ranging from positive affect such as hopefulness and
compassion for others, to negative emotions such as, bitterness, resentment,
fear, anger, depression, and anticipatory grief (Williams & Bakitas, 2012).
Regarding the ability to fulfill the responsibilities of providing care, some
caregivers have noted positive feelings of accomplishment, while others report
feeling overwhelmed (Williams & Bakitas, 2012). Upon reflection of the
caregiving experience, some individuals have found caregiving to be positive for
their self-esteem (Kim, Schulz, & Carver, 2007), while others have found that
managing tasks and emotions in the context of caring for a loved one was
immensely difficult (Williams & Bakitas, 2012). Given the broad spectrum of
emotional responses to the experience of caregiving, it is apparent that the act of
providing care to a loved one with cancer, is a complex experience that is
marked by both positive and negative affect.
The provision of care for an individual with cancer is often a challenging,
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disruptive, and time-consuming activity (Williams & Bakitas, 2012). Given the
level of burden facing caregivers, it is not surprising that multiple studies report
higher levels of anxiety and depression in caregivers than the patients
themselves (Mellon et al., 2006; Vickery et al., 2003). This finding is of central
importance to understanding the experience of distress in caregivers because it
acknowledges the psychological impact of the diagnosis and treatment of the
individual with cancer on the caregiver. The experience of illness and treatment
is clearly different for caregivers. They are often faced with the very real prospect
of losing their partner or loved one. Such a possibility may produce feelings of
grief and helplessness because they are unable to take a direct role in combating
the cancer (Vickery et al., 2003).
Relative to social consequences, caregivers have frequently reported
problems with employment, education, isolation, financial well-being, and the
ability to fulfill roles (Stenberg et al., 2010). When a loved one is diagnosed with
cancer, understandably, there are changes in the roles, expectations,
responsibilities and relationship dynamics of the family as individuals adjust to
the reality of such a diagnosis and impact of the disease (Northouse, Williams,
Given, & McCorkle, 2012). Accordingly, the level of burden on caregivers often
increases. This increased burden may be particularly evident in caregivers who
must balance their caregiving responsibilities with the provision of care for
children and/or ailing parents. These individuals may feel overwhelmed with the
demands on their time and energy as they try to balance their responsibilities to
their loved ones with their own personal and employment-related obligations
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(Coristine, Crooks, Grunfeld, Stonebridge, & Christie, 2003). Further, caregivers
without flexible jobs or employers who can accommodate such needs have often
been required to use sick leave and vacation time in order to fulfill their new and
potentially rapidly expanding obligations, which may subsequently create an
additional level of economic strain (Stenberg et al., 2010). Thus, it is apparent
that the social consequences of being a caregiver extend beyond the realm of
one’s daily social participation in enjoyable activities, to also include the potential
limitation of one’s future occupational and economic stability.
With regard to the financial burden of caregiving, an American study of the
time costs associated with informal caregiving for cancer survivors found that on
average, caregivers provided 8.3 hours of care per day for 13.7 months (Yabroff
& Kim, 2009). When the economic burden of caregiving was evaluated relative to
the value of the caregiver’s time providing care, the value of lost employment,
and out-of-pocket expenditures (e.g., transportation, parking, home
modifications, cancer care supplies, etc.), the financial costs were considerable,
ranging from $31,442 to $91,670, depending on the specific type of cancer (Van
Houtven, Ramsey, Hornbrook, Atienza, & van Ryn, 2010). These estimates of
time costs and out-of-pocket expenditures highlight the substantial financial
burden that often may be experienced by caregivers.
In addition to the financial stressors noted previously, caregivers have
reported feelings of isolation (Northouse et al., 2012; Williams & Bakitas, 2012).
Not only does the work of caregiving disrupt their opportunity to engage socially
with others (Stetz & Brown, 2004), but the caregiver’s personal needs are often
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neglected as their focus remains on the needs of the individual with cancer
(Schubart, Kinzie, & Farace, 2008). Feelings of isolation and loneliness were
particularly significant in caregivers without access to family or friends (Schubart
et al., 2008). The inherent difficulty in serving as a caregiver to a loved one with
cancer lies in both the overwhelming nature of the role and the fact that despite
one’s best effort, that the individual with cancer may still suffer and possibly
succumb to their illness. Thus the fear of losing a loved one may in and of itself
induce tremendous feelings of anticipatory grief in the caregiver.
Caregivers are often expected to grieve, while simultaneously supporting
the physical, psychological, social and practical needs of their loved one. They
must also work to maintain their regular family and employment-related
responsibilities, while balancing their own fears, anxieties and concerns for the
well-being of their loved one. In light of the essential role of caregivers and the
numerous personal and care-related demands they face, it would seem important
to work to understand their experiences and identify meaningful ways to assist
them. Research seeking to understand the experience of caregivers has
suggested that the provision of care for an individual with cancer may constitute
a distressing life experience (Longacre et al., 2012; Roing, Hirsch, & Holstrom,
2008). Since the presence of elevated distress in caregivers has been identified
as a factor that may compromise both the physical health and psychological wellbeing of both caregivers and individuals with cancer (Hagedoorn et al., 2008;
Northouse et al., 2001), investigations into the factors which can influence
distress may inform our understanding of the caregiver experience. Improved
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knowledge regarding the factors that contribute to and/or exacerbate distress
may help to identify meaningful ways to both detect and possibly alleviate
distress in these individuals.
Distress
Psychosocial distress has been identified as a significant and ongoing
problem among individuals diagnosed with cancer. Distress has become so
prevalent that the National Comprehensive Cancer Network (NCCN) has
established a Distress Management Panel to address the issue. The NCCN
(2013) has defined distress as:
…a multi-determined unpleasant emotional experience of a psychological
(cognitive, behavioral, emotional), social, and/or spiritual nature that may
interfere with the ability to cope effectively with cancer, its physical
symptoms and its treatment. Distress extends along a continuum, ranging
from common normal feelings of vulnerability, sadness and fears, to
problems that can become disabling, such as depression, anxiety, panic,
social isolation, and spiritual crisis (p.6).
As highlighted by the presence of a “continuum” of distress, there is an
inherent distinction to be made between the pathologic experience of distress
(e.g., clinical depression, anxiety disorders, etc.) and one’s natural response to a
catastrophic life event; be that the threat to one’s own life, or to the life of a loved
one. Transitory negative feelings are a normal part of the cancer experience and
are to be expected as individuals react to an unanticipated threat, potential and
actual losses, and to the potential side effects of unpleasant and/or painful
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treatments (Haman, 2008). Cancer and its treatment often create feelings of
uncertainty, anticipated changes to personal roles and functioning, and practical
concerns related to medical care and financial well-being. As individuals and
caregivers attempt to manage these concerns, they are likely to experience
emotions such as sadness, anger and fear. The majority of individuals will
experience brief episodes of sadness or anxiety, insomnia, loss of interest in
activities, thoughts of helplessness and hopelessness, or worries about potential
catastrophe (e.g., loss of life) (Haman, 2008).
While most individuals will eventually adapt to the changes brought on by
the cancer experience (Vickery et al., 2003), a subset of individuals will
experience distress to the extent that adaptive coping is impaired severely
enough or long enough to be considered disruptive (Haman, 2008). A few days
characterized by tearfulness and decreased interest in regular activities may be
viewed as a component of adaptive coping to the changes and losses that are
inherent in the experience for both the patient and caregiver (Haman, 2008).
However, if the symptoms persist for extended periods of time – some sources
suggest more than one week (Haman, 2008) while others advocate for at least
two weeks or more (American Psychological Association [APA], 2000) –
problems may arise with social support networks, one’s physical well-being, and
influence even treatment compliance and survival in individuals with cancer
(Haman, 2008). Notably, certain symptoms such as suicidal ideation with
accompanying plan and intent require immediate intervention, even if the
symptoms only last for short periods of time. Generally, it has been suggested
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that if distress persists for greater than a week, leads to noncompliance with
treatment recommendations (McDonough, Boyd, Varvares, & Maves, 1996), or
puts the individual (or others) in danger, intervention is required (Haman, 2008).
Ideally, problematic distress in both those with cancer and their caregivers should
be identified and addressed in order to avoid negative outcomes such as, fatigue,
weight loss, decreased medical compliance, and increased hospital stays
(DiMatteo, Lepper, & Croghan, 2000) in those with cancer, and compromised
psychological functioning, and changes to the immune system that limit glucose
control and increase cardiovascular vulnerability (Rohleder, Marin, Ma, & Miller,
2009) in caregivers.
Distress in individuals with cancer. Normal emotions such as sadness,
worry, and fear occur in every person, and are undoubtedly exacerbated with a
diagnosis of any serious disease such as cancer. Clinical psychiatric disorders
such as depression and anxiety do not develop overnight; rather, they are the
cumulative outcome along the continuum of mental health that extends beyond
normal emotional responses and psychological reactions (Mohan & Pandey,
2002). Research has established that across the trajectory of illness – from initial
diagnosis through treatment, termination of treatment, survivorship, or recurrence
and palliation – psychosocial distress is evident in approximately 25% to 45% of
those with cancer (Carlson, 2003; Carlson et al., 2004; Singer et al., 2012;
Zabora, Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001). Moreover,
large-scale studies conducted at the Tom Baker Cancer Centre in Alberta,
Canada (Carlson et al., 2004) and the Johns Hopkins Kimmel Cancer Centre in

23
Baltimore, Maryland (Zabora et al., 2001) of a representative sample of
individuals screened for psychosocial distress detected high levels of fatigue (in
nearly 50% of patients), depression (24%), anxiety (24%), and pain (26%), in
addition to financial hardship and other challenges. Distress is a common
sequela of cancer as a disease and thus requires careful consideration in the
context of understanding the individual’s response to the diagnosis of malignant
disease.
From a therapeutic perspective, untreated depression has been shown to
affect medical compliance, appetite, wound healing, and contribute to increases
in length of hospital stays (DiMatteo et al., 2000; Jenkins, Carmody, & Rush,
1998; McDonough et al., 1996). Furthermore, the impact of depression on
functions such as sleep, motivation and energy level are also well documented
(Roscoe et al., 2007). By intensifying fatigue and weight loss, depression has the
potential to amplify treatment-related side effects for individuals with cancer,
contributing to a vicious cycle that may not only worsen depression and overall
rates of distress, but also negatively influence disease control through decreased
medical compliance (DiMatteo et al., 2000).
Relative to the impact of depression on medical compliance, research has
demonstrated that depressed individuals with cancer take more breaks in
treatment and thus require a greater length of time in order to complete the
prescribed treatment protocol (Archer, Hutchison, & Korszun, 2008). These
findings have critical implications for individuals with head and neck cancer given
that the success of radiation therapy – one of the key forms of treatment for head
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and neck cancer – is dependent in part on the completion of therapy as close as
possible to the prescribed time (Lydiatt, Moran, & Burke, 2009). In consideration
of these factors, the chances of survival are likely to be lessened in those
individuals who experience depression, when compared to those who are not
depressed (Archer et al., 2008). Thus, given the numerous challenges facing an
individual with cancer, support from caregivers is essential in order to facilitate
successful coping, adjustment, and sometimes even survival (Foster et al.,
2005). As a result, understanding the factors that contribute to elevated distress
would appear to be an important component to ensuring the optimal well-being of
both those with cancer and their caregivers.
Distress in caregivers. While cancer has been shown to impact the
quality of life of caregivers in myriad ways, researchers have recently suggested
that the psychological well-being of caregivers is the area most significantly
impacted during the initial stages of the caregiving experience (Northouse,
Katapodi, Schafenacker, & Weiss, 2012). When the level of demand for care that
is placed on caregivers exceeds their available resources (e.g., psychological
wherewithal, personal coping mechanisms, social support, etc.), caregivers
report feeling overwhelmed and distressed (Drabe, Wittmann, Zwahlen, Büchi, &
Jenewein, 2012). Distress in caregivers is problematic for two key reasons; first
for the problems that it poses to caregivers personally, and second for the
consequent impact on the individuals with cancer. Both the personal
consequences of distress for caregivers and the resultant impact on those with
cancer are discussed hereunder.
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Relative to the personal toll of distress on caregivers, research indicates
that between 20% to 40% of caregivers experience high levels of distress or
depression (Edwards & Clarke, 2004; Longacre et al., 2012). However these
incidence rates increased when the individual with cancer demonstrated poor
physical functioning, high symptom distress, and advanced disease (Kurtz, Kurtz,
Given, & Given, 2004). The prevalence of high emotional distress in caregivers is
problematic for multiple reasons. Not only does it compromise their psychological
well-being, but highly distressed caregivers may also experience changes to their
immune system that can limit glucose control, promote flare-ups in autoimmune
diseases, and increase vulnerability to cardiovascular diseases (Rohleder et al.,
2009). These biologic consequences of distress increase the potential for the
caregiver’s own health to suffer and, consequently, impede their ability to provide
adequate care to the individual with cancer. This clearly holds the potential to
impact both the caregiver and the individual for whom they must provide care.
Regarding the impact of caregiver distress on individuals with cancer,
research indicates that because of caregivers’ negative emotional states and
impaired cognitive and physical functioning, caregivers have more difficulty with
the effective administration of medication (Lau et al., 2010) and provision of
optimal care (Park et al., 2009; van Ryn et al., 2011) to individuals with cancer.
With respect to psychological functioning, high levels of anxiety in caregivers
have been shown to increase anxiety in the individuals with cancer (Segrin et al.,
2007), and longitudinal data suggest that when caregivers are highly distressed,
there is a significant negative effect on the long-term adjustment of the individual
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with cancer (Northouse et al., 2001). Consequently, it would appear that there is
a reciprocal relationship between the psychological health of both caregivers and
individuals with cancer.
The findings of Northouse and colleagues (2001) are in line with the work
of Hagedoorn and colleagues (2008) who conducted a meta-analysis of 46
studies that examined distress in couples coping with cancer (n = 2,468 couples).
They discovered a significant relationship between distress in caregivers and
those with cancer (r = 0.29, p < .001) even after controlling for illness-related
factors (e.g., disease stage). These findings indicate that both the individual with
cancer and their caregiver’s emotional responses to the illness were interrelated.
These results suggest that individuals with cancer and their caregivers react to
the experience of cancer as an “emotional system”, and that both the individual
and their caregiver(s) should be viewed as the recipients of care from the
perspective of health practitioners (Northouse et al., 2012). In consideration of
the dyadic nature of the patient-caregiver relationship, a greater understanding of
the factors that influence caregiver distress may have important implications not
only for improving caregiver outcomes, but also for the individuals with cancer,
given that the distress level of one individual (e.g., the caregiver) may influence
the distress level and overall experience of the other individual (e.g., the person
with cancer), and vice versa (Northouse et al., 2001; Segrin et al., 2007).
Benefits of distress management. When the psychological needs of
individuals with cancer remain unresolved, these individuals are more likely to
visit emergency rooms and make use of community health services (Carlson &

27
Bultz, 2004). This increased service utilization is related to the physical
symptoms resulting from psychological distress such as sleep disturbances,
headaches and gastrointestinal symptoms (Carlson & Bultz, 2004).
Consequently, these individuals place greater demands on the increasingly
scarce time of their healthcare providers. Additionally, clinical studies have
demonstrated that certain forms of psychosocial intervention (e.g., cognitive
behavioural therapy, psycho-educational interventions) are beneficial to
individuals with cancer (Chambers, Pinnock, Lepore, Hughes, & O’Connell, 2011;
Fors et al., 2010; Hammerlid et al., 1999; Newell, Sanson-Fisher, & Savolainen,
2002). Newell and colleagues (2002) found that psychosocial interventions
involving counseling (either structured or unstructured) and guided imagery have
been shown to improve quality of life and the general functioning of individuals
with cancer. Furthermore, participants from multiple studies asserted that they
would use the psychological resources again and would recommend them to
other individuals diagnosed with cancer (Hamilton, Miedema, MacIntyre, &
Easley, 2011; Miller et al., 1998). Thus, this information suggests that if
psychological distress can be identified early and addressed in a meaningful
manner (i.e., lessened or alleviated), then perhaps we can improve the overall
functioning of individuals with cancer and also possibly reduce the economic
burden on the healthcare system that arises as a result of untreated or poorly
managed distress.
Several reviews of the literature have noted that psychological therapies
may assist individuals in several ways including, improving sexual functioning
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(Penedo et al., 2007), enhancing quality of life, emotional adjustment, and coping
skills (Hamilton et al., 2011; Henderson et al., 2011), and increasing physical
health and functional adjustment (Penedo et al., 2007). Further, such intervention
has been reported to reduce disease- and treatment-related symptoms in
individuals with cancer (Hart et al., 2012) and general physical symptoms in
caregivers (Birnie, Garland, & Carlson, 2010). Addressing negative psychosocial
outcomes such as distress is a critical component to the delivery of
comprehensive healthcare. Without the early identification of problematic distress
levels, individuals’ may experience innumerable consequences related to
physical, psychological and social functioning – the core components of one’s
evaluation of their perceived quality of life. Therefore, these consequences may
ultimately result in decreased quality of life for those living with cancer as well as
their caregivers.
Thus, efforts to support the identification of distress in both individuals with
cancer and their caregivers should be undertaken in an effort to inform the
individuals charged with their care (and those most suited to assisting them) of
when the level of psychosocial concern (e.g., distress) has reached a
problematic point and specifically where intervention efforts may be directed in
order to be of most benefit. Fortunately, a number of validated instruments have
been devised which are capable of assessing the level of an individual’s
perceived distress and their accompanying multidimensional concerns. The use
of these tools in both clinical and research environments may help to develop a
better understanding of not only the prevalence of distress in individuals with
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head and neck cancer and their caregivers, but also the specific problems that
these individuals face and the consequent impact of this distress and these
perceived problems on their quality of life and daily functioning. Outlined next is a
summary of the measures deemed best suited to address the specific objectives
of this program of research.

Measurement Instruments
The measurement instruments utilized in the studies comprising the
dissertation included: (1) the Distress Thermometer and accompanying Problem
Checklist to measure distress and perceived problems; (2) the EORTC Quality of
Life Questionnaire (EORTC-QLQ-C30), and (3) the EORTC Head and Neck
module (EORTC-QLQ-H&N35), to evaluate both global and head and neck
cancer-specific quality of life, and (4) the Caregiver Quality of Life-Cancer Scale
(CQOLC) to assess quality of life from the perspective of caregivers. Additionally,
all participants of the studies described in this dissertation were requested to
complete a brief form to assess demographic information in addition to diseaseand treatment-related variables. In the case of caregivers, the form requested
both their personal demographic information and the disease- and treatmentrelated information of their loved one with head and neck cancer.
Distress Thermometer. The Distress Thermometer was developed in
1999 by the National Comprehensive Cancer Network (NCCN) in an effort to
provide a means of assessing psychological well-being in individuals with cancer
in a non-stigmatizing manner (NCCN, 2013). The term “distress” was utilized
because it was viewed as less stigmatizing than terms such as “psychiatric” or
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“psychological” (NCCN, 2013). The “thermometer” component of the Distress
Thermometer is comprised of an 11-point Likert scale ranging from 0 (no
distress) to 10 (extreme distress). Respondents were asked to circle the number
that best described how much distress they had been experiencing throughout
the past week including the present day (NCCN, 2013). Owing to the brief nature
of the Distress Thermometer as a means of assessing distress, it has been
classified as an “ultrashort” measure based on the fact that it contains less than
five items (Vodermaier, Linden, & Siu, 2009). To date, the Distress Thermometer
has been validated extensively in oncology populations across various cancer
sites (Butt et al., 2008; Gessler et al., 2008; Hegel et al., 2008; Hoffman, Zevon,
D'Arrigo, & Cecchini, 2004; Jacobsen et al., 2005) and disease stages (Akizuki et
al., 2003; Gessler et al., 2008; Gil, Grassi, Travado, Tomamichel, & Gonzalez,
2005; Hegel et al., 2008; Recklitis, Licht, Ford, Oeffinger, & Diller, 2007). A
systematic review of distress measures determined that the Distress
Thermometer was found to have moderate reliability, validity and criterion
measures based on a review of 15 studies that used the Distress Thermometer
and comprised a total of 4,088 participants (Vodermaier et al., 2009).
Although assessments of acceptable coefficient values of reliability are
somewhat arbitrary, as a general guideline, reliability coefficients that fall below
0.50 indicate poor reliability, while values that range between 0.50 and 0.75
suggest moderate levels of reliability, and coefficients above 0.75 represent good
reliability (Portney & Watkins, 2009). In their review of distress screening
measures, Vodermaier et al. (2009) reported that the Distress Thermometer
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demonstrated a moderate degree of reliability. Further, Vodermaier and
colleagues (2009) found the measure to be generalizable based on its use in
oncology-related populations including those with mixed diagnoses (e.g., multiple
cancer sites), disease stages, and also in individuals awaiting bone marrow
transplantation. While the Distress Thermometer has demonstrated moderate
reliability and generalizability, questions may be raised as to the ability of a single
item measure such as the Distress Thermometer to accurately capture the
experience of distress in individuals. However, examination of the concurrent
validity of the Distress Thermometer with other established measures of distress
may prove to assuage these potential concerns.
With respect to validation of a screening tool such as the Distress
Thermometer, data pertaining to the sensitivity and specificity of the measure
may provide valuable information regarding the ability of the measure to
accurately discern between the true presence, or absence, of clinically significant
distress. Specifically, sensitivity measures the validity of a screening procedure
and is based on the probability that an individual who is experiencing distress will
test positive for distress according to the measure (e.g., a true positive), whereas
a measure’s specificity is based on the probability that an individual who is not
distressed will test negative for distress according to the measure (Portney &
Watkins, 2009).
Sensitivity values for the Distress Thermometer ranged from 0.59 to 0.89
while specificity values fell between 0.49 and 0.85 in a systematic review of
distress measures (Vodermaier et al., 2009). While these values appear to be
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quite divergent, it should be noted that the cutoff scores used by researchers in
the systematic review varied considerably. The lowest cutoff score used was 3
(Gil et al., 2005), while the highest was 7 (Hegel et al., 2008), however scores of
4 or 5 were the most commonly used cutoff scores. Despite the varying cutoff
scores used by researchers, the NCCN has recommended that scores of 4 or
higher be considered clinically significant (NCCN, 2013). This recommendation
has been verified through the validation efforts of other researchers in both
individuals with cancer (Hoffman et al., 2004; Jacobsen et al., 2005; Ransom,
Jacobsen, & Booth-Jones, 2006) and caregiver populations (Zwahlen,
Hagenbuch, Carley, Recklitis, & Buchi, 2008). As such, the present study
employed the recommended cutoff score for analysis purposes.
Furthermore, a recent meta-analysis of short screening tools for cancerrelated distress supported the use of the Distress Thermometer and noted that it
is comparable to longer distress measures, but provides superior efficiency
(Mitchell, 2010). Furthermore, in his review of short distress screening measures,
Mitchell (2010) noted that the best available evidence supported the use of the
Distress Thermometer due to its acceptability with participants, costeffectiveness, and overall accuracy, especially when compared with longer,
multi-item screening measures, such as the Hospital Anxiety and Depression
Scale (HADS). Furthermore, owing to its brief administration and simple scoring
procedure (e.g., scores of greater than or equal to 4 suggest problematic
distress), the Distress Thermometer provides an easy-to-use clinical screening
measure that affords simple intra rater comparison of data. Hence, for busy
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clinicians who may not have time to score and review longer measures, a quick
comparison of an individual’s previous Distress Thermometer score(s) with a
current score may provide useful clinical information (e.g., on previous clinic
visits, the individual regularly rated their distress as a 2, however today they
reported a 7, which alerts the clinician that follow-up may need necessary). This
information can then be utilized in a discussion with the individual and if
necessary, the offer of referral to supportive care services can be extended.
In addition to the single-item Likert scale assessment of distress, the
Distress Thermometer contains a 38-item complementary Problem Checklist.
The Problem Checklist seeks to determine whether problems exist in the
practical, familial, physical, or spiritual domains of an individual’s life (NCCN,
2013). A key benefit of the Problem Checklist is that it may enable clinicians to
identify potential sources of distress quickly and subsequently address these
concerns as part of the treatment of the whole individual (Gessler et al., 2008).
With respect to the family members, recent efforts have been undertaken
to validate the Distress Thermometer for use in the caregiver population
(Zwahlen et al., 2008; Zwahlen et al., 2011). Findings from the validation efforts
indicated that the Distress Thermometer had good diagnostic utility in caregivers
and that a cutoff score of 4 maximized the sensitivity of the measure, which may
reduce the risk of missing distressed family members (Zwahlen et al., 2008).
Collectively, these validation efforts provide support for the use of the Distress
Thermometer as a screening measure in family members of individuals
diagnosed with cancer.
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In summary, currently available evidence supports the use of the Distress
Thermometer in both head and neck cancer and caregiver populations. Further,
use of the accompanying Problem Checklist may enable clinicians to quickly
identify areas of concern and determine where intervention efforts should be
directed in order to provide the most benefit to those in need. Use of the Distress
Thermometer and its accompanying Problem Checklist to screen for distress and
related areas of concern in caregivers and those with head and neck cancer may
help to elucidate the prevalence of distress in individuals in these populations
and also target the specific problems facing these individuals. Additionally, in
order to better understand the consequent impact of this distress and the related
areas of concern, investigations into perceived quality of life among those with
head and neck cancer and their caregivers are important. Thus, use of validated,
multidimensional quality of life measures, such as those described next, may
provide useful insight into the subjective impact of one’s perceived problems and
level of distress.
European Organisation for Research and Treatment of Cancer
Measures. The EORTC is a series of self-administered cancer-specific
measurement instruments that are designed to assess quality of life within
oncology populations (Sherman et al., 2000). The core questionnaire, the
EORTC-QLQ-C30 (version 3.0) (Aaronson et al., 1993), serves as a generic
measure of quality of life for all cancer sites. It consists of 30 items, which are
divided into five functional scales (physical, role, emotional, cognitive and social
functioning), three symptoms scales (pain, fatigue, and nausea/vomiting) and a
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measure of global health status, or quality of life (Fayers et al., 2001).
Additionally, there are six single item scales included on the measure (dyspnea,
insomnia, appetite loss, constipation, diarrhea, and financial concerns). The sum
of all items provides an indication of an individual’s overall quality of life (Scott et
al., 2008). Responses for items 1 through 28 are recorded on a 4-point Likert
scale ranging from 1 (not at all) to 4 (very much). Responses for items 29 and 30
are recorded on a 7-point Likert scale where 1 indicates very poor health or
quality of life and 7 indicates excellent health or quality of life. Respondents are
asked to answer each item relative to how they have been feeling ‘during the last
week’ (Bjordal et al., 2000). Completion of the core questionnaire is anticipated to
take less than 10 minutes. Both the subscale and overall scores are transformed
to a scale of 0-100 with higher scores implying a high level of problems or
symptoms or, alternatively, a high level of functioning or global quality of life,
depending on which subscale is evaluated (Bjordal et al., 2000). The core
instrument has been validated in diverse samples of oncology populations within
North America and Western Europe (Aaronson et al., 1993; Bjordal & Kaasa,
1992; Hjermstad, Fossa, Bjordal, & Kaasa, 1995; King, Dobson, & Harnett, 1996;
Sherman et al., 2000). Overall, the core measure has demonstrated strong
psychometric properties including reliability, validity and sensitivity to change
(Bjordal et al., 2000; Sherman et al., 2000). Specifically, evaluations of validity
and reliability have determined that all scales consistently show Cronbach’s
alpha coefficients of > 0.70 (Bjordal et al., 2000), which suggests that all scales
demonstrated at least moderate if not good levels of reliability according to the
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criteria outlined by Portney and Watkins (2009). Consequently, the EORTC-QLQC30 was determined to be a suitable measurement instrument for use in the
current research efforts.
While it is important to address general quality of life issues that may be
relevant to most individuals diagnosed with cancer, there are a number of
disease-specific issues that arise in head and neck cancer that also need to be
addressed. With this in mind, the creators of the EORTC-QLQ-C30 stipulated
that the core instrument was intended to be used in conjunction with an
accompanying site-specific module, in order to provide a more comprehensive
assessment of an individual’s difficulties (Sherman et al., 2000). Studies confirm
that both general and site-specific measures each contribute unique and
important information regarding quality of life (D'Antonio, Zimmerman, Cella, &
Long, 1996; Gliklich, 1997). Notably, the EORTC has devised a range of cancer
site-specific measures, which include, prostate, ovarian, esophago-gastric,
esophageal, neuroendocrine carcinoid, multiple myeloma, lung, hepatocellular
carcinoma, gastric, endometrial, colorectal liver metastases, colorectal, cervical,
breast, brain, bone metastases, and head and neck cancer sites (EORTC, 2013).
The EORTC-QLQ-H&N35 (Aaronson et al., 1993) was designed for use
among a wide variety of individuals with head and neck cancer, varying in
treatment modality and disease stage (Bjordal & Kaasa, 1992; Singer et al.,
2012). It is one of the most widely tested disease-specific quality of life measures
for oncology populations (Bjordal et al., 2000); to date it has been used in 26
countries and 19 languages indicating broad cross-cultural acceptance (Singer et
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al., 2012). In total, the head and neck module contains 35 items divided into
seven multi-item scales that assess pain, swallowing, senses (taste and smell),
speech, social contact, social eating, and issues pertaining to sexuality
(Aaronson et al., 1993). The module also contains eleven single items. Like the
core questionnaire, responses for the first 30 items on the head and neck cancer
module are recorded on a 4-point Likert scale ranging from 0 (not at all) to 4
(very much), whereas the last five items are presented in a yes/no format.
Respondents are asked to answer each item relative to how they have been
feeling ‘during the last week’ (Bjordal et al., 2000). Completion of the head and
neck cancer module is anticipated to take approximately less than 10 minutes
(Bjordal et al., 2000). Like the core questionnaire (e.g., EORTC-QLQ-C30), the
subscale and overall scores are transformed to a scale of 0-100 with higher
scores implying a high level of problems or symptoms or, alternatively, a high
level of functioning or global quality of life, depending on which subscale is being
evaluated (Bjordal et al., 2000). The EORTC-QLQ-H&N35 module has been
validated in diverse samples of head and neck cancer sites (Aaronson et al.,
1993; Bjordal & Kaasa, 1992; Sherman et al., 2000; Singer et al., 2012). Overall,
the EORTC-QLQ-H&N35 module has demonstrated strong psychometric
properties including reliability, validity, and sensitivity to change (Bjordal et al.,
2000; Sherman et al., 2000; Singer et al., 2012). Specifically, evaluations of test
validity and reliability have determined that all scales consistently show
Cronbach’s alpha coefficients of > 0.70 (values ranged from 0.75 to 0.95), with
the exception of the senses scale which demonstrated a coefficient of 0.54 in one
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study (Sherman et al., 2000), 0.68 in another (Bjordal et al., 2000), and 0.61 in a
more recent evaluation (Singer et al., 2012). Overall, the EORTC core
questionnaire and accompanying head and neck cancer module are reported to
be excellent measures with good psychometric properties. Further, the H&N35
has been used in both clinical trials and observational studies, and has proven to
be well accepted and feasible in both settings (Singer et al., 2012). Owing to the
sound psychometric properties, in addition to the proven record of acceptability
and feasibility of the EORTC measures in previous observational research, the
EORTC global and head and neck specific instruments were deemed suitable to
assess perceived quality of life among the individuals diagnosed with head and
neck cancer taking part in this investigation.
Caregiver Quality of Life-Cancer Scale. The CQOLC is a 35-item selfreport measure of caregiver quality of life that contains four primary factors
(burden, disruptiveness, positive adaptation and financial concerns) and a total
CQOLC score (Weitzner, Jacobsen, Wagner, Friedland, & Cox, 1999). This brief
measure was designed to assess the impact of supporting a loved one with
cancer on the caregiver’s physical, emotional, social, financial and familial
functioning (among other areas) (Edwards & Ung, 2002). Each item included in
the CQOLC is rated on a 5-point Likert scale ranging from 0 (not at all) to 4 (very
much). Respondents are asked to ‘indicate how true each statement has been
for them during the past seven days’. The maximum total score on the CQOLC
measure is 140 with a higher total score indicating better overall quality of life.
With regard to the four subscale factors, lower scores in the burden,
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disruptiveness and financial concerns domains indicate elevated levels of
concern (or poorer quality of life). However, the positive adaptation factor is
reverse-coded, so a lower score is indicative of better overall adaptation to the
circumstances. In essence, since the positive adaptation domain assesses how
well an individual is adapting to the situation and since it is reverse-coded, a
lower score (e.g., -20) would indicate better adaptation than a higher score (e.g. 10). Conversely, the remaining subdomains (e.g., burden, disruptiveness,
financial concerns) are not reverse-coded; therefore a higher score on each
domain (e.g., 20) would indicate a higher degree of perceived penalty than a
lower score (e.g., 10).
With respect to reliability, the internal consistency coefficient (Cronbach’s
alpha) of the CQOLC was determined to be 0.91 while the test-retest correlation
coefficient was 0.95 (Weitzner et al., 1999). Additionally, a review of the
psychometric properties of quality of life measures for caregivers of individuals
with cancer determined that the CQOLC was the best available quality of life
measure for caregivers of individuals with cancer (Edwards & Ung, 2002). The
review conducted by Edwards and Ung (2002) also noted that the CQOLC met or
exceeded the minimum psychometric criteria for reliability and validity. Therefore,
the CQOLC was determined to be a psychometrically sound measure. This
factor, considered in conjunction with the findings of Edwards and Ung (2002) in
their review of caregiver quality of life measures, contributed to the decision that
the CQOLC was the most appropriate instrument for use in the evaluation of
quality of life in caregivers of individuals diagnosed with head and neck cancer.
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In addition to the evaluation and selection of measures, an equally
important component of any research endeavour is the rationale for the design
and implementation of the protocol. Thus, in addition to the description of the
distress and quality of life measures and their validation characteristics,
consideration for how the measures were to be distributed and the rationale
surrounding the distribution method is warranted.
Measurement Rationale
As noted in the previous sections, questionnaires were selected as the
means of obtaining data from participants for the present research initiatives. In
general, questionnaires are structured surveys that are self-administered and
utilize either pen and paper or electronic formats (Portney & Watkins, 2009). The
questionnaires used in the present investigations were based on the traditional
pen and paper format in an effort to ensure that participants who did not have
access to the Internet were not excluded from participation. The use of
questionnaires was determined to be the most efficient way to gather
standardized data from a large sample of participants in a relatively short period
of time (Portney & Watkins, 2009). The use of standardized written forms
ensured that all participants were exposed to the same questions in the same
manner, thus reducing the potential for bias from interactions with an interviewer
(Portney & Watkins, 2009). Additionally, questionnaires have been found to be a
useful research tool for examining phenomena that can be assessed through
self-observation (Portney & Watkins, 2009), such as personal perceptions and
values.
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The use of written questionnaires to elicit survey data from participants is
commonly referred to as self-report measurement, which offers a direct way to
obtain information related to perceptions, fears, motivations and attitudes
(Portney & Watkins, 2009). Additionally, due to limited time and resources during
clinical encounters, it may be difficult to obtain the extensive amount of personal
information and perspectives required for the proposed analyses. However, the
use of written measures to evaluate the perceived level of distress and quality of
life of those with head and neck cancer and their caregivers affords the possibility
of gathering a great deal of subjective information in an efficient manner.
Additionally, in an effort to minimize the potential for recall bias, or the
possible inaccuracy of recalling previous experiences or medical history, all
measurement instruments asked individuals to report their experiences based on
how they had been feeling over the past seven days in order to allow participants
to reflect on their general level of distress and quality of life. The relatively short
time frame may help to minimize inaccuracies in the reports that may arise out of
recall bias (e.g., the inability to accurately recall events or perceptions), however
the seven day time period was also deemed long enough to ensure that
participant responses were reflective of one’s general experience for that week
rather than a reactionary or falsely elevated level of distress owing to a single
event. Furthermore, research has shown that self-report measures are generally
valid, despite the potential for recall bias (Portney & Watkins, 2009). Ultimately,
the use of self-report measures may be particularly beneficial for evaluations of
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quality of life and distress, where individuals may be hesitant to reveal sensitive
mental health concerns in a time-limited clinical encounter.
Despite the fact that distress may be causing disruptions in daily
functioning, many individuals may conceal their distress from their primary
physician and healthcare team (Weisman, 1976). Individuals displaying such
behaviour may rationalize their secretive response as an appropriate one
because they believe that their physician and healthcare team need to focus their
energy on the treatment of their disease. Conversely, oncologists and healthcare
team members may lack the time or skills required to accurately identify and refer
individuals exhibiting significant distress to the appropriate psychological
resources (Carlson et al., 2004; Sollner, 2001; Zabora, Loscalzo, & Weber,
2003). The outcome of these combined elusive approaches is the collective
avoidance of the problem. Consequently, distress may remain undisclosed and
only become apparent when it has increased to a point where the individual is no
longer able to independently manage the situation. However, the use of written,
self-report measures to evaluate distress and quality of life of those with head
and neck cancer and their caregivers affords the possibility of gathering a great
deal of subjective information in a clinical situation where individuals may
previously have chosen not to reveal sensitive mental health concerns.
Thus, in summary the Distress Thermometer, EORTC and CQOLC
assessment tools are psychometrically sound measurement instruments capable
of detecting levels of quality of life and the presence of clinically significant
distress among individuals diagnosed with head and neck cancer and their
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caregivers. Further, the utilization of self-report techniques within the present
study has the advantage of deriving data from the individual centrally involved in
the phenomena. Perceptions of distress and quality of life are deeply personal
experiences and thus, the individual at the center of that experience can provide
the most meaningful and clinically relevant information. The use of data derived
from psychometrically sound self-report measures to identify distressing areas in
one’s life may allow for appropriate assistance and psychosocial intervention
when warranted. Thus, through the valid identification of distress, the potential to
improve quality of life and positively influence post-treatment outcomes may
emerge.
Summary of Problem
A diagnosis of head and neck cancer carries with it a unique set of
treatment-related challenges that influence physical function, social interaction
and emotional expression. As a result of the anatomic characteristics of the head
and neck region, treatment for head and neck cancer may result in deficits to
one’s physical appearance and varying degrees of dysfunction in respiration,
swallowing, and speech (Vartanian et al., 2004). Consequently, individuals may
experience substantial problems in family and social settings (Semple et al.,
2004). Not surprisingly, treatment of head and neck cancer has been associated
with some of the highest rates of anxiety, depression and suicide when
compared with other cancer sites (Bjordal & Kaasa, 1995; Kendal, 2006; Misono
et al., 2008). These findings suggest that head and neck cancer is highly
traumatic psychosocially with a multitude of complex patient concerns emerging.
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Relative to the caregiver experience, these individuals are expected to
support the physical, psychological, social and practical needs of their loved one,
while simultaneously grieving their own losses – both real and anticipated. They
must also work to maintain their regular family and employment-related
responsibilities, while balancing their fears, anxieties and concerns for the wellbeing of their loved one. Ultimately, the provision of care for an individual with
cancer may be a challenging, disruptive, and time-consuming endeavor (Williams
& Bakitas, 2012). Given the level of burden facing caregivers, it is not surprising
that multiple studies report higher levels of anxiety and depression in caregivers
than in the individuals with cancer (Mellon et al., 2006; Vickery et al., 2003).
Since the presence of elevated distress in caregivers has been identified as a
factor that may compromise both the physical health and psychological wellbeing of both caregivers and those with cancer (Hagedoorn et al., 2008;
Northouse et al., 2001), investigations into the factors which can influence
distress may inform our understanding of the caregiver experience.
Psychological distress related to cancer is a persistent and universal
concern that must be addressed in a clinically meaningful manner. Distress has
become so problematic that the Canadian Strategy for Cancer Control has
formally recognized it as the “sixth vital sign” (Rebalance Action Focus Group
[RAFG], 2005), implying that distress monitoring should be undertaken as
routinely as the monitoring of one’s heart rate or blood pressure. Despite this
acknowledgment, less than 10% of distressed individuals are identified and
referred to the appropriate psychosocial resources (Kadan-Lottick,
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Vanderwerker, Block, Zhang, & Prigerson, 2005). Failure to acknowledge and
treat elevated distress among individuals with head and neck cancer jeopardizes
treatment outcomes, decreases quality of life, and increases healthcare costs
(Zabora et al., 2001). Thus, in order to minimize the overall negative impact of
head and neck cancer and address the consequences resulting from decreased
quality of life and distress, efforts must be made to understand the presence of
and variation in distress and quality of life across both individuals with head and
neck cancer and their caregivers.
Both individuals with head and neck cancer and their caregivers
experience significant disruption in their lives as a result of the physical and
psychological impact of the disease and its treatment. Currently, there exists a
gap in the knowledge regarding how these individuals perceive this impact and
the meanings associated with these disruptions. Thus the identification of
distress and its potentially negative influence on quality of life is of paramount
importance. Perhaps best stated by Owen and colleagues (2001), “until a major
therapeutic breakthrough takes place reducing treatment morbidity, improving
patients overall quality of life and minimizing the psychosocial impact will be our
greatest challenge” (p.351). In order to attend to the psychosocial needs of
individuals with head and neck cancer and their caregivers, it is imperative to
develop an understanding of the life factors associated with elevated distress.
For this reason, instruments exploring the multidimensional factors related to
quality of life will be assessed in conjunction with validated measures of distress
and demographic information in an effort to identify and characterize the

46
relationship between distress and quality of life in both individuals with head and
neck cancer and their caregivers. With this information, healthcare practitioners
may be able to identify those individuals most at risk for distress and
subsequently recommend the appropriate psychosocial resources as required.
Thus, the purpose of the present study is to address the following objectives:
1. To assess perceived distress and quality of life in individuals with head
and neck cancer and their caregivers.
2. To explore the frequency of reported concerns (e.g., practical, physical,
psychosocial, spiritual, etc.) in individuals with head and neck cancer and
their caregivers.
3. To determine the relationship between distress and specific diseaseand/or treatment-related variables in caregivers of individuals with head
and neck cancer.
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Chapter 2
Distress and quality of life in individuals diagnosed with head and neck cancer: A
prospective, longitudinal analysis

Background
Head and neck cancer consists of a group of related malignancies that
arise in the skin, oral cavity, salivary glands, pharynx, larynx, nasal cavity and
paranasal sinuses (Walden & Aygun, 2013). Owing to the location of the disease,
individuals with head and neck cancer not only confront a potentially lifethreatening disease, but must also endure treatments which often cause
significant highly visible disfigurement and disruptions to essential functions such
as breathing, eating, swallowing, and speech (Doyle, 2005; Howren,
Christensen, Karnell, & Funk, 2012). Even prior to treatment and depending on
the primary site and extent of the disease, individuals may experience symptoms
that include hoarseness, difficulty swallowing, enlarged cervical lymph nodes,
nonhealing sores or ulcers in the mouth, ear pain, and/or nasal bleeding or
blockage (Marur & Forastiere, 2008). As a result of these symptoms and the
anatomical location of the disease, treatment considerations in head and neck
cancer are often complex with a high probability of debilitating consequences.
The delivery of current treatment options in head and neck oncology (e.g.,
surgery, radiation therapy, chemotherapy or a combination of multiple modalities)
may result in a wide range of head and neck-specific side effects including the
loss of taste and smell, decreased sensation, facial disfigurement, excessive dry
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mouth, sticky (or thick) saliva, and residual pain and swelling (List & Bilir, 2004).
Further, due to differences in the toxicity of treatment and the desire for organ
preservation, head and neck cancer and the consequences of its treatment may
present marked disability (List & Bilir, 2004), leaving nearly half of individuals with
the disease unable to return to work for extensive periods of time following
treatment, if at all (Shone & Yardley, 1991; Taylor et al., 2004). The treatment
and recovery process may be further complicated by additional factors such as
the presence of comorbidities (Paleri et al., 2010), continued use of tobacco and
alcohol (Danker et al., 2011; Duffy et al., 2002; Gritz et al., 1999), and
psychosocial concerns such as depression and poor social support which may
influence compliance with prescribed treatment plans (DiMatteo, Lepper, &
Croghan, 2000; McDonough, Boyd, Varvares, & Maves, 1996). Given these
myriad concerns and potential complications, coupled with the sheer visibility of
the disease and treatment sequelae, it is not surprising that researchers have
classified head and neck cancer as the most emotionally traumatic form of
cancer (Björklund, Sarvimäki, & Berg, 2010; Koster & Bergsma, 1990). This
acknowledgment of the psychological toll of head and neck cancer has led to an
increased emphasis in oncology research toward the evaluation and
consideration of an individual’s subjective concerns, including perceived distress,
throughout the continuum of care (Howren et al., 2012). Consequently,
explorations into the experience of distress in individuals with head and neck
cancer throughout the disease trajectory may provide valuable insight into the
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factors that have led to its designation as the most emotionally traumatic form of
cancer.
Concerns throughout the continuum of care
Receiving a diagnosis of cancer represents the initial phase of what is
termed the “continuum of care” in oncology. This continuum begins with the initial
diagnosis of a malignancy and then proceeds to treatment, rehabilitation (if
required) and then survivorship if the treatment has been successful, or palliation
and death if treatment has not served to eliminate the disease (Byock, 2000).
Because of the multidisciplinary nature of treatment for head and neck cancer
and the length of time that is often required to complete treatment protocols and
support long-term concerns, the continuum of care in head and neck cancer is
particularly complex (Sharp et al., 2002). Owing to this increased complexity, a
number of distinct head and neck-related concerns may arise at varying points in
time. In order to better understand these multidimensional concerns, it may be
useful to examine previous efforts to understand issues that arise over the period
of care.
Diagnosis. Upon receiving a diagnosis of malignancy, individuals enter
the initial phase of the care continuum. During this stage, individuals often find
themselves overwhelmed with fear, anxiety, and thoughts related to their
mortality (Ettema, Reminger, & Robbins, 2013). As they begin to interact with
members of their healthcare team, individuals may find that they are required to
absorb a vast amount of information and acquire new vocabulary related to their
disease and its treatment; it is often not until after the healthcare team has left
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the room and the reality of the diagnosis has set in, that individuals begin to
process the information provided to them and formulate questions (Penson,
2006). One’s initial response to receiving a diagnosis of head and neck cancer
may be characterized by denial, disbelief, or despair, and researchers have
reported that individuals may have difficulty making decisions and processing all
of the information conveyed to them, which may increase levels of anxiety
(Ettema et al., 2013). It is clear that the collective impact of a cancer diagnosis
and all the subsequent, often rapidly emerging events can be overwhelming to
the individual.
While most individuals will develop their own coping strategies to manage
their emotional responses, it is important to acknowledge that there is no “ideal”
way to cope (Ettema et al., 2013). The impact of receiving a diagnosis for head
and neck cancer can be devastating as individuals must address both the
physical and psychological consequences of the disease (Aarstad, Aarstad, Bru,
& Olofsson, 2005). Understandably, this is a time often marked by elevated
distress and anxiety (Singer et al., 2012), decreased energy, a worried outlook,
difficulty sleeping, pain (Whelan et al., 1997), and head and neck-specific
symptoms (Hammerlid et al., 2001). In addition to the potentially acute physical
concerns, for many individuals, receiving a diagnosis of cancer can create
substantial feelings of stress and worry (Johansson, Rydén, Ahlberg, & Finizia,
2012; Johansson, Rydén, & Finizia, 2008). In fact, a hazard ratio1 concerning the

1

A hazard ratio is a measure of how often a particular event happens in one group compared to
how often it happens in another group, in the context of time. A hazard ratio of one indicates that
there is no difference in survival between the two groups while a hazard ratio of greater than one
indicates that one group had better survival rates (National Cancer Institute; NCI, 2009).
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development of depressive symptoms in individuals with cancer was shown to be
3.5 times higher in those who were recently diagnosed with cancer when
compared to the general population (Polsky et al., 2005). Specific to head and
neck cancer, a prospective analysis determined that following diagnosis,
individuals reported elevated rates of depression, anxiety, anger, confusion, and
overall mood disturbance (Gritz et al., 1999). Ledeboer and colleagues (2005)
suggested that stress levels are likely to peak at the point of diagnosis
(Ledeboer, van der Velden, de Boer, Feenstra, & Pruyn, 2005), therefore,
receiving a diagnosis of cancer can be a traumatic experience, particularly when
the prognosis is guarded or unfavourable. Receiving the diagnosis may generate
anxiety and fears related to the uncertainty of what lies ahead, potentially painful
and debilitating treatments, and the potential loss of life. In consideration of these
factors, it is reasonable to suggest that the post-diagnostic period may be a time
marked by uncertainty, anxiety, and fear.
Treatment. Following the diagnostic work-up and treatment-planning
stage, individuals often proceed to treatment2. Research conducted by Wolff,
Leeper, Gratton, and Doyle (2004) advises that for some, the experience of head
and neck cancer treatment and its associated side effects can be more
devastating than the actual diagnosis of cancer itself. While not discounting the
sheer burden of receiving such a devastating diagnosis, Wolff and colleagues’
(2004) finding points to the overwhelming nature of the treatment and its side
effects. Side effects may include substantial changes to one’s physical
2

Based on the severity of disease and one’s personal goals and preferences, some individuals
may proceed directly to palliative care services or choose to forego medical treatment entirely.
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appearance and ability to verbally communicate resulting in changes to
perceived body image, self-esteem and self-concept (Doyle, 2005). Furthermore,
treatment of head and neck cancer has been associated with some of the highest
rates of anxiety, depression and suicide when compared with other cancer sites
(Bjordal, Kaasa, & Mastekaasa, 1995; Dropkin, 1986; Misono, Weiss, Fann,
Redman, & Yueh, 2008). These findings suggest that from a psychosocial
perspective, head and neck cancer is a highly complex and traumatic form of
illness with myriad concerns. As such, when treating an individual with head and
neck cancer it is imperative to consider the multidimensional needs of the
individual in an effort to address specific concerns and improve his or her overall
quality of life and well-being.
Research has shown that during treatment, quality of life in individuals
with head and neck cancer is compromised across a broad range of domains,
including physical (Bjordal et al., 2001), emotional, social, and role functioning
(Johansson et al., 2008). Perceptions of global, or overall, quality of life also have
been reported to be substantially compromised during this time (Johansson et
al., 2008). Relative to specific physical concerns during treatment, researchers
have noted that for those with head and neck cancer, physical concerns extend
beyond those generally associated with cancer such as pain, nausea, vomiting,
dyspnea (e.g., shortness of breath), constipation, diarrhea, decreased appetite,
sleep disturbances, fatigue and issues with sexuality (Johansson et al., 2008;
Ledeboer et al., 2005), to include additional challenges such as dysphagia (i.e.,
difficulty swallowing), odynophagia (i.e., painful swallowing), trismus (i.e., deficits
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in the ability to open the mouth), xerostomia (i.e., dry mouth), sticky (or thick)
saliva, facial weakness, drooling, limited shoulder mobility (a consequence of
neck dissection), dental issues, compromised ability to taste and smell, altered
voice and speech quality, and difficulties related to the airway such as breathing,
eating, laughing, and crying (Doyle, 1994; Eadie, 2007; Gritz et al., 1999;
Johansson et al., 2008; Ledeboer et al., 2005; Owen, Watkinson, Parcy, &
Glaholm, 2001). Additional work has noted that the side effects and problems
reported by individuals treated for head and neck cancer reach their peak shortly
after the completion of treatment (Hammerlid et al., 1997; Neilson et al., 2012).
Further, research has suggested that the type of treatment utilized (e.g., surgery,
chemotherapy, radiation therapy or a combination of therapies) may influence the
mental health of those with head and neck cancer (Singer et al., 2012), which is
understandable given that each treatment method has been associated with
significant acute side effects. For instance, radiation therapy may result in burns,
ulcers, bleeding, and mucositis (Trotti et al., 2003). Ultimately, the burden of
these added physical challenges may directly influence the psychological and
social dimensions of quality of life and contribute to increasing levels of overall
distress in some individuals.
Palliation. Unfortunately, when treatment efforts are unsuccessful or
when the cancer has progressed too far at the point of diagnosis, palliative care
may be offered to individuals in order to assist with end of life support. Palliative
care aims to reduce suffering and provide support and closure throughout the
final stages of an individual’s life (Lo, Quill, & Tulsky, 1999). Individuals with end
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stage head and neck cancer experience distinct problems related to the impact of
the tumour on the airway, the upper gastrointestinal tract, and the senses
(Forbes, 1997). Assessments of the most significant physical concerns in
individuals with head and neck cancer revealed fatigue, pain, weakness,
dysphagia, xerostomia, communication deficits, and trouble with short walks
outside, as most problematic during the palliative phase of care (Forbes, 1997;
Lokker et al., 2012). With regard to psychosocial concerns, individuals with head
and neck cancer reported worrying, sadness, tenseness, depressed mood, and
feelings of powerlessness as most frequent at end of life (Lokker et al., 2012).
These needs may be more pronounced in the palliative phase of care,
particularly if the individual is experiencing problems with communication as a
result of the disease or its treatment. As such, effective communication is vitally
important to ensure optimal quality of life as one approaches the end of his or her
life; not only does it permit communication of physical problems and
requirements (e.g., pain medication), but it also allows for expression of
emotions, intentions, and desires. Loss of the ability to communicate effectively
may exacerbate distress at this important time.
Survivorship. For the purposes of this research, survivorship is defined
as the “period in a cancer patient’s life, which is post treatment, separate from
diagnosis and treatment and from end-of-life care” (Twombly, 2004, p. 1415).
While the available treatments for head and neck cancer have increased the
length of time that individuals may experience as disease-free, cure rates have
not improved substantially over the last 50 years (Greene, Page, Fleming, Balch,
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& Fritz, 2002). Further, the consequences of the disease and its treatment may
be substantial. For instance, even after the successful completion of treatment,
daily tasks such as eating, breathing, speaking and swallowing may pose
significant difficulty for those treated for head and neck cancer. Consequently,
survivors of head and neck cancer may require extensive rehabilitative treatment
which may include swallowing rehabilitation, speech therapy, and dental and/or
maxillofacial rehabilitation, in addition to physical and occupational therapies
(Ward & van As-Brooks, 2007). As a result of these multifaceted challenges,
individuals may experience substantial problems within the context of social and
family settings and associated functioning (Semple, Sullivan, Dunwoody, &
Kernohan, 2004).
In light of these potential concerns, the survivorship phase of the
continuum of care highlights the importance of assisting individuals as they work
to adjust to potentially distressing disease- and treatment-related changes and
ongoing quality of life concerns. Irrespective of an individual’s position along the
continuum, the potential for elevated distress – and the negative sequelae
associated with it – exists throughout all phases of one’s cancer-related
experience. As such, investigations into the experience of distress throughout the
continuum of care may afford a deeper understanding of the factors that serve to
mitigate or exacerbate distress in these individuals.
Distress in individuals with head and neck cancer
The experience of distress, whether as subclinical depressive
symptomatology or as a full clinical depressive or anxiety disorder, is common
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among individuals with head and neck cancer and may arise throughout the
course of illness, and even persist months or years beyond the completion of
treatment in cancer survivors (Bjordal & Kaasa, 1995; Hutton & Williams, 2001;
Massie, 2004; Neilson et al., 2012). The source of this distress is likely
multifaceted and may be related to the diagnosis itself, the consequences of
disease- and treatment-related sequelae, declines in general quality of life,
and/or the potential for disease progression, recurrence, or death.
Notably, the presence of distress has been reported to be more prevalent
in head and neck cancer than in other types of cancer (Kendal, 2006; Massie,
2004; Misono, Weiss, Fann, Redman, & Yueh, 2008). While estimates seem to
vary depending on the method of assessment (i.e., diagnostic interview versus
self-report questionnaires) and the point in time, data indicate that across the
trajectory of illness, distress is present in approximately 15% to 58% of
individuals diagnosed with head and neck cancer (Bjordal & Kaasa, 1995; Chen
et al., 2009; Katz, Kopek, Waldron, Devins, & Tomlinson, 2004; Lydiatt, Moran, &
Burke, 2009; Neilson et al., 2012). Further, the presence of elevated distress in
individuals with head and neck cancer has been reported to influence
immunocompetence, wound healing, treatment compliance, self-care behaviour,
and social participation (DiMatteo et al., 2000; McDonough et al., 1996; Spiegel
& Giese-Davis, 2003). Distress in individuals with head and neck cancer may be
exacerbated by the fact that distress is often not reported to, nor recognized by,
healthcare team members (Pirl et al., 2007).
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Relative to the experience of distress in individuals with head and neck
cancer, research has yielded conflicting data. Specifically, researchers have
reported trends of increased distress over time (Couper et al., 2010; Neilson et
al., 2012; Wang, 2006), decreased distress over time (Carlson, Waller, Groff,
Giese-Davis, & Bultz, 2013; Neilson et al., 2012), and also the maintenance of
distress levels throughout the continuum of care (Akechi et al., 2006; Andreu et
al., 2012; Carlson et al., 2013). Specifically, a recent study of distress in oncology
found that over a one year period, some participants experienced a reduction in
distress whereas for others, the rate remained the same (Carlson et al., 2013).
Researchers noted that both demographic factors (e.g., not being married) and
treatment-related factors (e.g., undergoing radiation therapy) predicted persistent
distress, while the receipt of psychosocial support predicted its reduction
(Carlson et al., 2013). Additionally, the maintenance of distress rates over time
has been reported previously (Akechi et al., 2006; Andreu et al., 2012); whereas
other longitudinal studies have reported increased rates of distress over time in
individuals with breast, prostate, and lung cancer (Couper et al., 2010; Wang,
2006). It is of concern, however, that cross-sectional research conducted on
long-term (7-11 years) survivors of head and neck cancer has noted a high rate
of distress present in long-term survivors (e.g., 31% of study participants), which
is particularly problematic given that these individuals had completed the clinical
follow-up program, which was typically five years in length and, thus, they were
not being offered any form of support or psychological treatment (Bjordal &
Kaasa, 1995).
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Recent head and neck cancer-specific inquiries have reported similarly
varied results. For instance, researchers have reported elevated rates of distress
around the 3-week post-diagnostic mark, and declines to lower than baseline
levels in long-term (e.g., 18 months) follow-up (Neilson et al., 2012). Yet others
have reported opposite findings marked by a decline in distress following
discharge from the hospital when compared to baseline assessments, and
increases in distress to higher than baseline levels during a six-month follow-up
(Singer et al., 2012). Reasons for these differing patterns may be attributable to
characteristics of each study. For instance, work conducted by Neilson and
colleagues (2012) was limited to individuals treated with radiotherapy, which may
differ from the experiences of individuals treated with surgery, chemotherapy, or
a combination of approaches. Likewise, Singer and colleagues (2012) were
limited by both their research design (i.e. lack of standardized assessment
periods) and the length of time permitted for follow-up (e.g., six months). In order
to determine which factors may contribute to perceived distress and quality of life
in individuals with head and neck cancer, an examination of the areas currently
overlooked in distress-related literature may serve to highlight specific areas
worthy of further investigation.
Limitations to currently available research
Previous research focusing on distress in individuals with head and neck
cancer has been limited in a number of important ways. First, owing to the
heterogeneous nature of head and neck cancer and its treatment options, a
number of studies have opted to focus the scope of their research on one
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particular issue, such as the treatment type (Bjordal & Kaasa, 1995; Neilson et
al., 2012; Singer et al., 2012), disease site (Johansson, Rydén, & Finizia, 2011;
Kugaya et al., 2000), or phase along the continuum of care (Aarstad, Beisland, &
Aarstad, 2012; Bjordal & Kaasa, 1995; Buchmann, Conlee, Hunt, Agarwal, &
White, 2013; Elani & Allison, 2011; Horney et al., 2011; Hutton & Williams, 2001;
Johansson et al., 2011; Katz et al., 2004; Kugaya et al., 2000). In terms of
limitations based on treatment type, both Neilson and colleagues (2012) and
Bjordal and Kaasa (1995) limited their participant pools to those undergoing only
radiation therapy, while Singer et al. (2012) permitted those receiving radiation
and/or chemotherapy, but not surgery. Additionally, site-specific research
conducted to date has focused on either laryngeal cancer (Johansson et al.,
2011), or a combination of laryngeal, oral, and pharyngeal sites (Kugaya et al.,
2000). Relative to one’s position along the continuum of care in oncology, a few
studies centered on distress in newly diagnosed individuals (Buchmann et al.,
2013; Horney et al., 2011; Kugaya et al., 2000), while a richer body of literature
has examined survivorship concerns in those with head and neck cancer
(Aarstad et al., 2012; Bjordal & Kaasa, 1995; Elani & Allison, 2011; Hutton &
Williams, 2001; Johansson et al., 2011; Katz et al., 2004). While limiting the
criteria for inclusion in a study may permit a more focused approach to the
research findings, it also serves to limit the generalizability of findings.
Second, most studies investigating the issue of distress in individuals with
head and neck cancer employed a cross-sectional research design (Bjordal &
Kaasa, 1995; Bornbaum et al., 2012; Buchmann et al., 2013; Elani & Allison,
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2011; Horney et al., 2011; M. R. Katz et al., 2004; Kugaya et al., 2000; Pandey et
al., 2007; Verdonck-de Leeuw et al., 2007), which may fail to describe distress
and quality of life-related experiences relative to time or one’s progression
through the continuum of care.
Third, there are a number of commonly used exclusion criteria in
psychosocial oncology research that may serve to bias the results of the study
towards a lower degree of distress. For instance, several studies have purposely
excluded individuals with head and neck cancer who were not receiving
treatment with a curative intent (Elani & Allison, 2011; Horney et al., 2011; Katz
et al., 2004; Neilson et al., 2012; Pandey et al., 2007; Verdonck-de Leeuw et al.,
2007). This effort to limit the sample of participants to those with the potential for
cure may bias the data towards a healthier subset of individuals and thus, may
not accurately reflect the full range of distress and quality of life-related
experiences in individuals diagnosed with head and neck cancer.
Another common phenomenon in longitudinal oncology research is that
individuals are frequently excluded from participation if they experience a
recurrence or metastases of disease during the study (Aarstad et al., 2012;
Bjordal et al., 1999; Horney et al., 2011; Neilson et al., 2012). However,
exclusion of individuals during such a potentially distressing experience may
serve to bias the sample towards a lower rate of distress. It also limits our
understanding of how individuals react to and cope with these experiences.
Some longitudinal studies excluded participants if they failed to return one of the
data sets following a reminder call (Bjordal et al., 1999); this practice may not
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account for myriad factors including the possibility of hospitalization and/or
physical or psychological deterioration. Others have requested that participants
only return follow-up questionnaires if they did not experience new serious
disease (Beisland, Aarstad, Osthus, & Aarstad, 2013), which may fail to account
for concerns arising during recurrence. Some researchers have opted to not
include individuals who received “bad news” at follow-up appointments
(Verdonck-de Leeuw et al., 2007), while others excluded participants with
existing or previous psychological conditions (e.g., depression, anxiety) (Elani &
Allison, 2011). Exclusion criteria that serve to restrict the pool of potential
participants to only those who do not receive “bad news” at their appointments or
to those with no history of psychological morbidity, fail to acknowledge the
importance of identifying potential distress in these instances.
Distress-related research that purposely excludes individuals experiencing
a distressing life event (e.g., receipt of “bad news”, palliative phase of illness,
disease recurrence, metastases, etc.) or those that may be prone to experiencing
pathologic distress (e.g., those with a history of a psychological condition), fails to
provide a comprehensive perspective on the very factors which may both cause
and exacerbate distress. Collectively, these commonly applied exclusion criteria
may serve to bias the data towards a lower rate of distress. In consideration of
these existing practices, the present study was designed to broaden the range of
concerns and potentially distressing factors accounted for beyond the
parameters currently employed in longitudinal research in head and neck
psychosocial oncology. Further, in consideration of the noted limitations to the
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current literature, a number of specific objectives were developed for this
research investigation.
Study-specific research objectives
The purpose of the current investigation was to explore the experience of
distress in individuals with head and neck cancer at standardized three-month
intervals throughout the first year following diagnosis. We further aimed to
explore the pattern of commonly reported problems and perceptions of quality of
life in these individuals. In addition, we sought to enhance the current body of
literature to include considerations of individuals frequently excluded from
participation in psychosocial oncology research, including those who had
received “bad news”, were not receiving treatment for a curative intent, or
experienced disease recurrence or metastases.
Accordingly, a number of specific objectives for this inquiry were
developed: (1) to determine the presence and trajectory of distress in individuals
with head and neck cancer at standardized intervals (e.g., every three months)
throughout the first year following diagnosis; (2) to describe the pattern in
frequency of perceived problems (e.g., practical, familial, emotional, spiritual,
physical) reported among participants at the same intervals; and (3) to assess
global and disease-specific quality of life in participants over the same period.

Method
Participants
All participants (n = 102) involved in this research protocol were recruited
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by their physician at the London Regional Cancer Program (LRCP) at the London
Health Sciences Centre, Victoria Campus, located in London, Ontario. This
sample may be considered as a sample of convenience based on the willingness
of individuals to participate following a request by their physician and subsequent
follow up by a member of the research team (C.B.). Prior to undertaking this
study, the Ethics Review Board at The University of Western Ontario approved
this protocol; Approval # 18283E (see Appendix A).
Inclusion criteria. Participants were required to be at least 18 years of
age and able to provide informed consent (i.e., no known cognitive impairments).
They also must have received a diagnosis for a primary malignancy of the head
and neck region. At the time of enrollment, individuals were required to be
between zero and one month post-diagnosis and could not have commenced
treatment.
Exclusion criteria. If individuals were unable to read, write or understand
English or if they were unable to visually see the questionnaires they were
excluded since the tasks involved in this study required participants to read and
understand the questionnaires in English, and respond to questions accordingly.
In total, 175 individuals were identified as potential participants. Of these
potential participants, 20 declined to participate while 155 individuals expressed
interest in taking part in the study. Reasons identified for the 20 individuals who
did not desire to participate included: too upset (n = 8), not interested (n = 5), too
ill (n = 3), not enough time (n = 2), too angry (n = 1), and too many other healthrelated concerns (n = 1). In total, 155 packages containing the letter of
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information and consent, the demographic questionnaire, and the research
instruments were disseminated.
The age of participants taking part in this study ranged from 23 years to 92
years (mean age 63.75, SD = 12.55). In total, the 71 male (mean age = 65.25
years, SD = 12.41) and 31 female participants (mean age = 60.33 years, SD =
12.39) resulted in a male-to-female ratio of approximately 2.3:1. Comprehensive
demographic data for the participants are presented in Table 2.1, while the
disease- and treatment-related data are presented in Table 2.2.
In addition, data pertaining to the status of alcohol and tobacco use (e.g.,
currently used, formerly used, never used) were collected throughout the first
year following diagnosis. The percentage of participants actively using tobacco
decreased throughout the first year from 13.3% at diagnosis, to 12.9% at threemonths, 13.1% at six-months, 6.4% at nine-months, before increasing to 10.0%
of participants at 12-months. Similarly, the percentage of participants actively
consuming alcohol also declined throughout the first year from 53.3% at
diagnosis, to 45.7% at three-months, 42.6% at six-months, 40.4% at nine-months
post-diagnosis, with an increase to 50.0% of participants at 12-months. Further, if
participants confirmed the active use of alcohol or tobacco products, they were
asked to specify what quantity of each product was consumed in an average
week. Regarding tobacco, participants decreased their mean cigarette pack use
by 0.94 packs per week, while alcohol consumption decreased by a mean of 5.38
beverages per week by the 12-month assessment.
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Table 2.1
Demographic Data of Individuals Diagnosed with Head and Neck Cancer
Variable
Sex
Male
Female
Marital status
Married/common-law
Separated/divorced/widowed/single
Unspecified
Education
Completed post-secondary education or training
Completed high school
Completed some of/less than high school
Unspecified
Occupational status
Retired
Working full-time
On disability/sick leave
Working part-time
Student
Unemployed/stay at home
Unspecified
Household income
≤ $25,000
$25,001 - $40,000
$40,001 - $55,000
$55,001 - $70,000
$70,001 - $85,000
> $85,000
Unspecified

n

%

71
31

69.6
30.4

66
21
15

64.7
20.6
14.7

33
29
16
24

32.4
28.4
15.7
23.5

39
28
15
4
2
1
13

38.2
27.5
14.7
3.9
1.4
0.7
12.7

7
10
5
7
8
14
51

6.9
9.8
4.9
6.9
7.8
13.7
50.0
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Table 2.2
Disease- and Treatment-Related Data for Individuals with Head and Neck
Cancer
Variable
Site of cancer
Oral cavity
Oropharynx
Multiple sites
Larynx
Ear
Nasal cavity and paranasal sinuses
Salivary glands
Neck
Unknown primary
Hypopharynx
Scalp
Nasopharynx
Tumour stage of disease
T1
T2
T3
T4
Unspecified
Treatment type
Chemotherapy and radiation therapy
Surgery
Surgery and radiation therapy
Radiation therapy
Surgery, chemotherapy and radiation therapy
Surgery and chemotherapy
No treatment

n

%

31
24
14
9
7
4
3
3
3
2
1
1

30.4
23.5
13.7
8.8
6.9
3.9
2.9
2.9
2.9
2.0
1.0
1.0

22
24
20
25
11

21.6
23.5
19.6
24.5
10.8

35
24
17
13
11
1
1

34.3
23.5
16.7
12.7
10.8
1.0
1.0

Note. Data pertaining to pathological site of cancer are organized and reported according to the
current standards set by the American Joint Committee on Cancer and endorsed by the American
Academy of Otolaryngology – Head and Neck Surgery (Deschler & Day, 2008).
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Procedure
Data collection. All individuals who consented received a package
containing a letter of information and consent (see Appendix C), a demographic
questionnaire (see Appendix E), the Distress Thermometer and accompanying
Problem Checklist (see Appendix I), the EORTC general quality of life
assessment tool (EORTC-QLQ-C30) (see Appendix G), the EORTC head and
neck cancer specific quality of life assessment tool (EORTC-QLQ-H&N35) (see
Appendix H), a list with the contact information for local psychological support
services (see Appendix K), and a self-addressed and prepaid return envelope to
ensure that participants did not incur any undue financial burden for their
participation.
The letter of information informed the participant of the general purpose of
the study, the risks and benefits associated with participating in the study, and
also notified them that they were under no obligation to complete the
questionnaires nor would they suffer any consequences for declining to
participate. If an individual agreed to participate in the study, they were assigned
a coded participant number at the outset and were assured that they would not
be personally identified in any way other than by the primary researcher (C.B.)
and her supervisor (P.D.). In compliance with ethical requirements, informed
consent was indicated by the voluntary completion and return of the
questionnaire to the researcher. This procedure of obtaining consent was
explicitly stated in the letter of information. If any of the questionnaires were not
completed in entirety with sufficient data to compute statistical analysis as per the
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requirements specified in the standardized scoring and procedures manual for
each questionnaire, they were destroyed and excluded from further data
analysis.
Sample size calculations. Sample size calculations were calculated
using Horatio Software (Version 3.0a) (Lee, 2004) to determine the number of
participants required to obtain adequate statistical power. It was determined that
“a total sample size (n) of 14 individuals would be sufficient to detect the
hypothesized effect (r2 = 0.12) of a five-level within-subject independent variable
81.9 percent of the time using a 0.05 alpha level and assuming a within-subject
correlation of 0.30” (Lee, 2004). Despite this modest number of required
participants, it was determined that a total of up to 175 individuals would be
invited to participate in the study in order to account for potential attrition among
participants. The decision to increase our proposed number of participants
beyond the recommended sample size was informed by previous longitudinal
designs in head and neck oncology populations, which have noted significant
attrition rates as high as 78.5% in one study (Mehanna & Morton, 2006) and 66%
in another (Kelly, Paleri, Downs, & Shah, 2007). As expected in an oncology
population, significant rates of attrition have been attributed to the death of
participants and/or substantial declines in physical condition (Abendstein et al.,
2006; Bjordal & Kaasa, 1995; Bjordal, Kaasa, & Mastekaasa, 1994; Kelly et al.,
2007; Mehanna & Morton, 2006). Collectively, these factors contributed to the
decision to increase the number of participants that would be recruited in order to
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ensure that the study would have enough participants to be sufficiently powered
statistically.
Measurement instruments. The measurement instruments utilized in this
study included: (1) the Distress Thermometer and accompanying Problem
Checklist to assess distress and perceived problems (NCCN, 2010), (2) the
EORTC global quality of life measure (EORTC-QLQ-C30) (Aaronson et al., 1993;
Fayers et al., 2001) and (3) the EORTC head and neck quality of life module
(EORTC-QLQ-H&N35) (Fayers et al., 2001), and (4) a demographic
questionnaire to assess both personal demographic information and diseaseand treatment-related characteristics of those with head and neck cancer. The
order of the Distress Thermometer and EORTC questionnaires was randomly
assigned as per predetermined stapling of the instruments (e.g., half of the
packages provided the Distress Thermometer first, while the other half offered
the EORTC measures first). This procedure of organizing the order of the
instruments was conducted in an effort to reduce any potential response bias due
to the influence of exposure to the preceding measure. Participants were
instructed to complete each questionnaire as per the enclosed instructions
provided on the measures themselves (e.g., the Distress Thermometer and
EORTC measures) in a location of their choosing (i.e., home or private office).
Additional pages were provided for participants to include any additional
information that they felt was pertinent to the research topic (i.e., any concerns or
life events that could serve as confounding factors influencing their distress or
quality or life at the time of the survey). It was estimated that the completion of all
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tasks would take 15-20 minutes. Within the packages distributed to all
participants, the demographic items appeared first since they were simple and
uncomplicated and helped transition the participant into answering the more
sensitive items that followed in the accompanying distress- and quality of liferelated questionnaires (Portney & Watkins, 2009).
Demographic and disease-related information. Demographic items
consisted of the participant’s age, sex, marital status, occupational status,
highest level of education obtained, and approximate household income. Relative
to the disease- and treatment-related characteristics, items for which data were
collected included the length of time since diagnosis, the specific site of the
malignancy (e.g., larynx, oral cavity, etc.), the pathological tumour stage of the
disease, the type of treatment received, the status of treatment (e.g., awaiting,
undergoing, completed, etc.), and whether or not the individual had experienced
a recurrence of the disease. Data pertaining to the use of alcohol and tobacco
products were also collected.
Data analysis
Raw data were analyzed using SPSS Statistics 20.0 for Macintosh (IBM,
2011). Descriptive data for continuous scale items and scales (e.g., Distress
Thermometer and EORTC measures) were presented through mean scores
while descriptive information for categorical data were presented with
frequencies and percentage values of subgroups (e.g., demographic, disease-,
and treatment-related variables). Given that the research design for this study
was prospective and longitudinal in nature, the possibility that participants may
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not return all questionnaire packages had to be accounted for. Thus, if a
participant failed to return a questionnaire package for a particular point of data
collection, they were still invited to complete and return subsequent data
packages. This decision was made in an effort to ensure the most complete data
set possible while also accounting for potential confounding factors which may
not permit a participant to return all data packages (e.g., hospitalization, too ill
from the disease or effects of treatment, etc.). Additionally, an a priori alpha level
of p ≤ 0.05 was used for statistical tests.
Descriptive statistics. Descriptive statistics (e.g., means, standard
deviations, frequency distributions, histograms, etc.) were calculated where
applicable for demographic data, treatment- and disease-related variables, and
the global and specific domains of each questionnaire (e.g., Distress
Thermometer, EORTC-QLQ-C30, EORTC-QLQ-H&N35). These analyses were
conducted in order to evaluate the normality of the sample and assess whether
parametric statistics would be appropriate for statistical analyses.
Objective one: Presence of distress. The presence of clinically
significant distress was identified based on a Distress Thermometer score of ≥ 4
in accordance with the recommendations of the National Comprehensive Cancer
Network (NCCN) (2013). In order to determine if parametric statistics would be
appropriate to use in the present analysis of distress, applicable histograms and
the Kolmogorov-Smirnov test of normality for Distress Thermometer data were
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analyzed3. Given that distress was evaluated by a continuous measure (e.g.,
Distress Thermometer) that was distributed to participants at five standardized
time points, a repeated measures analysis of variance (ANOVA) was utilized to
assess the relationship between the variables (e.g., distress and time). However,
in an effort to maintain statistical rigor, only those participants who returned all
data packages were included in the repeated measures analyses. In addition, the
magnitude of effect for length of time since diagnosis on level of distress was
determined through calculation of Eta Squared4 (Pallant, 2011). Effect sizes were
interpreted according to the guidelines proposed by Cohen (1988): 0.01
represented a small effect, 0.06 denoted a moderate effect, and 0.14 indicated a
large effect (p.284-7).
Despite the strict criteria of repeated measures analyses, all participant
data (regardless of the number of questionnaire packages returned) were
included in analysis of distress presence detected at each standardized interval.
Specifically, the number of cases of distress (defined by a Distress Thermometer
score of ≥ 4) were divided by the total number of respondents in order to
determine the percentage of participants at each assessment point who
experienced clinically significant distress.
Relative to anticipated outcomes, it was hypothesized that the presence of
distress detected within this sample would be highest at the point of diagnosis

3

The Kolmogorov-Smirnov test evaluates whether a distribution of scores is significantly different
from a normal distribution; a statistically significant value indicates a deviation from normality
(Field, 2009).
4
Eta Squared is an effect size statistic that ranges from zero to one and “represents the
proportion of variance in the dependent variable that is explained by the independent (group)
variable” (Pallant, 2011, p.242).
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and shortly following treatment (e.g., at the post-diagnostic and three-month
assessment points) (Hammerlid et al., 1997; Ledeboer et al., 2005; Neilson et al.,
2012). Further, in terms of the pattern of distress, it was anticipated that the
severity of distress would also peak at the point of diagnosis and shortly following
treatment before gradually declining in longer-term follow up (Neilson et al.,
2012).
Objective two: Perceived problems. Perceived problems were assessed
through use of the Problem Checklist which accompanies the Distress
Thermometer (NCCN, 2013). The specific subdomains of the Problem Checklist
include practical, familial, emotional, spiritual/religious, and physical problems.
Frequency data were presented for each subdomain at standardized three-month
intervals in an effort to explore the most commonly reported concerns among
participants. Given the potential for substantial physical impairment related to
both head and neck cancer and its treatment, it was hypothesized that physical
problems (e.g., pain, fatigue, nausea, mouth sores, etc.) would be the most
frequently reported concerns among participants at each time interval.
Objective three: Global and head and neck cancer-specific quality of
life. We sought to descriptively compare the mean differences in EORTC scores
for each component of quality of life between participants at each time interval.
All participant data (regardless of the number of questionnaire packages
returned) were included in the analyses at each standardized interval.
Furthermore, we compared the level of mean change between baseline
assessments of quality of life with mean scores reported at both the three-month
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and 12-month assessments in order to determine if any clinically significant
differences had occurred.
In order to facilitate the interpretation of results, clinically significant
differences in quality of life data were assessed. Clinical significance is denoted
by the practical implications of the differences relative to the impact on an
individual’s health or well-being (Hammerlid et al., 2001). Clinical significance
data provide important information relative to the interpretation of clinically
meaningful differences between groups, or in the present case, points in time
following diagnosis. Specifically, score changes of 10 points or greater indicated
a clinically significant difference (Aaronson et al., 1993).
Based on previous findings in the literature, it was hypothesized that
symptom burden would peak during and just after treatment (i.e., around the
three-month post-diagnostic mark for most individuals) (Bjordal et al., 2001;
Hammerlid et al., 1997), with a slow recovery process where most symptoms and
quality of life-related concerns level off around 12-months following diagnosis
(Bjordal et al., 2001). It was anticipated that role functioning would decline
significantly shortly following treatment, but return to near baseline levels by the
12-month follow-up; emotional functioning was anticipated to be lowest at the
point of diagnosis and increase slightly throughout time (Bjordal et al., 2001). The
remaining functional domains (e.g., social, cognitive) were not anticipated to
change in a clinically significant manner (Bjordal et al., 2001).
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Results
Response rate. Overall, 65.8% of individuals (n = 102) completed and
returned at least one questionnaire throughout the 12-month data collection
period. Notably, 12.1% of participants (n = 17) returned all five data packages.
Comprehensive data pertaining to the individual response rates for each
standardized time interval is presented in Table 2.3.
Additionally, in an effort to enhance the current body of literature beyond
the existing body of exclusion criteria, this study included participants who had
developed metastases (n = 3), were not being treated with a curative intent (n =
2), experienced a recurrence of disease (n = 1), discontinued treatment prior to
completion due to complications (n = 1), and had a pre-existing psychological
disorder (e.g., depression) (n = 1).
Furthermore, a subset of the 155 potential participants (n = 7) opted to
withdraw from the study: two withdrew after returning the three-month follow-up
package, three withdrew after the six-month assessment, and two withdrew after
the nine-month assessment. Reasons for withdrawal from the study were only
provided by two participants; one noted that she was too ill to continue while the
other reported that his treatment had not been successful and no longer wished
to participate. In addition, seven individuals died during the course of the study.
Notably, participants who completed all questionnaires in the study did not differ
from participants who did not complete all components of the study in terms of
distress when measured at both baseline (t(73) = -1.80, p = 0.076) and 12months (t(28) = -0.482, p = 0.633) post-diagnosis.
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Table 2.3
Response Rate Data for Individuals Diagnosed with Head and Neck Cancer
Point of
assessment
Withdrawals
(n)
Deceased
(n)
Maximum
possible
participants
(n)
Total
responses
(n)
Response
rate (%)

Diagnosis

3-month

6-month

9-month

12-month

Total

0

0

2

3

2

7

2

1

4

0

0

7

153

152

146

143

141

155

75

70

61

47

30

102

49.0

46.1

41.8

32.9

21.3

65.8

Note. The column of total values represents a summary of participant response rate data for the
entire study. As a result, data in this column may not represent a summative value of the data
contained in the corresponding row.
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Data analysis
Objective one: Presence of distress. Based on a Distress Thermometer
score of ≥ 4 (NCCN, 2013), clinically significant distress was identified in 35 of 75
individuals (46.7%) immediately following diagnosis, in 29 of 70 individuals
(41.4%) three months following diagnosis, in 19 of 61 individuals (31.2%) six
months following diagnosis, in 10 of 47 individuals (21.3%) nine months following
diagnosis, and in 10 of 30 individuals (33.3%) one year following diagnosis of
head and neck cancer. In addition, when the frequency of Distress Thermometer
scores was examined at each time point (see Figure 2.1), it was apparent that
while Distress Thermometer scores of zero were most frequently reported by
participants, that a diverse range of higher scores were also reported by
participants at each time interval.
In addition, statistical tests evaluating the parametric nature of data
revealed that none of the Kolmogorov-Smirnov statistic values for Distress
Thermometer scores were found to be statistically significant (e.g., postdiagnosis, p = 0.200; three-month, p = 0.178; six-month, p = 0.200; nine-month, p
= 0.186; 12-month, p = 0.052). These Kolmogorov-Smirnov findings, taken in
conjunction with the relatively normal distributions of data evident in the
histograms of Distress Thermometer data (see Appendix L), indicated that
parametric statistics were appropriate to assess the trajectory of distress in this
participant sample. Consequently, a repeated measures ANOVA was employed
for temporal-based statistical analysis.
A one-way repeated measures ANOVA was conducted to compare scores
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25

Number of participants (n)

20
DT 0
DT 1
DT 2

15

DT 3
DT 4
DT 5

10

DT 6
DT 7
DT 8
DT 9

5

DT 10

0
At diagnosis

3 month
6 month
9 month
Follow-up time interval (months)

12 month

Figure 2.1. Frequency of Distress Thermometer Scores at Each Assessment
Point for All Participants (n = 102)
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on the Distress Thermometer at the point of diagnosis, and the three-, six-, nine-,
and 12-month follow-up assessments. The means and standard deviations of the
data included in the repeated measures analysis are presented in Table 2.4.
Findings related to Mauchly’s test5 indicated that the assumption of sphericity
had been violated 2(9) = 20.34, p = 0.017, thus, degrees of freedom were
corrected using the Greenhouse-Geisser estimate of sphericity (Epsilon;  =
0.72) (Field, 2009). Results from the repeated measures ANOVA indicated that
there was a significant effect of time on distress, F (2.87, 40.19) = 4.11, p = 0.01,
Multivariate Partial Eta Squared = 0.45. Notably, when the F-statistic from the
present analysis (F = 4.11) was compared with the critical value6 for the Fdistribution (FCritical = 2.83) (Field, 2009), it was determined to be greater than the
critical value, thus indicating that the length of time since diagnosis did influence
perceived distress. Further, when the magnitude of effect (Multivariate Partial Eta
Squared = 0.45) was evaluated according to the guidelines for effect size
(Cohen, 1988), it was apparent that the length of time since diagnosis
demonstrated a very large effect on the perceived level of distress.
Since an F-ratio is an omnibus test, post-hoc tests were required in order to
determine specifically which time point(s) significantly influenced the perceived
level of distress in individuals with head and neck cancer. Consequently, pairwise

5

Mauchly’s test evaluates the hypothesis that the variances of the differences between time
points are equal. Therefore, if Mauchly’s test is significant it indicates that there are significant
differences between the variances of differences, and thus the condition of sphericity (i.e. the
equality of variances of the differences between time intervals) is not met (Field, 2009).
6
The critical value is the number that a test statistic must exceed in order to reject the null
hypothesis (Field, 2009).
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Table 2.4
Descriptive Statistics for Distress Thermometer Scores for Individuals Diagnosed
with Head and Neck Cancer throughout the First Year Following Diagnosis Who
Returned all Packages
Assessment time

n

Distress

Mean Distress

Thermometer Score

Thermometer Score

SD

≥ 4 (n)
At diagnosis

17

13

5.27

2.79

3-month follow-up

17

8

3.07

1.98

6-month follow-up

17

7

3.80

2.96

9-month follow-up

17

5

2.67

2.66

12-month follow-up

17

6

3.07

3.04
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comparisons7 of Distress Thermometer scores were conducted. Since multiple
comparisons were conducted, a Bonferroni correction was applied to the alpha
level in order to control the overall Type I error rate (Field, 2009). Interestingly,
only the nine-month follow-up assessment demonstrated a statistically significant
improvement from baseline (e.g., at diagnosis) Distress Thermometer scores (p =
0.05). No other statistically significant differences were detected between the
assessment times.
With respect to the specific trajectories of distress evident in those
participants who returned all data packages (n = 17), a number of specific
patterns of distress emerged (see Figure 2.2). Specifically, several participants
initially noted high levels of distress, which gradually decreased with time (n = 6;
see P1-P6 in Figure 2.2). Other participants reported elevated distress following
diagnosis with a decline following treatment and subsequent increase at long
term follow-up (n = 3; P7, P9, P15). Some participants reported low levels of
distress during both the initial and long-term (e.g., 12-month) follow-up
assessments, but noted a peak in distress following treatment (n = 2; P10, P11),
while others noted consistently low levels of distress throughout the entire
trajectory (n = 2; P12, P13). Conversely, a number of participants reported
persistently high levels of distress throughout the entire trajectory of assessment
(n = 3; P8, P14, P16). One additional participant reported generally low levels of
distress with two peaks of distress at both the diagnostic and six-month follow-up
points (n = 1; P17).

7

Pairwise comparisons are comparisons of pairs of the mean values for scores at each interval of
time (Field, 2009).
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9

P1
P2

Distress Thermometer score

8

P3
P4

7

P5
P6

6

P7
P8

5

P9
4

P10
P11

3

P12
P13

2

P14
P15

1

P16
0

P17
At diagnosis

3 month
6 month
9 month
Time since diagnosis

12 month

Figure 2.2. Trajectory of Distress via Distress Thermometer Data for Participants
Who Returned Data at All Assessment Points (n = 17)

95
Objective two: Perceived problems. Perceived problems were assessed
through use of the Problem Checklist (NCCN, 2013) and organized into five
subdomains (practical, familial, emotional, spiritual/religious, and physical).
Notably, participants cited emotional and physical problems frequently at all time
intervals. In particular, worry was reported as the most commonly cited emotional
problem with 58.7% of participants reporting it at diagnosis. Reports of
problematic worry declined to 38.6% at three-months, and 32.8% at six-months
before increasing to 36.2% at nine-months and 40.0% at 12-months. Most of the
other emotional problems (e.g., depression, fears, nervousness) displayed a
similar pattern of peaked frequency at diagnosis and one-year follow-up. Relative
to physical concerns, problems with eating, fatigue and sleep presented ongoing
challenges for participants. Comprehensive data pertaining to the frequency of
reported problems on the Problem Checklist are presented in Table 2.5
Objective three: Global and head and neck cancer-specific quality of
life. Clinically significant change was evaluated at three- and 12-months
following baseline assessments at diagnosis. Clinically significant differences in
quality of life scores were defined by a difference in EORTC scores of greater
than or equal to 10 points (Aaronson et al., 1993; Osoba et al., 1998).
Comprehensive data pertaining to the quality of life scores among participants
throughout the three-month standardized intervals are presented in Table 2.6.
With regard to the general quality of life measure (e.g., EORTC-QLQ-C30), a
clinically significant decline in role functioning was detected at the three-month
follow-up, but appeared to resolve by the 12-month follow-up when compared to
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Table 2.5
Problem Checklist Data for Individuals Diagnosed with Head and Neck Cancer
throughout the First Year Following Diagnosis
Variable

At diagnosis
n (%)
75

3 month
n (%)
70

6 month
n (%)
61

9 month
n (%)
47

12 month
n (%)
30

n
Practical problems
Child care
1 (1.3)
1 (1.3)
0 (0.0)
0 (0.0)
0 (0.0)
Housing
1 (1.3)
3 (4.3)
5 (8.2)
1 (2.1)
3 (10.0)
Insurance/Financial
13 (17.3)
9 (12.9)
7 (11.5)
7 (14.9)
4 (13.3)
Transportation
8 (10.7) 10 (14.3)
5 (8.2)
2 (4.3)
2 (6.7)
Work/School
10 (13.3)
5 (7.1)
4 (6.6)
2 (4.3)
3 (10.0)
Family problems
Dealing with children
8 (10.7)
0 (0.0)
1 (1.6)
0 (0.0)
1 (3.3)
Dealing with partner
7 (9.3)
6 (8.6)
4 (6.6)
5 (10.6)
4 (13.3)
Emotional problems
Depression
25 (33.3) 21 (30.0) 15 (24.6)
7 (14.9)
5 (16.7)
Fears
32 (42.7) 21 (30.0) 11 (18.0) 11 (23.4)
9 (30.0)
Nervousness
32 (42.7) 17 (24.3) 14 (23.0) 11 (23.4)
9 (30.0)
Sadness
20 (26.7) 24 (34.3) 13 (21.3)
8 (17.0)
8 (26.7)
Worry
44 (58.7) 27 (38.6) 20 (32.8) 17 (36.2) 12 (40.0)
Loss of interest in usual
activities
20 (26.7) 21 (30.0) 19 (31.2)
9 (19.2)
6 (20.0)
Spiritual/religious problems
Spiritual/religious
7 (9.3)
3 (4.3)
3 (4.9)
1 (2.1)
3 (10.0)
Physical problems
Appearance
19 (25.3) 24 (34.3) 14 (23.0)
9 (19.2)
9 (30.0)
Bathing/dressing
6 (8.0)
3 (4.3)
4 (6.6)
0 (0.0)
1 (3.3)
Breathing
14 (18.7) 11 (15.7) 11 (18.0)
2 (4.3)
4 (13.3)
Changes in urination
3 (4.0)
7 (10.0)
6 (9.8)
4 (8.5)
3 (10.0)
Constipation
14 (18.7) 14 (20.0) 12 (19.7)
4 (8.5)
6 (20.0)
Diarrhea
10 (13.3) 10 (14.3)
6 (9.8)
2 (4.3)
2 (6.7)
Eating
30 (40.0) 35 (50.0) 20 (32.8) 16 (34.0) 10 (33.3)
Fatigue
36 (48.0) 34 (48.6) 18 (29.5) 17 (36.2) 12 (40.0)
Feeling swollen
14 (18.7) 14 (20.0) 10 (16.4)
9 (19.2)
8 (26.7)
Fevers
2 (2.7)
3 (4.3)
4 (6.6)
1 (2.1)
0 (0.0)
Getting around
7 (9.3) 14 (20.0)
9 (14.8)
1 (2.1)
4 (13.3)
Indigestion
10 (13.3)
8 (11.4) 10 (16.4)
5 (10.6)
5 (16.7)
Mouth sores
18 (24.0) 24 (34.3) 10 (16.4)
5 (10.6)
3 (10.0)
Nausea
10 (13.3) 14 (20.0)
7 (11.5)
5 (10.6)
4 (13.3)
Nose dry/congestion
18 (24.0) 29 (41.4) 15 (24.6) 11 (23.4)
9 (30.0)
Pain
33 (44.0) 29 (41.4) 19 (31.2) 10 (21.3) 10 (33.3)
Sexual
14 (18.7) 15 (21.4) 11 (18.0)
6 (12.8)
2 (6.7)
Skin dry/itchy
18 (24.0) 26 (36.6) 19 (31.2) 16 (34.0) 11 (36.7)
Sleep
41 (54.7) 23 (32.9) 19 (31.2)
8 (17.0)
7 (23.3)
Tingling in hands/feet
13 (17.3) 13 (18.6) 15 (24.6)
9 (19.2) 11 (36.7)
Note. n = number of patients at each assessment point (some did not return all questionnaires).
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Table 2.6
EORTC Quality of Life Mean Score Data for Individuals Diagnosed with Head
and Neck Cancer throughout the First Year Following Diagnosis
Variable

At
diagnosis
75

3
month
70

6
month
61

9
month
47

12
month
30

03
month ∆
---

0  12
month ∆
---

n
EORTC QLQ-C30
Global health status
64.04
56.57
59.84
68.97
63.89
-7.47
+0.15
Functioning scales
Physical functioning
80.27
73.90
72.51
83.12
81.72
-6.37
+1.45
Role functioning
72.52
60.33
66.80
79.79
75.81
-12.19*
+3.29
Emotional functioning
69.41
74.30
73.57
79.61
77.15
+4.89
+7.74
Cognitive functioning
80.82
77.93
80.46
85.11
81.18
-2.89
+0.36
Social functioning
72.83
65.96
67.62
79.08
77.69
-6.87
+4.86
Symptom scale/single items
Fatigue scale
33.93
41.63
39.44
28.37
32.97
-7.70
-0.96
Nausea/vomiting scale
7.88
17.84
7.79
4.07
11.83
-9.96
+3.95
Pain scale
26.58
28.05
23.77
19.86
24.73
-1.47
+1.85
Dyspnea
13.96
17.84
19.67
13.12
16.13
-3.88
+2.17
Insomnia
39.19
29.11
30.60
17.73
23.66
+10.08*
-15.53*
Appetite loss
22.52
39.44
28.96
25.53
25.81
-16.92*
-3.29
Constipation
14.86
17.37
16.94
9.93
13.98
-2.51
-0.88
Diarrhea
5.02
10.80
6.01
3.55
4.30
-5.78
-0.72
Financial difficulties
17.81
19.48
21.86
15.60
13.98
-1.67
-3.83
EORTC QLQ-H&N35
Pain scale
27.14
29.11
21.72
17.91
15.32
-1.97 +11.82*
Swallowing scale
18.58
26.64
22.61
18.62
17.75
-8.06
+0.83
Senses scale
18.02
32.04
37.16
31.38
33.33
-14.02*
-15.31*
Speech scale
20.87
24.33
22.13
17.02
17.92
-3.46
-2.95
Social eating scale
23.20
31.92
28.42
21.16
25.00
-8.72
+1.80
Social contact scale
14.68
18.22
16.12
14.26
15.05
-3.54
+0.37
Sexuality scale
26.58
33.80
37.16
24.61
33.32
-7.22
+6.74
Teeth problems
16.67
15.49
21.86
13.48
22.58
+1.18
+5.91
Opening mouth
17.12
27.70
20.77
13.48
24.73
-10.58*
+7.61
Dry mouth
31.53
41.31
54.64
49.65
47.31
-9.78
-15.78*
Sticky saliva
29.28
48.36
52.19
46.81
36.56
-19.08*
+7.28
Coughing
30.59
39.20
27.05
26.95
21.47
-8.61
-9.12
Feeling ill
15.77
23.00
13.11
4.96
13.98
-7.23
-1.79
Pain killers
56.76
43.66
42.62
36.88
48.39
+13.10*
+8.37
Nutritional
41.89
56.34
52.46
36.17
51.61
-14.45*
+9.72
supplementation
Feeding tube
5.41
14.08
11.48
12.77
12.90
-8.67
-7.49
Weight loss
31.08
42.25
31.15
19.15
32.26
-11.17*
+1.18
Weight gain
14.86
22.54
29.51
21.28
25.81
-7.68 +10.95*
Note. n = number of patients at each assessment point (some did not return all questionnaires).
a
High score on function scales and the global quality of life scale imply high function.
b
High score on symptom scales/single items imply high level of perceived problems.
c
∆ = mean individual change over time (∆ ≥ 10 = clinical significance).
d
+ = improved function or reduced level of symptoms over time.
e
- = deteriorated function or increased level of symptoms over time.
* = clinically significant difference.
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baseline values. Further, a clinically significant increase in symptom burden
between baseline and three-month assessment scores was reported for loss of
appetite, while a clinically significant reduction in symptom burden was observed
for insomnia at both the three- and 12-month assessments.
With respect to the EORTC-QLQ-H&N35, data revealed the presence of
clinically significant differences in a number of the head and neck-specific items
detected for changes to senses (e.g., taste and smell), difficulty opening mouth
(e.g., trismus), sticky saliva, and reductions in weight. Further, the use of
nutritional supplementation appeared to increase in a clinically significant
manner, while the use of pain medication appeared to decrease in a clinically
significant manner when three-month assessments were compared with baseline
values. Furthermore, at the 12-month follow-up assessment, clinically significant
reductions in head and neck symptom burden were reported in assessments of
pain and weight gain, while clinically significant increases in head and neck
symptom burden were reported for dry mouth (e.g., xerostomia) and senses
(e.g., taste and smell). No other changes in symptoms or functional domains
were found to be clinically significant when evaluated at the three- and 12-month
assessments and compared to mean baseline values.

Discussion
This investigation explored the experience of distress in individuals with
head and neck cancer at standardized three-month intervals throughout the first
year following diagnosis. We further sought to describe the pattern of commonly
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reported problems and perceptions of quality of life of these individuals while
including considerations of those frequently excluded from psychosocial
oncology research. With regard to the specific objectives of this study, the
presence of distress, perceived problems, and quality of life concerns were
explored.
Presence of distress
With respect to the presence and trajectory of distress, it was anticipated
that the level of distress detected within this sample would be highest shortly
following treatment (e.g., at the post-diagnostic and three-month assessment
points) and then gradually decline throughout long-term follow-up. However,
while the mean pattern of distress appeared to almost meet the hypothesized
trajectory (see Table 2.4); in fact, the rates of distress appeared to increase in
severity at both the six- and 12-month follow-ups, which was contrary to the
predicted trend of declining presence and severity. Further, data revealed that
clinically significant distress was present in a portion of participants throughout
the first year following diagnosis. In particular, when the mean scores from all
participants (regardless of how many envelopes they returned) were examined,
distress appeared to peak at the point of diagnosis and subsequently declined at
nine-month follow-up, but was followed by a surge at the 12-month follow-up.
Thus, the hypothesis that the presence of distress reported by participants would
be highest at the point of diagnosis and shortly following treatment (e.g., at the
post-diagnostic and three-month assessment points) was supported by the
present findings. A similar pattern was detected when the mean scores of the 17
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participants who returned all envelopes were examined. While the frequency and
pattern of these data might suggest that in general, distress is most elevated at
the point of diagnosis and declines gradually following treatment (Coyne, 2013),
in fact, examination of mean and frequency/proportion-related data alone may
only reveal a small fragment of this phenomenon.
To elaborate, Coyne’s (2013) suggestion that distress in individuals with
cancer decreases following the diagnosis and treatment stages of cancer is
widely accepted, but it has recently been shown to be an incomplete observation
(Fielding & Lam, 2013). The problem with this generalized description of the
phenomenon of distress in oncology centers on the manner in which distress
data are analyzed; in particular, the use of group mean values as the primary
(and often sole) outcome of the trajectory of distress. For instance, as noted by
Fielding and Lam (2013),
If in a study 50% of the sample score 10 out of 10 on a notional distress
scale declining to 0 out of 10 over time, whereas the other 50% score 0
out of 10 increasing to 10 out of 10 over the same period, the observed
group mean will remain at 5 out of 10 and the conclusion would be there is
no change in distress. (p.1).
Based on this anecdote, the conclusion that there was no change in distress is
inaccurate based on the individual scores; however, when data are evaluated
based on mean scores alone, it does appear as though the distress remained
unchanged throughout the study. In an effort to overcome the limitations of
mean-based analyses, some researchers have begun to utilize a method of

101
statistical analysis termed growth mixture modeling8, which essentially breaks
down longitudinal data samples into distinct patterns or trajectories (Fielding &
Lam, 2013). When this growth mixture modeling technique was applied to
distress data from individuals with cancer, distinct patterns of distress emerged
that were substantially different from the commonly accepted notion that distress
declines over time (Henselmans et al., 2010; Lam et al., 2011; Lam, Shing,
Bonanno, Mancini, & Fielding, 2012).
Ultimately, four distinct patterns of distress emerged through analyses of
multiple participant groups in varying disease sites (e.g., breast cancer,
nasopharyngeal cancer) (Henselmans et al., 2010; Lam, Ye, & Fielding, 2012;
Lam et al., 2009; Lam et al., 2011). The first and most commonly occurring
pattern suggests that the majority of individuals with cancer (approximately 60
percent) are resilient and experience persistently low levels of distress with
minimal and transient increases in distress throughout the cancer experience
(Fielding & Lam, 2013). The second pattern more closely resembles the classic
pattern of high levels of perceived distress early in the trajectory of disease with a
gradual decline in distress over time. The third is represented by those who
report low levels of distress early in the trajectory of disease with a gradual
increase in distress that peaks around the end of treatment before declining
substantially afterwards. Finally, the fourth pattern, evident in approximately 5-

8

Growth mixture modeling “represents unobserved heterogeneity between subjects in their
development using random effects and finite mixtures. This allows different sets of parameter
values for mixture components corresponding to different unobserved subgroups of individuals,
capturing latent trajectory classes with different growth curve shapes”, p.143-144). Thus, this
modeling approach permits detection of individual nuances in the data that might remain
unidentified using other analytic approaches.
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20% of individuals with cancer, demonstrates consistent levels of high distress
that persist throughout the cancer trajectory (Fielding & Lam, 2013; Henselmans
et al., 2010; Lam et al., 2012; Lam et al., 2009; Lam et al., 2011; Lam et al.,
2012). Consequently, these chronically distressed individuals present the largest
psychosocial need and would likely benefit most from psychosocial interventions
when compared to those with lower grade, and/or transient distress.
While the sample size of the present investigation was too small to permit
the mixture growth modeling technique described above, examination of the
individual trajectories of participants who completed all data sets provided some
interesting insights. In particular, all four patterns described above were detected
within the present sample. Specifically, out of the 17 participants who returned all
data sets, 11.8% of participants noted persistently low levels of distress,
consistent with the most commonly occurring pattern described by Fielding and
Lam (2013). A further 35.3% of participants reported the classic pattern of high
initial distress that decreased over time, while an additional 17.7% of participants
reported high initial distress followed by a decline, however, for these individuals,
distress levels increased for a second time during long-term follow-up. In
addition, 17.7% participants demonstrated low initial distress with a gradual
increase that peaked around the end of treatment before declining substantially
afterwards, while a further 17.7% participants reported chronic levels of high
distress throughout the entire study, thus representing the fourth pattern
described by Fielding and Lam (2013). Additionally, one participant (5.9%)
reported elevated distress at both diagnosis and the six-month follow-up. This
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participant could likely be classified according to the pattern marked by
persistently low levels of distress accompanied by periodic and transient
increases in distress throughout the continuum of care (Fielding & Lam, 2013).
While the course of distress is a deeply personal experience that may be
influenced by a number of potential factors, ultimately, developing a deeper
understanding of distress is important because distress patterns in the first year
following diagnosis can predict distress levels up to six years later (Lam et al.,
2011; Lam et al., 2012). Thus, if we can determine which trajectory of distress an
individual is experiencing within the first year, we will likely be able to better
target psychosocial resources to the individuals who will require them and may
receive the greatest benefit. Further, in addition to enhancing our understanding
of both the presence and trajectory of distress in individuals with head and neck
cancer, it is also important to identify and attend to the range of perceived
problems that may contribute to elevated levels of distress.
Perceived problems
Throughout the first year following diagnosis, both physical and emotional
concerns represented the most commonly reported problems among
participants. Notably, a number of physical and emotional concerns were
consistently reported by a high proportion of participants; in particular, problems
with fatigue, eating, and worrying were cited by at least 30 percent of participants
at each follow-up interval, with myriad additional concerns arising in varying
proportion throughout the trajectory of disease. These results were contrary to
the hypothesis that physical concerns would be cited most frequently at all time
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points. In fact, physical concerns (e.g., eating) were reported to be most frequent
at only the three-month follow-up. While the Problem Checklist was not intended
to be a comprehensive measure of the potential range of problems facing the
participants, it does offer insight into some of the most commonly reported areas
of concern. For instance, “problems with eating” was a frequently reported
concern among participants. However, when “problems with eating” are
considered through a qualitative context, it is apparent that the meaning
associated with such symptoms may actually change significantly over the
trajectory of disease.
For example, a recent qualitative study reported that during the acute
phase of illness (i.e., during treatment) some individuals with head and neck
cancer were unable to eat due to the side effects of treatment (e.g., mucositis,
pain, difficulty swallowing, etc.) and, thus, were reliant on nutritional support such
as feeding tubes or fortified drinks (Ottosson et al., 2013). Others who were still
able to eat reported having to adjust their food intake to soft or liquid foods that
were quite neutral in flavour (i.e. no dry or spicy foods). These changes were
perceived as stressful by participants as they struggled to consume an adequate
amount of calories to continue treatment (Ottosson et al., 2013). As time
progressed, attitudes concerning eating shifted from a requirement for survival to
the attempt to accept that eating may never again be a pleasurable activity for
some (Ottosson et al., 2013). Thus, while “problems with eating” were noted
during treatment and in long-term follow-up in the present study, the meaning
associated with these problems to the individual may be varied and significant.
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An additional treatment-related problem that may also create substantial
physical, psychological and social losses for individuals with head and neck
cancer is fatigue. Research indicates that fatigue is common in individuals with
cancer, but unfortunately it can be difficult to treat (Cruciani, 2006). It is important
to understand the impact of fatigue on individuals with head and neck cancer in
order to ascertain why such a high proportion of participants in the present study
reported fatigue as being problematic. Similar to our findings, a qualitative study
conducted by Molassiotis and Rogers (2012) noted that for individuals with head
and neck cancer, fatigue persisted throughout the first year following diagnosis
and actually worsened at the one-year follow-up. The worsened fatigue noted
during the long-term follow-up by Molassiotis and Rogers (2012) may have been
attributable to the recent return to work by some of their participants who noted
that their fatigue made the return to work experience very stressful. In general,
fatigue appeared to cause considerable frustration for participants who reported
that they were unable to do the things they used to do, which resulted in
restrictions to their activity level, ability to complete household tasks and errands,
and overall social participation (Molassiotis & Rogers, 2012). While the burden of
fatigue is substantial on its own, the problem with fatigue is that it often serves to
exacerbate other problems (e.g., swallowing problems, pain, altered taste, dry
mouth) (Ottosson et al., 2013). Furthermore, fatigue has recently been related to
depression and negative perceptions of quality of life (Sawada et al., 2012),
suggesting that the consequences of fatigue extend beyond the physical realm
into psychological and social domains.
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In addition to physical concerns, participants in the present study reported
a number of ongoing emotional problems. In particular, worrying was reported by
a high proportion of participants at all assessment points. While research specific
to the term “worry” in head and neck cancer is sparse, researchers have
previously classified this concern in individuals with cancer into two domains,
namely cancer-specific worries (e.g., future diagnostic tests, cancer recurrence,
diagnosis of another type of cancer) and health-related worries (e.g., health,
dying) (Gotay & Pagano, 2007). While these domains are certainly not
exhaustive, they do highlight the fact that thoughts of one’s own mortality are
deeply connected to the source of worry in individuals with cancer. Additionally,
for those living with cancer who have significant others, aging parents, and/or
young children, worries related to the long-term security and well-being of these
individuals may also be pervasive (Davis-Ali, Chesler, & Chesney, 1993). Also,
worries related to one’s cancer experience may shift as time progresses and
even after the successful completion of treatment, worries about the potential
recurrence of disease may persist (Savard & Ivers, 2013). While the present
study did not investigate specific sources of participants’ worry, the high
proportion of participants who reported it to be problematic throughout the
trajectory of disease, suggests it to be a pervasive problem.
Relative to commonly reported problems, the present study observed that
in general participants noted problems with eating, fatigue, and worry most often.
Recent evidence increasingly suggests that unresolved symptoms (including
problems with eating and fatigue), can significantly predict trajectories of distress
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in individuals with cancer (Lam et al., 2012). Thus, while the course of distress is
a deeply personal experience that may be influenced or exacerbated by a
number of potential factors, it is important to acknowledge that physical and
psychological symptoms are not mutually exclusive. Furthermore, data derived
from the Problem Checklist in the present study have provided empirical
confirmation of the qualitative accounts articulated by both Ottosson and
colleagues (2013) with regard to problems with eating and Molassiotis and
Rogers (2012) in relation to problems with fatigue. While emotional and physical
problems represented the highest proportion of reported concerns among
participants in the present study, the prevalence of these reports should in no
way diminish the impact of less frequently reported problems such as
“work/school”, “insurance/financial” or “dealing with partner”, since issues such
as these have the potential to be immensely distressing. In essence, the
subjective experience of an item such as, “problems dealing with partner” cannot
be inferred through mere acknowledgment on a brief questionnaire. As such,
considerations of an individual’s subjective perception of quality of life remain
important in order to better understand the experience of distress in individuals
with head and neck cancer.
Global and head and neck cancer-specific quality of life
The concept of quality of life has been defined by the World Health
Organization (WHO) as:
an individual’s perception of their position in life, in the context of their
culture and values system where they live, and in relation to their goals,
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expectations, standards and concerns. It is a broad ranging concept,
incorporating in a complex way a person’s physical health, psychological
state, level of independence, social relationships, personal beliefs and
relationship to salient features of the environment. (WHO, 1998, p.17).
An essential component to the concept of quality of life is the notion that these
domains are interrelated and must be considered collectively; they must also be
evaluated relative to the meaning and value that the individual places on each
component. Consequently, in order for assessments of quality of life to have
clinical or research utility, they must be capable of accounting for the factors
most relevant to one’s current life situation – in this case, his or her experience
with head and neck cancer and its accompanying consequences.
Owing to the myriad potential concerns of an individual with head and
neck cancer, a key objective of the present study explored the perceived quality
of life globally, and relative to a number of specific areas known to be
problematic for those with head and neck cancer. As such, numerous specific
concerns (e.g., role functioning, symptom burden) were found to change in a
clinically significant manner over the course of the study; consequently, these
areas are explored below.
Role functioning. Within the context of the EORTC-QLQ-C30, role
functioning was assessed according to an individual’s ability to meet work-related
obligations, engage in daily activities, and pursue hobbies and/or other leisure
time activities (Aaronson et al., 1993). Data from the present study were
consistent with predictions and indicated a clinically significant decline in one’s
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ability to fulfill meaningful roles at the three-month assessment when compared
to evaluations at diagnosis. These findings are in line with previous longitudinal
work (Bjordal et al., 2001; Hammerlid et al., 1997). Similar to the findings of
Bjordal and colleagues (2001) and Hammerlid et al. (1997), the clinically
significant decline in role functioning observed at the three-month assessment
appeared to resolve by the one-year follow-up. Previous research into the factors
that contribute to role functioning in individuals with cancer has determined that
one’s level of symptom burden (e.g., fatigue, appetite loss, insomnia, etc.) is
closely aligned with one’s ability to fulfill role-based activities and obligations
(Aaronson et al., 1993; Bjordal et al., 2001). As predicted, in the present study
participants’ symptom-related burden peaked at the three-month assessment
and leveled off around 12-months for most items, however, certain exceptions to
this pattern were evident. Specifically, items such as insomnia, senses, sexuality,
problems with teeth, dry mouth, pain killers, and weight gain demonstrated
alternative patterns in symptom burden. As such, exploration into the clinically
significant differences in symptom burden detected at the three-month
assessment (e.g., insomnia, pain, appetite loss, etc.) may provide some context
regarding the temporary depletion of role functioning among individuals with
head and neck cancer.
Insomnia. Insomnia has been characterized as difficulty associated with
sleeping that may involve challenges with initiating sleep and/or trouble
maintaining effective sleep (Savard & Morin, 2001). Sleep disturbances, including
insomnia, have been shown to decrease mental health, quality of life, and work
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productivity, to increase utilization of healthcare resources, and also to predict
future complications in individuals with cancer (Katz & McHorney, 2002;
Manocchia, Keller, & Ware, 2001; Roscoe et al., 2007). Previous research has
indicated that sleep disorders such as insomnia are common in individuals with
head and neck cancer (Duffy et al., 2008; Shuman et al., 2010). The present
study detected a similar problem with sleep-related concerns as evidenced by
the high proportion of participants reporting problematic sleep and/or fatigue at
multiple assessment points on the Problem Checklist. Relative to the specific
influence of these perceived problems on one’s quality of life, evidence from the
present study indicated a clinically significant decline in reported insomnia at both
the three- and 12-month assessments when compared with assessments at
diagnosis. These findings were contrary to our prediction that symptom-related
burden would peak in severity at the three-month post-diagnostic point. However,
our findings were in line with the work of both Savard and colleagues (Savard,
Ivers, Villa, Caplette-Gingras, & Morin, 2011) and Shuman et al. (Shuman et al.,
2010) who both observed elevated rates of insomnia prior to treatment with
gradual declines as time progressed. Additionally, Shuman et al. (2010)
postulated that the elevated rates of pre-treatment insomnia could possibly be
attributed to anxiety related to the recent diagnosis in conjunction with symptoms
stemming from the malignancy, such as pain.
Pain. Within the present sample, a clinically significant reduction in
perceived pain was observed at 12-month assessments when compared with
values obtained at diagnosis. Despite the rich body of literature noting the
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presence of long-term pain in individuals with head and neck cancer (Breivik et
al., 2009; Chua et al., 1999; Funk et al., 2012; Shuman, 2012; Whale et al.,
2001), the present data are in line with the recent work of Shuman and
colleagues (2012) who noted an improvement in pain in individuals with head
and neck cancer one-year following diagnosis when compared to pre-treatment
levels.
Interestingly, a clinically significant reduction in the use of painkillers was
observed at the three-month follow-up in the present study, suggesting that pretreatment pain (as inferred through the elevated use of pain alleviation
medication prior to treatment) was actually worse than pain levels during and/or
shortly following treatment. While surprising, this finding of elevated pretreatment pain suggests that the physical burden associated with an untreated
tumour in the head and neck region can be substantial (Shuman, 2012).
Consequently, assessments of quality of life in head and neck cancer would be
remiss if they failed to acknowledge the impact of pain on an individual’s
perceived well-being and overall functioning. Not only can elevated pain
negatively influence one’s perceived quality of life (Funk et al., 2012), but it has
also been shown to reduce functional capacity (Vallerand, Templin, Hasenau, &
Riley-Doucet, 2007), and to predict disability (Taylor et al., 2004), depression
(Shuman, 2012) and insomnia (Shuman, 2012), and further, to compromise
nutritional intake and weight maintenance (Paillaud et al., 2003) in individuals
with head and neck cancer. As a result, addressing pain may help to reduce or
alleviate numerous multidimensional concerns.
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Weight-related changes. In the present study, participants reported
clinically significant weight loss, reductions in appetite, and increased use of
nutritional supplementation three months following diagnosis. Fortunately, by the
12-month assessment, participants reported a clinically significant increase in
weight when compared to assessments at diagnosis. The weight loss observed
in the present study (at the three-month post-diagnostic mark) is significant
because the involuntary loss of even five percent of one’s body weight over a six
month period has been related to increased treatment toxicities, treatment
delays, complications, extended hospital stays, and decreased survival (Dewys
et al., 1980; Kubrak et al., 2009). Further, individuals with cancer who are
nutritionally compromised are at an increased susceptibility to infections and
generally demonstrate poorer responses to treatment (Nitenberg & Raynard,
2000), which likely contributes to the decreased rates of survival among these
individuals.
Furthermore, the type of treatment employed may also influence nutrition
and one’s ability to maintain their weight. Specifically, chemotherapy and
radiation therapies have been shown to cause acute mucositis, loss of taste
sensation, compromised salivary gland function, dysphagia, odynaphagia,
nausea, vomiting, loss of appetite, etc. – all of which may negatively influence
nutritional and subsequent functional status (Garg, Yoo, & Winquist, 2010;
Paccagnella et al., 2009; Payakachat, Ounpraseuth, & Suen, 2012). Moreover,
severe malnutrition can cause unintentional treatment breaks and
hospitalizations, which may consequently reduce treatment efficacy (Barret et al.,
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2012; Cox et al., 1992). These nutrition-related complications have been
associated with significant costs to both the individuals and the healthcare
system (Garg et al., 2010; Paccagnella et al., 2009). Thus, attending to the
quality of life concerns of individuals with head and neck cancer may serve to not
only improve individual well-being, but may also provide economic benefits to the
healthcare system at large. Thus, it is imperative to be aware of these problems
so that the consequences of head and neck cancer may be alleviated whenever
possible in order to optimize quality of life.
Possible confounding factors
Since the source of distress is certainly not limited to the consequences of
cancer and its treatment-related sequelae, participants were invited to disclose
any information that they felt may have influenced their perceived level of
distress or quality or life at the time of the survey. Regarding specific disclosures,
one participant reported being worried about his spouse’s health in addition to his
own health-related concerns. Another participant disclosed that he was
experiencing residual problems related to a car accident several years prior.
Understandably, these experiences may have influenced how these individuals
were able to cope with their disease and its treatment. Relative to the distress of
these participants, the individual who had been in a car accident reported
clinically significant distress at the three-month assessment. However, the
participant who was concerned about his spouse’s health did not report clinically
significant distress at any of the assessment intervals. While the frequency of
these potentially confounding factors is too low to draw any firm conclusions,
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future research into the influence of co-existing stressful life events may provide
interesting insights into how individuals cope with the experience of cancer while
managing significant co-existing life challenges.
Limitations of Current Study
First, the sample size and rate of attrition serve as noteworthy limitations
to the present study. While substantial declines in participant responses occurred
throughout the 12-month data collection period, the rates of attrition were
particularly elevated at the nine- (67.1% attrition) and 12-month (78.7%) followup assessments. While attrition in the present study was higher than rates
reported in previous longitudinal studies in head and neck oncology – 78.5%
reported by Mehanna and Morton (2006) and 66% reported by Kelly et al. (2007)
– the differences are not substantial. Furthermore, despite the high proportion of
participants who did not complete all of the follow-up assessments, we did gather
a total of 17 completed participant data sets; based on sample size calculations,
only 14 completed participant data sets were required for the study to be
sufficiently powered (Lee, 2004). In an effort to ensure that those participants
who completed all data sets did not differ substantially from participants who did
not complete all data sets, t-test analyses were performed in order to compare
the mean Distress Thermometer scores of respondents at both baseline and 12months post-diagnosis. Since no statistically significant differences were
detected at either point in time, we believe that the rate of attrition detected in this
sample did not bias the results relative to the levels of perceived distress
observed.
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Second, this study design did not permit assessment of pre-diagnostic
distress given that participants were recruited following their diagnosis. Previous
research conducted in women with breast cancer has shown that the period of
time prior to diagnosis (i.e. following detection and symptoms and throughout
diagnostic workup) may be slightly more distressing than other points along the
continuum of care, including during treatment and in long-term follow-up (Nosarti,
Roberts, Crayford, McKenzie, & David, 2002; Vahdaninia, Omidvari, & Montazeri,
2009). Given this potential for elevated distress prior to receiving a confirmed
diagnosis, it is possible that the trajectories of distress detected in the present
sample would be altered if pre-diagnostic distress-related data were included.
Consequently, future work examining the influence of pre-diagnostic distress on
the trajectory of distress in individuals with head and neck cancer is
recommended.
Furthermore, the length of current follow-up time was restricted to 12
months. While the literature pertaining to distress-related concerns in long-term
survivors of head and neck cancer is well established (Mehanna & Morton, 2006;
Semple, 2001; Ward & van As-Brooks, 2007), the decision to limit the length of
study inquiry to 12 months was based on two primary factors. The first was due
to the feasibility of the study given that the data collection procedure was
conducted primarily by a single investigator (C.B.). The second factor supporting
a 12-month follow-up assessment period was the collective findings of Lam et al.
(2011) and Lam et al. (2012) who have shown that the trajectory of distress in the
first year following diagnosis significantly predicts one’s level of distress up to six
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years following diagnosis. Thus, the decision to limit the length of inquiry to 12
months following diagnosis was deemed appropriate given the predictive
relationship between the trajectories of distress reported in the first year postdiagnosis with long-term levels of distress in individuals with cancer.
Conclusion
This study investigated distress, quality of life, and commonly reported
problems in 102 individuals diagnosed with head and neck cancer. Data indicate
that: (1) distress was most prevalent at the point of diagnosis and (2) that the
length of time following diagnosis had a large effect on the level of perceived
distress. Additionally, clinically significant declines in role functioning and
increases in symptom burden (e.g., pain, insomnia, senses, trismus, xerostomia,
sticky saliva, appetite loss, and weight loss) were observed early on following
treatment, but with exception of xerostomia and reduced senses, appeared to
resolve by the one-year follow-up. In addition, participants most frequently
reported physical and emotional concerns as being problematic throughout the
trajectory of disease.
While most individuals with cancer are resilient and tend to experience
persistently low levels of distress (Fielding & Lam, 2013), this is not the case for
all individuals. Recent evidence increasingly suggests that the presence of
unresolved symptoms (e.g., pain, fatigue, etc.) is a major predictive factor in the
trajectory of cancer-related distress (Lam et al., 2012). The results of the present
investigation would seem to provide support for this notion. Further, the
connection between unresolved symptoms and persistent distress suggests that
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improving symptom management in individuals with cancer may provide a costeffective means of reducing some cancer-related distress (Fielding & Lam,
2013). Although Fielding and Lam (2013) have suggested that most individuals
find a way to cope with the experience and challenges of cancer, the challenge
for healthcare practitioners lies in seeking to identify and assist those who
cannot. The present findings support the systematic monitoring of distress and
the factors which may compromise quality of life, and through this process,
healthcare providers may efficiently identify those individuals who are
experiencing elevated distress and/or disease-related burden in hopes of
optimizing short- and long-term outcomes.
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Chapter 3
A Cross-Sectional Analysis of Distress in Caregivers of Individuals Diagnosed
with Head and Neck Cancer

Background
The diagnosis of head and neck cancer brings with it profound changes
for not only the individual with cancer, but also for the loved ones who often play
a critical role in their care. Owing to the broad range of potential impairments and
psychosocial needs of individuals with head and neck cancer (Bornbaum et al.,
2012; Doyle, 1994; Payakachat, Ounpraseuth, & Suen, 2012), caregivers often
fulfill an indispensable role in an individual’s support team throughout the
treatment and post-treatment period (Kagan, Clarke, & Happ, 2005). Caregivers
provide a wide range of support to their loved ones which often includes
emotional support (e.g., talking about worries, fears, etc.), instrumental support
(e.g., liaising with medical team, communicating with distant family members),
tangible support (e.g., assistance with transportation, finances, household tasks),
and medical support (e.g., accompaniment to treatments, help with administering
medications) (Yabroff & Kim, 2009).
A recent review into the role of caregiving in head and neck cancer
evaluated both the presence of distress and the factors known to influence such
caregiving (Longacre, Ridge, Burtness, Galloway, & Fang, 2012). Longacre and
colleagues observed that throughout the studies included in their review,
between 20-40% of caregivers reported experiencing clinically significant levels
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of distress. Further, caregivers of individuals with head and neck cancer were
more likely to experience poorer rates of psychological wellbeing when compared
to both population norms (e.g., the general public, assumed healthy individuals)
(Ostroff, Ross, Steinglass, Ronis-Tobin, & Singh, 2004; Vickery, Latchford,
Hewison, Bellew, & Feber, 2003) and those with head and neck cancer (Hodges
& Humphris, 2009; Vickery et al., 2003). Longacre and colleagues (2012) noted
that, in general, caregivers of those with head and neck cancer were primarily
female spouses in their mid- to late-fifties, a finding that is understandable given
that men are most often afflicted with the disease and that the median age of
diagnosis was recently reported as between 50-59 years of age (Cooper et al.,
2009). While acknowledgement of the most common characteristics of those
providing care for individuals with head and neck cancer remains important, it
may fail to adequately convey the gravity of precisely what the role of providing
care to a person with head and neck cancer actually entails and the impact that
caregiving has on those who serve in that capacity.
The diagnosis of head and neck cancer forces both the individual with
cancer and their caregiver to confront not only a life threatening disease, but also
a series of potential and actual losses related to the disease and its treatment.
Owing to the anatomic characteristics of the head and neck region, treatment of
head and neck cancer may result in deficits to the individual’s physical
appearance that cannot easily be hidden, in addition to varying degrees of
dysfunction in respiration, eating, swallowing, and communication (Chen et al.,
2009; Katz, Irish, Devins, Rodin, & Gullane, 2003; Koster & Bergsma, 1990).
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Following treatment for head and neck cancer, additional undesirable side effects
such as facial weakness, drooling, trismus (i.e., difficulty opening the jaw),
physical scarring, and poor speech intelligibility may persist (Doyle, 2005;
Jeremic et al., 2011; Katz et al., 2003). The presence of these side effects may
cause embarrassment and significantly impact not only the individual’s
internalized feelings of self-esteem and self-concept, but also their willingness to
interact socially (Doyle, 2005; Semple, Sullivan, Dunwoody, & Kernohan, 2004).
Formerly simple pleasures such as dining out at a restaurant may become a
source of tremendous stress and embarrassment for those with head and neck
cancer. As a result, individuals may choose to not participate in these types of
social situations which may then coincidently restrict the social activities of the
caregiver if the caregiver is a spouse or family member of the individual with
cancer (Roing, Hirsch, & Holstrom, 2008).
Although the individual with cancer sits at the core of diagnosis and
treatment, the needs of caregivers are often forgotten or overlooked throughout
the cancer care process (Eton, Lepore, & Helgeson, 2005; Northouse, 2002;
Zwahlen, Hagenbuch, Jenewein, Carley, & Buchi, 2011). Though such exclusion
is not intentional, failure to acknowledge the caregiver in the context of the
person with cancer is problematic because the role of caregiving is immensely
challenging. The role of caregiving is complex, yet highly unique to every
individual; this is not only due to the numerous medical terms and procedures
that a caregiver may have to understand or be able to perform (e.g., wound
cleaning, dressing changes, etc.), but also because caregivers must learn to
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reconcile their own sense of helplessness during a time when strength and
support are required (Blood, Simpson, Dineen, Kauffman, & Raimondi, 1994).
Undoubtedly, the challenges of cancer and its treatment have an enormous
impact on the psychosocial functioning of both individuals with head and neck
cancer and their caregivers. As a result, it is important to evaluate the
psychosocial functioning of these caregivers in order to identify factors that may
influence distress so that the appropriate resources and interventions can be
offered when required.
At present, a key barrier to the recognition of distress in caregivers lies in
the fact that throughout the continuum of care, the individual with cancer, as
opposed to their caregiver, is the focus of the cancer care team. As a result, the
individual with cancer has a higher probability of receiving a referral for
supportive care services (Zwahlen et al., 2011) such as psychological
counseling, support groups, and assistance with practical concerns through
social work departments. Caregivers of individuals with cancer have reported
receiving low levels of support from others, including specialists (Northouse,
2002) and from the individual with cancer themselves (Eton, Lepore, & Helgeson,
2005). Understandably, caregiver concerns often remain relegated to the
background, while attention is focused on the individual with cancer (Zwahlen et
al., 2011). Caregivers have reported finding it challenging, and have even
reported feeling guilty, when seeking support for themselves (Eriksson & Lauri,
2000). However, when caregivers do not directly seek out assistance for their
distress and/or broader concerns, these problems often go unnoticed by those
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most able to provide direct assistance (e.g., medical professionals and support
staff) (Zwahlen et al., 2011). As a result, it is important to understand the factors
that may contribute to elevated distress in caregivers of individuals with head and
neck cancer so that those most at risk of experiencing elevated distress may be
identified in order to ensure that the appropriate resources and interventions can
be recommended when required. The ability to understand the impact of cancer
on both “patient” and caregiver, cannot be discounted and efforts to understand
the phenomena associated with distress is clearly warranted.
Distress in caregivers of individuals with head and neck cancer
In an effort to understand and describe the variables related to distress in
caregivers of individuals with cancer, Sherwood and colleagues (2008)
developed a conceptual framework to address these types of concerns. In their
framework they posited that a caregiver’s psychological health (e.g., distress,
depressive symptoms, anxious symptoms, etc.) is influenced by two primary
factors; these factors include both the disease characteristics of the individual
with cancer (e.g., time since diagnosis, disease stage, patient functioning and
needs) and the caregiver’s personal characteristics and resources (e.g.,
sociodemographic factors, social support, coping style) (Sherwood et al., 2008).
Relative to the known disease-related characteristics associated with
psychological health in caregivers of those with head and neck cancer, data
indicate that the time frame following diagnosis and during treatment (e.g., 2-6
months post-diagnosis) is particularly stressful for caregivers (Blood et al., 1994).
Following this time period, the level of burden experienced by caregivers was
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perceived to decrease in association with increasing time following diagnosis
(Blood et al., 1994). Further, while not extensively assessed to date, some
researchers have noted that caregivers report a high degree of fear related to the
possibility that the cancer will recur (Watt-Watson & Graydon, 1995); these fears
in caregivers are sometimes even stronger than those of the patients themselves
(Hodges & Humphris, 2009). Thus, the very real emotional fears that may be
experienced by caregivers can have a substantial impact on their psychological
health and overall well-being.
With regard to the relationship between caregiver psychological health
and personal characteristics and/or resources, several variables have been
examined to date. Specifically, research into one’s level of education has
revealed somewhat mixed results. Some authors have found no relationship
between education and psychological health (Ross, Mosher, Ronis-Tobin,
Hermele, & Ostroff, 2010), whereas others have reported that caregivers with
higher education levels placed increased value on the use of psychological
support (for both themselves and the patient) and subsequently, actively sought
more contact with psychological resources (e.g., self-help groups) (Baghi et al.,
2007). Research into the effect of sex on perceived distress again has been
mixed, with some investigators noting an increased desire for psychological
support among women (Baghi et al., 2007), while others have reported no
significant associations between sex and psychological health (Ross et al., 2010;
Verdonck-de Leeuw et al., 2007). To date, no significant associations have been
detected between age and psychological health in caregivers of individuals with
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head and neck cancer (Ross et al., 2010; Verdonck-de Leeuw et al., 2007).
Nevertheless, research into the factors that underlie and contribute to distress
and decreased quality of life are important because perceptions of burden and
lowered quality of life in caregivers have been established as early predictors of
prolonged hospital stays in individuals with dementia (Lang et al., 2010). It is
possible that a similar effect may be present when considering caregivers of
individuals with head and neck cancer. Investigating the factors that predict
distress may facilitate the early identification of vulnerable individuals, which may
allow for the delivery of targeted services and interventions that prevent severe
and/or persistent symptoms of distress and ultimately facilitate long-term
adjustment (Neilson et al., 2012) of caregivers. Hence, developing a greater
understanding of the factors that contribute to caregiver distress and quality of
life may have important implications not only for improvement of caregiver
outcomes, but also for the individual with head and neck cancer. In order to
determine which specific factors may contribute to caregiver distress and
perceptions of quality of life, an examination of areas that are currently
overlooked in the caregiver distress literature may serve to highlight avenues of
research that warrant investigation.
Limitations of the current literature
Previous research into distress in caregivers of individuals with head and
neck cancer has been limited in a number of important ways. First, currently
available resources related to the caregiving experience of individuals with head
and neck cancer have included participants who cared for individuals who were
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generally between two and 48 months post-diagnosis (Baghi et al., 2007; Hodges
& Humphris, 2009; Ross et al., 2010; Verdonck-de Leeuw et al., 2007). These
studies included a range of lengths in time since diagnosis which included, three
to six months post-diagnosis (Hodges & Humphris, 2009), six to 24 months postdiagnosis (Baghi et al., 2007; Ross et al., 2010; Verdonck-de Leeuw et al., 2007),
and two to 48 months post-diagnosis (Blood et al., 1994). There has also been a
subset of research focused on issues arising in early survivorship; more
specifically, studies have included caregivers of individuals who were between
one and five years post-diagnosis (Drabe et al., 2008; Mellon, Northouse, &
Weiss, 2006). However, since distress-related concerns have been reported in
individuals with head and neck cancer in both the newly diagnosed (HaisfieldWolfe, McGuire, & Krumm, 2012) as well as long-term survivorship phases
(Bjordal & Kaasa, 1995), and since previous research has demonstrated a
relationship between distress levels of those with cancer and their caregivers
(Zwahlen et al., 2011), it would appear reasonable to assume that distressrelated concerns may arise in primary caregivers during both the newly
diagnosed and long-term survivorship phases. As such, the present investigation
sought to broaden the spectrum of exploration into caregiver concerns relative to
the length of time since diagnosis.
In addition to research related to the specific length of time since provision
of a diagnosis, to the author’s knowledge, research exploring the relationship
between caregiver distress and the treatment status of the individual with head
and neck cancer (e.g., awaiting treatment, undergoing treatment, completed
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treatment) has not previously been explored. While data do exist related to
concerns that may arise in the context of survivorship (e.g., post-treatment) for
caregivers of individuals who have been treated for head and neck cancer
(Drabe et al., 2008; Mellon et al., 2006), there is a paucity of comparative data
related specifically to the relationship between stage of treatment and caregiver
distress. This paucity of data is particularly problematic because research into
those with head and neck cancer has revealed that the presence of distress is
related to one’s treatment status (Neilson et al., 2012; Zabora et al., 1997), and
further, the transmission of distress from the person receiving treatment to their
caregiver may be particularly strong in “caregiver-care recipient” systems
(Hodges, Humphris, & Macfarlane, 2005; Mellon, Kershaw, Northouse, &
Freeman-Gibb, 2007). Thus, research which explores the direct effect of
treatment status on caregiver distress may be beneficial since information related
to highly distressing periods throughout the continuum of care may help clinicians
to better target their psychosocial resources to the most distressing events
known to exist along the continuum of care in caregivers.
Furthermore, all distress-related research efforts to date in this population
have involved the use of multi-item distress measures (Longacre et al., 2012).
This includes the use of measures such as the Hospital Anxiety and Depression
Scale (Zigmond & Snaith, 1983), the Mental Health Inventory (Veit & Ware,
1983), and the Global Assessment of Recent Stress (Linn, 1985), among others
(Longacre et al., 2012). The utility of an “ultrashort” (Vodermaier, Linden, & Siu,
2009) measure such as the Distress Thermometer has been established in
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caregiver oncology populations (Zwahlen, Hagenbuch, Carley, Recklitis, & Buchi,
2008; Zwahlen et al., 2011), and ultrashort measures have been found
particularly useful and effective for distress screening purposes in busy, clinical
environments (Vodermaier et al., 2009). Yet despite these findings, to date, the
Distress Thermometer has only been utilized to assess distress in caregivers of
individuals with brain cancer (Keir, Calhoun-Eagan, Swartz, Saleh, & Friedman,
2008). Consequently, use of an ultrashort measure, such as the Distress
Thermometer, to assess distress in caregivers of individuals with head and neck
cancer may enhance the opportunity to promote the regular screening of distress
in this population, given the tool’s reliability and ease of clinical use (Vodermaier
et al., 2009). In consideration of these noted limitations to the current literature, a
number of specific objectives were developed related to this research
investigation and are discussed below.
Study-specific research objectives
The overarching purpose of the present investigation was to determine
what factors were associated with elevated distress among caregivers of
individuals with head and neck cancer. We further aimed to explore how distress
may be related to certain outcomes in those caregivers. Specifically, we sought
to understand how both the caregiver’s personal demographic factors and the
disease- and treatment-related characteristics (e.g., treatment status) of the
individual with head and neck cancer may contribute to elevated distress and
decreased quality of life in caregivers of individuals with head and neck cancer.
Distress in caregivers was assessed through use of an ultrashort distress
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screening tool, the Distress Thermometer (National Comprehensive Cancer
Network [NCCN], 2013). Further, because current resources are limited to the
experiences of head and neck cancer caregivers between two months and five
years following the point of diagnosis, we sought to enhance the literature to
include considerations of caregivers in both the newly diagnosed and long-term
follow-up (e.g., survivorship) phases of the continuum of care. Accordingly, a
number of specific objectives for this inquiry were developed: (1) to determine the
presence of distress in caregivers of individuals diagnosed with head and neck
cancer; (2) to describe the range of perceived problems (e.g., practical, familial,
emotional, spiritual, physical) reported among caregiver participants; (3) to
assess the relationship between distress and quality of life in caregivers of
individuals with head and neck cancer; (4) to evaluate if a relationship existed
between perceived distress level and specific demographic characteristics of
caregivers; and (5) to determine if a relationship existed between caregiver
distress and the disease- and/or treatment-related characteristics of the
individual with head and neck cancer.

Method
Participants
Participants (n = 119) involved in this research protocol were recruited inperson through one of two possible venues. The first was through their physician
in the London Regional Cancer Program (LRCP) at the London Health Sciences
Centre, Victoria Campus, located in London, Ontario. The second possible venue
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was the annual meeting of the International Association of Laryngectomees. The
decision to recruit at two venues was based on the effort to increase the
maximum possible number of participants in the sample and also to enhance the
generalizability of the data to a group beyond Southwestern Ontario. This sample
may be considered as a sample of convenience based on the willingness of
individuals to participate following a request by their physician or a member of
the research team (e.g., C.B., P.D.). Prior to undertaking this study, the Ethics
Review Board at The University of Western Ontario approved this protocol;
Approval # 18019E (see Appendix B).
Inclusion criteria. In order to be included in this study, participants were
required to be at least 18 years of age and able to provide informed consent (i.e.,
no known cognitive impairments). They were also required to identify themselves
as the primary caregiver of an individual diagnosed with head and neck cancer.
Exclusion criteria. If individuals were unable to read, write or understand
English or if they were unable to visually see the questionnaires they were
excluded since the tasks involved in this study required participants to read and
understand the questionnaires in English, and respond to questions accordingly.
In total, 200 individuals were identified as potential participants and
subsequently received packages containing the letter of information and consent,
the demographic questionnaire, and the research instruments. The age of
participants in this study ranged from a minimum of 28 years to a maximum of 83
years. The mean age for all participants was 61.60 years (SD = 11.19). In total,
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the 90 female (mean age = 59.03 years) and 29 male participants (mean age =
61.56 years) resulted in a female-to-male ratio of approximately 3:1.
In addition, the length of time since the individual with head and neck
cancer had received his or her diagnosis ranged from 0 to 274 months (mean =
26.59; SD = 49.92). When divided into intervals of time since diagnosis, data
revealed a large number of participants in the newly diagnosed phase including
those less than one month from diagnosis (n = 14) and those who were between
one and three months post-diagnosis (n = 31). Other lengths of time following
diagnosis reported by caregivers included: four to six months (n = 10), seven to
nine months (n = 8), 10 to 12 months (n = 9), 13 to 18 months (n = 9), 19 to 24
months (n = 3), 25-60 months (n = 15), 61 to 120 months (n = 7), 121-240
months (n = 8), and greater than 240 months (n = 1). Comprehensive
demographic data for these participants are presented in Table 3.1, while the
disease- and treatment-related data for the individuals for whom they were
providing care are presented in Table 3.2.
Procedure
Data collection. All individuals who consented to participate received a
package containing a letter of information and consent form (see Appendix D), a
demographic questionnaire (see Appendix F), the Distress Thermometer and
accompanying Problem Checklist (NCCN, 2013) (see Appendix I), the Caregiver
Quality of Life-Cancer Scale (CQOLC) (Weitzner, Jacobsen, Wagner, Friedland,
& Cox, 1999) (see Appendix J), a list with the contact information for local
psychological support services (see Appendix K), and a self-addressed and

141
Table 3.1
Demographic Data of Caregiver Participants
Variable
Sex
Female
Male
Relationship to patient
Spouse
Family member
Friend
Marital status
Married/common-law
Separated/divorced/widowed/single
Unspecified
Education
Completed college/university
Completed high school
Completed less than high school
Occupational status
Retired
Working full-time
Working part-time
Unemployed/stay at home
Receive disability benefits
Household income
≤ $25,000
$25,001 - $40,000
$40,001 - $55,000
$55,001 - $70,000
$70,001 - $85,000
> $85,000
Unspecified

n

%

90
29

75.6
24.4

98
19
2

82.4
16.0
1.7

107
11
1

89.9
9.2
0.8

61
46
12

51.3
38.7
10.1

60
33
15
6
5

50.4
27.8
12.6
5.0
4.2

8
15
17
12
5
27
35

6.7
12.6
14.3
10.1
4.2
22.7
29.4
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Table 3.2
Disease- and Treatment-Related Data for Individuals with Head and Neck
Cancer Cared for by Caregiver Participants
Variable
n
%*
Site of cancer
Oral cavity
39
32.8
Larynx
24
20.2
Pharynx
18
15.1
Multiple sites
11
9.2
Sinuses/paranasal sinuses
6
5.0
Salivary glands
6
5.0
Neck
6
5.0
Ear
5
4.2
Scalp
1
0.8
Unknown primary
3
2.5
Stage of disease
T1
13
10.9
T2
7
5.9
T3
15
12.6
T4
29
24.4
Unspecified
55
46.2
Treatment status
Awaiting treatment
42
35.5
Undergoing treatment
25
21.0
Completed treatment
46
38.7
Unspecified
6
5.0
Treatment type
Surgery
36
30.3
Surgery and radiation therapy
25
21.0
Chemotherapy and radiation therapy
22
18.5
Surgery, radiation therapy, chemotherapy
11
9.2
Radiation therapy
10
8.4
Unspecified
8
6.7
Surgery and chemotherapy
5
4.2
Chemotherapy
2
1.7
Recurrence of cancer
Recurrence
29
24.4
No recurrence
90
75.6
Note. Not all columns add to 100.
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prepaid return envelope to ensure that participants did not incur any undue
financial burden for their participation in this study.
The letter of information informed the participant of the general purpose of
the study, the risks and benefits associated with participating in the study, and
also notified them that they were under no obligation to complete the
questionnaires nor would they suffer any consequences for declining to
participate. In compliance with ethical requirements, informed consent was
indicated by the voluntary completion and return of the questionnaire to the
researcher. This procedure of obtaining consent was explicitly stated in the letter
of information. If any of the questionnaires were not completed in entirety with
sufficient data to compute statistical analysis as per the requirements specified in
the standardized scoring and procedures manual for each questionnaire, they
were destroyed and excluded from data analysis.
Sample size calculations. Sample size calculations were conducted
using G*Power 3 Software (Version 3.1) (Faul, Erdfelder, Lang, & Buchner,
2007) in order to identify the number of participants required to obtain adequate
statistical power. It was determined that a total sample size (n) of 54 individuals
would be sufficient to detect the hypothesized effect (d = 0.5) of a within-subject
independent variable design 95.0 percent of the time using a 0.05 alpha level
(Faul et al., 2007). Despite this relatively low number of required participants, it
was determined that a total of 200 individuals would be invited to participate in
the study with the goal of obtaining a response rate of approximately 50%
(Baruch, 1999).
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Measurement instruments
The measurement instruments utilized in this study included: (1) the
CQOLC to assess quality of life, (2) the Distress Thermometer and
accompanying Problem Checklist to assess distress and perceived problems,
and (3) a demographic questionnaire to assess both the caregiver’s personal
demographic information and the disease- and treatment-related characteristics
of the individual for whom they were providing care (i.e. the individual with head
and neck cancer). The order of the Distress Thermometer and CQOLC
questionnaires was randomly assigned as per predetermined stapling of the
instruments (e.g., half of the packages provided the Distress Thermometer first,
while the other half offered the CQOLC first). This procedure of organizing the
order of the instruments was conducted in an effort to reduce any response bias
due to the influence of exposure to the preceding measure. Participants were
instructed to complete each questionnaire as per the enclosed instructions
provided on the measures themselves (e.g., the Distress Thermometer and
CQOLC) in a location of their choosing (i.e., home or private office). Additional
pages were provided for participants to include any additional information that
they felt was pertinent to the research topic (i.e., any concerns or life events that
could serve as confounding factors influencing their distress or quality or life at
the time of the survey). It was anticipated that completion of all tasks would take
approximately 10-15 minutes.
Demographic information. Demographic items consisted of the
participant’s age, sex, relationship to the individual with head and neck cancer
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(e.g., spouse, family member, friend, etc.), marital status, occupational status,
highest level of education obtained, and approximate household income. Relative
to the disease- and treatment-related characteristics of the individual for whom
they were providing care, items for which data were collected included the length
of time since diagnosis, the specific site of the malignancy (e.g., larynx, oral
cavity, etc.), the tumour stage of the disease, the type of treatment received, the
status of treatment (e.g., awaiting, undergoing, completed, etc.), and whether or
not the individual had experienced a recurrence of the disease.
Data analysis
Raw data from the current study were analyzed using SPSS 20.0 for
Macintosh (IBM, 2011). Moreover, an a priori alpha level of p ≤ 0.05 was used for
statistical tests.
Descriptive statistics. Initially, descriptive statistics (e.g., means,
standard deviations, frequency distributions, histograms, etc.) were calculated for
demographic data, treatment- and disease-related variables, and the global and
specific domains of each questionnaire (e.g., Distress Thermometer, CQOLC).
These analyses were conducted in order to evaluate the normality of the sample
and to assess whether parametric statistics would be appropriate for statistical
analyses.
Objective one: Presence of distress. The presence of clinically
significant distress was identified based on a Distress Thermometer score of ≥ 4
in accordance with the recommendations of the National Comprehensive Cancer
Network (NCCN) (2013). Rates of distress detected in this sample were then
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compared to previous findings in the literature. It was hypothesized that the rate
of distress detected within this sample would fall within 20-40% of participants, in
accordance with the rates described in current literature (Longacre et al., 2012).
Objective two: Perceived problems. Data pertaining to perceived
problems were derived from the Problem Checklist, which accompanies the
Distress Thermometer (NCCN, 2013). Frequency data were presented for each
of the Problem Checklist items in an effort to explore the most commonly
reported concerns among caregivers of individuals with head and neck cancer. It
was hypothesized that emotional problems (e.g., worry, fears, sadness,
nervousness, decreased interest, depression) would be the most frequently
reported concerns among participants.
Objective three: Relationship with quality of life. Relationships
between distress level and the global (e.g., overall) and specific domains (e.g.,
burden, disruptiveness, financial concerns, and positive adaptation) of quality of
life were evaluated. Given that both the Distress Thermometer and the CQOLC
outcomes were comprised of continuous variables, a correlation coefficient was
utilized. Additionally, coefficients of determination9 were calculated for any quality
of life outcomes that demonstrated a significant relationship with distress in order
to describe the level of variance shared by the two variables (Pallant, 2011).
Interpretation of the correlations was based on the evaluation criteria cited in
Portney and Watkins (2009).

9

2

A coefficient of determination (r ) is the “coefficient representing the amount of variance in one
variable (Y) that can be explained (accounted for) by a second variable (X)” (Portney & Watkins,
2009, p.865).
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In addition, it was hypothesized that there would be a moderate degree of
association between distress and global quality of life in caregivers of individuals
with head and neck cancer. Based on previous work related to quality of life and
distress in individuals with head and neck cancer (Bornbaum et al., 2012;
Pandey, Devi, Ramdas, Krishnan, & Kumar, 2009), it was also predicted that this
correlation would be negative, indicating that as one’s level of distress increased,
that their perceived quality of life would decrease. Relative to the specific
domains of quality of life (e.g., burden, disruptiveness, financial concerns, and
positive adaptation), it was hypothesized that both burden and disruptiveness
would demonstrate a moderate degree of relationship with distress. Both level of
burden and perceived disruptiveness have been related to psychological health
(e.g. distress) in previous investigations of the caregiver experience in head and
neck oncology (Longacre et al., 2012).
Objective four: The influence of demographic characteristics. To
assess the relationship between perceived distress level and the demographic
characteristics of caregivers, variables such as sex, age, marital status,
occupational status, household income, level of education, and relationship to the
individual with cancer were evaluated. Given that both age and Distress
Thermometer scores were continuous variables, and since several of the
demographic variables (e.g., occupational status, household income, level of
education) were ordinal variables, the Spearman’s Ranked Correlation
Coefficient was employed. In addition, coefficients of determination were
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calculated for variables that indicated a significant relationship with distress
(Pallant, 2011).
Lastly, since sex was a nominal, dichotomous variable and it was
evaluated relative to a continuous variable (e.g., Distress Thermometer score),
an unpaired, or independent-samples, t-test was utilized for statistical analysis.
The magnitude of effect was determined through calculation of Eta Squared10
(Pallant, 2011). Interpretation of the effect size of a variable was based on the
guidelines proposed by Cohen (1988).
Relative to hypotheses, it was anticipated that caregiver sex would
demonstrate a moderate relationship with distress. This hypothesis was based
on previous research into the relationship between sex and caregiver distress,
which found that female caregivers typically reported a higher rate of perceived
distress than their male counterparts (Baghi et al., 2007). Consistent with
previous findings (Ross et al., 2010; Verdonck-de Leeuw et al., 2007), a strong
relationship with age was not anticipated. Moreover, no significant relationships
were expected between distress and the remaining demographic variables (e.g.,
marital status, occupational status, household income, level of education).
Objective five: Distress and patient-related characteristics. To assess
the relationship between perceived distress level and the disease- and treatmentrelated characteristics of the individual with head and neck cancer, variables
such as disease stage, number of treatment methods, and time since diagnosis

10

Eta squared is an effect size statistic that ranges from zero to one and “represents the
proportion of variance in the dependent variable that is explained by the independent (group)
variable” (Pallant, 2011, p.242).
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were explored. Given that both the Distress Thermometer score and length of
time since diagnosis were continuous variables and since several of the diseaseand treatment-related variables (e.g., disease stage, number of treatment
methods) were ordinal variables, Spearman’s Ranked Correlation Coefficient
was utilized for statistical analysis. Coefficients of determination were calculated
for any variables that demonstrated a significant relationship with distress
(Pallant, 2011).
Since disease recurrence was a nominal, dichotomous variable and it was
evaluated relative to a continuous variable (e.g., Distress Thermometer score),
an unpaired t-test was employed for statistical analysis. Lastly, a one-way
between-groups analysis of variance (ANOVA) was performed in order to explore
the impact of treatment stage on level of distress. Treatment stage was divided
into three groups; those awaiting treatment, those currently undergoing
treatment, and those who had completed treatment. Magnitude of effect for both
the t-test and ANOVA was determined through calculation of Eta Squared
(Pallant, 2011).
Similar to previous findings we hypothesized that disease recurrence
(Hodges & Humphris, 2009; Watt-Watson & Graydon, 1995), and time since
diagnosis (Blood et al., 1994) would each demonstrate small, but significant
relationships with distress. To the authors’ knowledge, a relationship between
caregiver distress and treatment stage (e.g., awaiting, undergoing, completed)
has not been reported previously. Nevertheless, we predicted that distress and
treatment stage would reveal a significant relationship. We further anticipated
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that disease stage would not demonstrate a significant relationship with distress,
despite conflicting evidence on the topic (Kugaya et al., 2000; Verdonck-de
Leeuw et al., 2007).

Results
Participants
Response rate. Overall, 59.5% of individuals (n = 119) returned the
completed questionnaire package. Most participants were recruited through the
LRCP at the London Health Sciences Centre (n = 109; 91.6%), while only a small
percentage of participants were successfully recruited through the annual
meeting of the International Association of Laryngectomees (n = 10; 8.4%).
Data analysis
Descriptive statistics. In order to assess the normality of the data
sample, descriptive statistics (e.g., means, standard deviations, frequency
distributions, and histograms) were calculated for demographic data, treatmentand disease-related variables, and the global and specific domains of each
questionnaire (e.g., Distress Thermometer, CQOLC). While the majority of
variables were normally distributed, both age (SD = 11.19) and time since
diagnosis (SD = 49.92) demonstrated a high degree of variance. Consequently,
histograms for both age and time since diagnosis were reviewed (see Figure
3.1). In essence, these data indicate that most participants in the present study
fell within the middle-aged range (e.g., between mid-forties and late-sixties) and
provided care for an individual who had received a diagnosis within the previous
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five years. Additionally, the CQOLC global and specific outcomes demonstrated
moderate-to-high degrees of variance. Consequently, statistical analyses
pertaining to these items employed the use of non-parametric statistics. The
results of the histogram analyses are shown in Figure 3.1 while additional
descriptive analyses are presented in Table 3.3.
Objective one: Presence of distress. When based on a Distress
Thermometer score of ≥ 4 (NCCN, 2013), clinically significant distress was
identified in 54 of the 119 participants (45.4%). Consequently, the incidence of
distress was higher than the predicted range of 20-40%, which was based on
currently available literature (Longacre et al., 2012). Comprehensive data on the
frequency of Distress Thermometer scores is presented in Figure 3.2.
Objective two: Perceived problems. While emotional concerns
comprised five of the eight most frequently reported problems among caregivers
(e.g., worry, 64.7%; fears, 44.5%; sadness, 43.7%; nervousness, 41.2%;
decreased interest in typical activities, 20.2%), certain physical concerns were
also prominent (e.g., sleep, 44.5%; fatigue, 43.7%; eating, 20.2%).
Comprehensive data pertaining to the frequency of perceived problems reported
by caregivers are presented in Figure 3.3.
Objective three: Relationship with quality of life. Correlations between
the dependent variables: distress, global quality of life, and the specific domains
of quality of life (e.g., burden, disruptiveness, financial concerns, and positive
adaptation) were assessed. Since the variables were continuous and because
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Figure 3.1. Histogram Representations of the Distribution of Age and Time
(Months) Since Diagnosis Data for Caregiver Participants (n = 119)
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Table 3.3
Descriptive Statistics for Caregiver Data
Variable

n

Range

Min.

Max.

Mean

SD

Age (years)

119

55

28

83

61.60

11.19

Sex

119

1

0

1

0.24

0.43

Marital status

119

2

0

2

1.08

0.31

Education

119

2

0

2

1.41

0.67

Occupational status

119

4

0

4

2.08

1.40

Household income

119

6

0

6

2.72

2.31

Relationship to patient

119

2

1

3

1.19

0.43

Time since diagnosis (months)

119

274

0

274

26.59

49.92

Recurrence

119

1

0

1

0.24

0.43

Cancer site

119

9

1

10

4.28

2.64

Speech method

119

5

0

5

0.44

1.17

Stage

119

4

0

4

1.58

1.71

Surgery?

119

1

0

1

0.65

0.48

Radiation?

119

1

0

1

0.57

0.50

Chemotherapy?

119

1

0

1

0.34

0.47

No. treatment methods

119

3

0

3

1.54

0.79

Treatment stage

119

3

0

3

1.93

0.97

Burden (CQOLC)

119

40

0

40

22.77

9.30

Disruptiveness (CQOLC)

119

28

0

28

21.74

5.74

Positive adaptation (CQOLC)

119

28

-28

0

-15.95

5.80

Financial concerns (CQOLC)

119

12

0

12

9.77

3.19

Total quality of life (CQOLC)

119

98

0

98

50.93

20.61

Distress (DT score)

119

10

0

10

3.61

2.90
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30
26

Frequency (n)

25
19

20

17

15
12

11
9

10

8

7
5

5

3

2

0
0

1

2

3

4

5

6

7

8

9

10

Distress Thermometer score
Figure 3.2. Frequency of Distress Thermometer Scores Reported Among
Caregivers of Individuals with Head and Neck Cancer

= Clinically significant distress (Distress Thermometer scores ≥ 4)

Problem Checklist items
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Worry (E)
Fears (E)
Sleep (Ph)
Fatigue (Ph)
Sadness (E)
Nervousness (E)
Eating (Ph)
Decreased interest (E)
Depression (E)
Skin dry/itchy (Ph)
Partner (F)
Work/School (Pr)
Pain (Ph)
Insurance/Financial (Pr)
Indigestion (Ph)
Nose dry/congested (Ph)
Tingling hands/feet (Ph)
Sexual (Ph)
Nausea (Ph)
Appearance (Ph)
Transportation (Pr)
Diarrhea (Ph)
Feeling swollen (Ph)
Constipation (Ph)
Breathing (Ph)
Getting around (Ph)
Mouth sores (Ph)
Spirit./Relig. Concerns (S)
Housing (Pr)
Memory/concentration (Ph)
Changes in urination (Ph)
Bathing/Dressing (Ph)
Children (F)
Child care (Pr)
Fevers (Ph)

77
53
53
52
52
49
24
24
23
23
22
15
15
14
13
13
13
9
9
9
8
8
8
7
6
6
6
4
4
4
4
3
2
2
2
0

20
40
60
80
100
Frequency of individuals reporting problem

Figure 3.3. Frequency of Reported Problems in Caregivers of Individuals with
Head and Neck Cancer
Note. (Pr) = Practical concerns; (F) = Family concerns; (E) = Emotional concerns; (S) =
Spiritual/Religious concerns; (Ph) = Physical concerns

n
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CQOLC scores did not demonstrate a normal distribution (see Table 3.3), the
Spearman’s Rank Correlation Coefficient was utilized. Data indicate that there
was a moderate-to-good degree of correlation observed between distress and
global quality of life (rs = -.521, p = .000). This statistically significant relationship
accounted for 27.14% of variance in the sample. Significant correlations were
also detected between distress and perceived burden (rs = -.606, p = .000) and
disruptiveness (rs = -.405, p = .000) subscales of the CQOLC quality of life
measure. While the burden subscale demonstrated a moderate-to-good degree
of association and explained 36.72% of the variance in respondents’ scores on
the Distress Thermometer, the disruptiveness subscale demonstrated only a fair
degree of association and, thus, only accounted for 16.40% of variance. The
relationships between distress and both financial concerns (rs = -.095, p = .305)
and positive adaptation (rs = .048, p = .604) did not reveal statistically significant
relationships.
The negative correlations between global quality of life and distress
indicated that there was an inverse relationship between distress and one’s
overall quality of life implying that as distress increases, one’s perceived level of
quality of life decreases. The same principle applies to the positive adaptation
subdomain; that is, as one’s level of positive adaptation increases, the level of
perceived distress decreases. However, due to scoring practices, inverse
correlations between the remaining subdomains of quality of life (e.g., burden,
disruptiveness, financial concerns) do not imply an inverse effect. For instance,
as one’s level of perceived burden increases, so does one’s level of distress.
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Comprehensive data pertaining to the correlations between distress and quality
of life scores among participants are presented in Table 3.4.
Objective four: The influence of demographic characteristics.
Statistical analysis was conducted utilizing Spearman’s Ranked Correlation
Coefficient for several of the variables (e.g., distress, sex, age, marital status,
occupational status, household income, level of education, and relationship to the
individual with cancer). Although data pertaining to age was collected as a
continuous variable, it did not demonstrate a normal distribution when subjected
to descriptive analysis (see Figure 3.1) and, thus, was included in the
Spearman’s Rank Correlation Coefficient analysis. Data revealed that none of
the demographic variables demonstrated a statistically significant relationship
with the perceived level of distress (see Table 3.5). Thus, no coefficients of
determination were calculated for any of the variables. Comprehensive data
pertaining to the correlations between distress and the demographic
characteristics of participants are available in Table 3.5.
In addition, an independent-samples t-test was conducted to compare
distress scores for male and female caregivers. Prior to analyzing the output of
data, Levene’s test for equality of variances was performed11. Since Levene’s
test was significant (F = 8.866, p = .004), equal variances between male and
female participants were not assumed. Data indicated that there was a significant
difference in scores between female participants (M = 3.92, SD = 3.05) and male

11

Levene’s test compares the level of variance between the two groups and when the difference
between the groups is statistically significant, equal levels of variance between the variables
cannot be assumed (Portney & Watkins, 2009).
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Table 3.4
Correlations Between Distress and Quality of Life (n = 119)

Positive

Burden

Global

Burden

Disruptive

Adapt.

Finance

QOL

Distress

1

.579*

.168

.274*

.889*

-.606*

.000

.067

.003

.000

.000

1

-.017

.334*

.723*

-.405*

.852

.000

.000

.000

1

.015

.381*

.048

.867

.000

.604

1

.398*

-.095

.000

.305

1

-.521*

Spearman’s
rho
Correlation
p level

Disruptiven

Spearman’s

ess

rho
Correlation
p level

Positive

Spearman’s

Adaptation

rho
Correlation
p level

Financial

Spearman’s

Concerns

rho
Correlation
p level

Global

Spearman’s

QOL

rho
Correlation
p level

Distress

.000

Spearman’s
rho
Correlation
p level

* Correlation is significant at the minimum level of p ≤ 0.05 level (2-tailed).

1
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Table 3.5
Correlations Between Distress and Demographic Characteristics (n = 119)

Age

Marital

Occup.

Relation

Age

Status

Status

Income

Educat.

ship

Distress

1

-.217

-.584*

-.387*

-.212

-.311*

-.173

.018

.000

.000

.020

.001

.060

1

.195

-.041

.112

.382*

-.024

.033

.660

.225

.000

.796

1

.216*

.145

.187*

.076

.018

.115

.041

.411

1

.267*

.110

.177

.003

.233

.054

1

.100

.017

.277

.857

1

-.010

Spearman’s
rho
Correlation
p level

Marital

Spearman’s

Status

rho
Correlation
p level

Occupation

Spearman’s

Status

rho
Correlation
p level

Household

Spearman’s

Income

rho
Correlation
p level

Education

Spearman’s
rho
Correlation
p level

Relationship

Spearman’s

to patient

rho
Correlation
p level

Distress

.915

Spearman’s
rho
Correlation
p level

* Correlation is significant at the minimum level of p ≤ 0.05 level (2-tailed).

1
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participants (M = 2.655, SD = 2.13; t (68.06) = 2.49, p = .015, two-tailed),
suggesting higher perceived distress among female caregivers. However, the
magnitude of the differences in the means (mean difference = 1.27, 95% CI: .25
to 2.28) was small (Eta Squared = 0.02) (Cohen, 1988), since only 2% of the
variance in caregiver distress was explained by sex.
Objective five: Distress and patient-related characteristics. Data
revealed that disease stage, number of treatment methods, and length of time
since diagnosis did not demonstrate a significant correlation with distress. As a
result, no coefficients of determination were calculated for the variables.
Comprehensive data pertaining to the correlations between caregiver distress
and the disease- and treatment-related variables of individuals diagnosed with
head and neck cancer are presented in Table 3.6.
In addition, an independent-samples t-test was conducted to compare
distress scores for caregivers of individuals with head and neck cancer who had
experienced a recurrence in disease versus those who had not experienced a
recurrence. Since Levene’s test for equality of variances was not significant (F =
1.22, p = .271), equal variances between the groups were assumed. Contrary to
our prediction, there was no significant difference in distress scores for
caregivers of individuals who had experienced a recurrence (M = 4.31, SD =
2.56) versus caregivers of those who had not experienced a recurrence (M =
3.39, SD = 2.97; t (117) = -1.489, p = .137, two-tailed). The magnitude of the
differences in the means (mean difference = -.92, 95% CI: -2.14 to .30) was small
(Eta Squared = 0.01) since only 1% of the variance in caregiver distress was
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Table 3.6
Correlations Between Distress and Patient-Related Variables (n = 119)
Number of

Disease

Spearman’s

Stage

rho

Disease

Treatment

Time Since

Stage

Methods

Diagnosis

Distress

1

.375

.095

-.034

.000

.303

.710

1

.208

-.037

.023

.686

1

-.168

Correlation
p level
Number of

Spearman’s

Treatment

rho

Methods

Correlation
p level

Time Since

Spearman’s

Diagnosis

rho
Correlation
p level

Distress

.068

Spearman’s
rho
Correlation
p level

* Correlation is significant at the minimum level of p ≤ 0.01 level (2-tailed).

1
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explained by disease recurrence. Thus disease recurrence was neither a
statistically, nor clinically significant factor influencing caregiver distress in this
sample of participants.
A one-way between-groups ANOVA was also performed in order to
explore the impact of treatment stage on level of distress. Participants were
divided into three groups according to their stage in the treatment process (e.g.,
awaiting treatment, undergoing treatment, completed treatment) with a fourth
group denoting those who did not specify the treatment stage of their loved one.
Levene’s test was not violated (p = .112). There was a statistically significant
difference at the p < .05 level in distress scores between the treatment statusrelated groups: F (3, 115) = 6.90, p = .000. In addition to reaching statistical
significance, the actual difference in mean scores between the groups was
substantial. The effect size, calculated using Eta Squared, was .15, indicating a
large effect (Cohen, 1988). Post-hoc comparisons using the Tukey’s Honestly
Significant Difference12 (HSD) test indicated that the mean distress score for
caregivers of individuals awaiting treatment (M = 4.81, SD = 2.74) was
significantly different from caregivers of those who had completed treatment (M =
2.28, SD = 2.29). Caregivers of individuals currently undergoing treatment (M =
3.76, SD = 3.02), and caregivers who did not specify treatment stage (M = 4.83,
SD = 3.92) did not differ significantly from caregivers of those who had either
completed treatment or were awaiting treatment.

12

Tukey’s honestly significant difference is “a multiple comparison test for comparing multiple
means following a significant analysis of variance” (Portney & Watkins, 2009, p.878).
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Discussion
The overarching aim of this investigation sought to explore the factors that
contribute to elevated distress and decreased quality of life in caregivers of
individuals with head and neck cancer. Specifically, this inquiry aimed to expand
the literature on caregiver distress to include considerations of the influence of
treatment status on caregiver distress, in addition to both the newly diagnosed
and long-term follow-up (e.g., survivorship) phases of the continuum of care.
Further, this project utilized an ultrashort measure of distress (e.g., the Distress
Thermometer) in a sample of caregivers of individuals who had been diagnosed
with head and neck cancer. Relative to the precise objectives of this study, a
number of areas of inquiry related to distress were explored.
Incidence of distress
With regard to the first objective concerning the presence of distress in
caregivers of individuals diagnosed with head and neck cancer, data revealed
that distress was present in approximately 45% of participants, which is notably
higher than our prediction and previously reported rates of between 20% in one
sample (Verdonck-de Leeuw et al., 2007) to 38% in others (Drabe et al., 2008;
Ross et al., 2010). The variability in reported incidence rates of distress in
caregivers may be related to a number of factors including the severity of
disease, which has previously been shown to influence distress in individuals
with head and neck cancer (Kugaya, Akechi, Okamura, Mikami, & Uchitomi,
1999; Kugaya et al., 2000). For instance, earlier research has noted a predictive
relationship between advanced stage head and neck cancer and psychologic
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distress (Kugaya et al., 2000). This relationship between advanced stage of
disease and distress in head and neck cancer may be attributed to several
potential factors including malnutrition (Neilson et al., 2012), physiologic
dysfunction (Ettema, Reminger, & Robbins, 2013), and poor performance status
(Kirkova et al., 2009), among others. Furthermore, the sheer fact that an
individual has been diagnosed with a late-stage level of disease (e.g., T3 or T4)
may produce feelings of distress (Kugaya et al., 2000).
Additionally, differences in the way that distress is defined and/or
diagnosed may contribute to the variability in reported rates of distress in
caregivers; for instance, studies utilizing formal, structured diagnostic instruments
or interviews tend to detect lower rates of distress than those which utilize selfreport inventories (Miller & Massie, 2009), such as the one utilized in this study.
The reason for this disparity may be related to the fact that diagnostic
instruments and/or interviews seek specific information related to the presence of
a diagnosable, pathologic condition (e.g., clinical depression, generalized anxiety
disorder), whereas self-report distress measures generally seek to identify a
broad continuum of distress-related experiences (e.g., lower threshold of
distress), and may include more inclusive criteria related to distress-inducing
factors (e.g., symptom distress, practical problems). Consequently, the higher
incidence rate of distress detected in the present study may be related to the use
of the self-report distress screening measure (e.g., the Distress Thermometer),
as opposed to a structured diagnostic measure of clinical depression.
Additionally, a number of authors have also suggested that the recommended
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cutoff score for determining clinically significant distress on the Distress
Thermometer (e.g., scores greater than or equal to four) should be altered (e.g.,
raised or lowered) in order to optimize the accuracy of the Distress Thermometer
(Akizuki et al., 2003; Dolbeault et al., 2008; Gessler et al., 2008; Gil, Grassi,
Travado, Tomamichel, & Gonzalez, 2005; Hegel et al., 2008; Vodermaier et al.,
2009).
Despite the recommendation by the creators of the Distress Thermometer
to use a cutoff score of four (NCCN, 2013), previous research conducted with the
Distress Thermometer has used both the recommended cutoff score, and other
self-designated cutoff scores which included scores of three (Dolbeault et al.,
2008; Dolbeault et al., 1999; Gil et al., 2005) and seven (Hegel et al., 2008;
Vodermaier et al., 2009), with a cutoff score of five (Akizuki et al., 2003; Butt et
al., 2008; Gessler et al., 2008; Trask et al., 2002; Tuinman, Gazendam-Donofrio,
& Hoekstra-Weebers, 2008) representing the most common alternative to the
creator-recommended score of four (NCCN, 2013).
The debate over which cutoff score provides the most accurate
assessment of actual distress appears to stem from a series of validation studies
performed on individuals afflicted with a range of cancer sites (e.g., breast, lung,
brain, colorectal, prostate, ovarian, head and neck, bone, bladder, non-Hodgkin’s
lymphoma, etc.) (Butt et al., 2008; Jacobsen et al., 2005), and treatment states
including those awaiting treatment (Trask et al., 2002), in active treatment (Butt
et al., 2008; Jacobsen et al., 2005) and those in survivorship (Recklitis, Licht,
Ford, Oeffinger, & Diller, 2007). The creators of the Distress Thermometer have
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recommended utilization of a cutoff score of 4 for distress screening purposes.
This recommendation has been verified through the validation efforts of other
researchers in both patient (Hoffman, Zevon, D'Arrigo, & Cecchini, 2004;
Jacobsen et al., 2005; Ransom, Jacobsen, & Booth-Jones, 2006) and caregiver
(Zwahlen et al., 2008) populations. As such, the present study employed the
recommended cutoff score for analysis purposes and consequently, the lower
cutoff score (in contrast to a score of five, or even seven) may have contributed
to the elevated rate of distress detected in this sample. Interestingly, if the
frequently used cutoff score of five had been utilized in the present study, the
presence of distress would have been reduced to 39.5% of participants (n = 47)
in contrast to the current rate of 45.4% of participants (n = 54). Thus, in terms of
difference between groups, the actual percentage of difference when comparing
Distress Thermometer cutoff scores of four versus five is relatively small (5.9%)
in the present sample. In addition, the elevated rate of distress detected in this
sample may have been related to a host of other factors including the range of
perceived problems experienced by caregivers.
Perceived problems
As predicted, emotional concerns such as worry, fear, sadness,
nervousness, and decreased interest in usual activities, represented the most
frequently reported problems among caregiver participants. However, physical
concerns such as difficulties with sleep, fatigue and appetite were also noted
frequently, followed by problems with one’s partner and additional practical and
physical concerns. Interestingly, the most commonly reported physical concerns
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(e.g., sleep, fatigue, appetite) were well aligned with the diagnostic criteria for
depression (Miller & Massie, 2009). A diagnosis of major depression consists of
symptoms, which last for at least two weeks, and include depressed mood or
anhedonia (i.e., the inability to experience pleasure from activities typically found
to be enjoyable) in addition to four of the following symptoms experienced daily:
altered appetite; fatigue; guilt; worthlessness; diminished concentration; insomnia
or hypersomnia; psychomotor retardation or agitation; or recurrent thoughts of
death including suicidal ideation (Miller & Massie, 2009). Notably, the
development of major depression is not a typical or anticipated response in
caregivers of individuals with head and neck cancer, however, it may be
considered a significant complication of the caregiver role that requires
individualized assessment and treatment given its potential to compromise the
quality of life and functional status (Miller & Massie, 2009) of the caregiver.
Regardless of the severity of the symptoms detected, the identification of
elevated distress and perceived problems in caregivers of individuals with head
and neck cancer may permit healthcare practitioners to offer targeted
psychosocial support and interventions in an effort to decrease distress and
reported problems in caregivers. While the Problem Checklist is by no means a
comprehensive measure of the potential range of problems facing a caregiver, it
does provide some insight into some of the most commonly reported areas of
concern.
While emotional and physical problems were the most frequently reported
concerns among caregivers in the present study, the prevalence of these reports
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should not in any way diminish the impact of less frequently reported problems
such as “memory/concentration” or “dealing with children”, since issues such as
these have the potential to be tremendously distressing for caregivers. In
essence, the subjective experience of an item such as, “problems dealing with
partner” cannot be inferred through simple acknowledgment on a questionnaire.
Consequently, considerations of one’s subjective quality of life remain important
in order to better understand the experience of distress in caregivers of
individuals with head and neck cancer.
Relationship with quality of life
Quality of life refers to an individual’s subjective perception of their
position in life relative to a variety of factors that may include one’s “physical
health, psychological state, level of independence, social participation” (WHO,
1998, p.17), among other components. Key to this broad-ranging concept is the
fact that all of these factors must be considered collectively and from the
perspective of the individual in order to account for the meaning and emphasis
that may be placed on one area over another. Therefore, in order for
assessments of quality of life to be useful for clinical or research purposes, they
must be able to account for the factors most relevant to one’s current life
situation. Due to the numerous potential concerns of a caregiver of an individual
with head and neck cancer, a key objective of the present study was to evaluate
the perceived quality of life of caregivers both globally, and relative to a number
of specific areas known to be problematic for caregivers. Thus, caregiver quality
of life was measured through an individual’s experience of burden, the disruption
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caused to their life, their financial concerns, and any positively adaptive
behaviour that may have reduced the negative impact of the disease. In addition,
one’s overarching assessment of quality of life was also evaluated. It is clear that
multiple facets of concern influence perceived quality of life, thus, the ability to
address an array of areas that may be impacted for the caregiver is essential.
Relative to global quality of life, the current data indicated that caregiver
distress and quality of life were inversely related to a moderate extent. This
inverse relationship between the two constructs suggests that as one’s level of
distress increased, perceived quality of life decreased. This finding is similar to
previous work in samples of individuals diagnosed with head and neck cancer
(Bornbaum et al., 2012; Pandey et al., 2009). Given that there is often a
tremendous burden placed on caregivers to provide physical, psychological, and
practical support (Blood et al., 1994), disruptions to one’s quality of life and
psychological well-being are understandable. In addition to global quality of life,
significant relationships were also detected between the burden and
disruptiveness domains of the caregiver quality of life measure; a finding that
aligned with our earlier predictions.
Caregiver burden is a commonly acknowledged phenomenon among
psychosocial oncology scholars (Stenberg, Ruland, & Miaskowski, 2010). The
concept of burden in head and neck oncology has been evaluated as both a
correlate of distress (Verdonck-de Leeuw et al., 2007) and as a psychological
outcome of providing care for an individual with cancer (Blood et al., 1994; Chen
et al., 2009). Similar to Verdonck-de Leeuw et al. (2007), the present study
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demonstrated a significant relationship between caregiver burden and perceived
distress. Ultimately, because measures of caregiver burden purportedly assess
the psychological impact of providing care, its significant correlation with
perceived distress, also a psychological construct, is logical. In addition, the
concept of disruptiveness (also commonly referred to as “caregiver strain”)
measured the adverse impact of providing care on the life of the caregiver
(Longacre et al., 2012). Relative to the CQOLC measure, disruptiveness was
evaluated through such item subjects as, “impact on daily schedule”,
“maintenance of outside activities”, and “responsibility for patient’s care”, among
others (Weitzner et al., 1999). When correlated with distress, disruptiveness
demonstrated a fair relationship that was determined to be statistically significant.
These findings are particularly salient given that previous research has
determined that greater perceived disruption to an individual’s daily routine was
associated with poorer psychological health (Blood et al., 1994).
Interestingly, results from the present study suggest that one’s ability to
adapt positively to the situation did not impact the perceived level of distress
detected among participants. These findings are consistent with previous
research conducted by Ross and colleagues (2010). Additionally, financial
concerns, evaluated through items related to “financial strain”, “insurance
coverage”, and one’s “anticipated economic future” (Weitzner et al., 1999), were
not shown to influence caregiver distress. This finding was consistent with
frequency data obtained through the Problem Checklist, where just over 10% of
participants noted problems with finances and/or insurance. Previous
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researchers have also noted the lack of a relationship between caregiver distress
and socioeconomic factors (Ross et al., 2010). In order to further explore the role
of financial status and other personal characteristics of caregivers, analysis of the
demographic factors relative to distress may provide useful insights.
The influence of demographic characteristics
As anticipated, no statistically significant correlations were detected
between perceived distress level and the majority of demographic characteristics
of caregivers. While the literature on existing relationships between caregiver
distress and demographic factors is mixed (Baghi et al., 2007; Ross et al., 2010;
Verdonck-de Leeuw et al., 2007), our data suggesting no significant correlations
with caregiver distress were aligned with the findings of earlier research (Ross et
al., 2010; Verdonck-de Leeuw et al., 2007). Interestingly, a small but significant
difference in perceived distress was detected between male and female
participants, with a higher level of distress reported by female caregivers. Thus,
the hypothesis that sex would demonstrate a moderate relationship with distress
was not entirely supported given the small magnitude of effect detected in this
sample. Several other authors have reported similar results when investigating
differences between the sex of caregivers (Baghi et al., 2007; Blood et al., 1994;
Zwahlen et al., 2011). However, when the effect size of the current data was
determined, the actual effect of this difference was found to be quite small
suggesting that the influence of one’s sex only accounted for a small proportion
of the variance in perceived distress among participants. Given that the
demographic characteristics of participants did not serve to explain the high rate
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of distress detected in this sample, examination of the disease- and treatmentrelated characteristics of the individuals with cancer may provide a greater
degree of insight into the factors related to elevated distress in caregivers of
individuals with head and neck cancer.
Distress and patient-related characteristics
As predicted, disease stage and number of treatment methods did not
demonstrate a statistically significant relationship with the perceived level of
distress. Additionally, in line with earlier findings (Blood et al., 1994), it was
hypothesized that the length of time since diagnosis would demonstrate a small,
but significant relationship with distress. While this prediction did not prove to be
accurate in the present sample, it did highlight some items that warrant further
consideration. Relative to the length of time since diagnosis, the present study
included a wide range of caregiving experiences. Specifically, this sample
consisted of a range of caregivers of individuals who were less than a week from
the point of diagnosis to those supporting long-term survivors (>20 years).
Existing research into the experience of caregivers of individuals with head and
neck cancer centers around data collected between two and 48 months postdiagnosis (Hodges & Humphris, 2009; Ross et al., 2009; Verdonck-de Leeuw et
al., 2007; Blood et al., 1994), in addition to a subset of work focused on issues in
short- to medium-term survivorship (e.g., one to five years following diagnosis)
(Mellon et al., 2007). However, concerns may arise at any point along the
continuum of care in oncology, from the point of a new diagnosis continuing
through long-term survivorship (e.g., greater than 10 years following diagnosis)
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phases. While no statistically significant effect was found related to the length of
time since the individual’s diagnosis, current findings suggest that perhaps it is
not the length of time that influences distress, but rather one’s position along the
continuum of care. For instance, analysis of the impact of treatment stage (e.g.,
awaiting treatment, currently undergoing treatment, completed treatment)
revealed a significant difference in distress scores between caregivers of those
who were awaiting treatment when compared with those who had completed
treatment. Further, this difference demonstrated a large effect, suggesting that
one’s treatment stage may have a sizeable and significant impact on perceptions
of caregiver distress. While additional work is required in order to verify this
relationship, the present findings suggest an interesting area for future research,
particularly given the potential implications for providing caregiver-targeted
psychosocial interventions. In addition, any examination of caregiver distress
would be remiss without consideration of factors that may serve to potentially
confound the results of the analyses.
Possible confounding factors
Distress is a natural human experience, which may arise from, or be
exacerbated by consequences unrelated to the cancer or the role of providing
care (NCCN, 2013). Consequently, information related to possible confounding
factors was collected from caregivers in an effort to identify any life events that
may have potentially influenced the distress level of the caregivers. Relative to
the collection of the data, no specific criteria for the type of information to be
disclosed were outlined, however participants were invited to share any
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information that they felt may have influenced their distress or quality or life at the
time of the survey. Consequently, a broad range of responses was collected from
participants.
Regarding the specific disclosures of possible confounding factors, one
participant reported the recent loss of a sibling while another informed the team
that she had recently undergone surgery and was still recovering despite
providing care for her husband. One participant disclosed that she was a breast
cancer survivor while another noted that he had been a caregiver twice before.
Understandably, these experiences may have directly influenced, either
positively or negatively, the manner in which these individuals approached their
role as a caregiver.
Relative to the perceived level of reported distress, both the individual who
had recently lost her sibling and the participant who had recently undergone
surgery reported clinically significant levels of distress according to the Distress
Thermometer (both participants reported Distress Thermometer scores of five).
However, the cancer survivor and the participant who had previously served as a
caregiver reported low levels of distress (Distress Thermometer scores of three
and zero, respectively). While the frequency of these reports is far too low to
draw any definite conclusions, future research into the influence of personal
survivorship from cancer and previous experience as a caregiver may provide
interesting insights into how individuals cope and experience the caregiver role
following these life experiences.
Limitations
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As with any research protocol, certain limitations must be considered.
First, while two venues were used for recruitment in an effort to enhance the
external validity of the data to a group beyond Southwestern Ontario, data
accrual from the international site was minimal. Consequently, the increased
generalizability that was sought cannot be assumed in the present sample.
Second, the demographic measure used in the present study did not
directly assess whether the participant had previously served as a caregiver for
an individual with cancer (or another chronic illness). It also did not directly
assess if the caregiver themselves had previously been diagnosed with or
treated for cancer. In retrospect, data of this type may have provided valuable
information relative to one’s perceived levels of distress and quality of life
throughout their caregiving experience. Future research regarding distress in
caregivers should ensure to take one’s previous experience as a caregiver
and/or as a cancer survivor into consideration in order to comprehensively
address the multidimensional issues related to distress in caregivers of
individuals with cancer.
Third, this study did not evaluate psychological characteristics of
caregivers, existing social support, or coping mechanisms, all of which may have
provided useful information related to the high levels of distress detected in
participants. For instance, a pessimistic attitude, poor levels of social support,
and maladaptive coping styles have been associated with psychological strain in
individuals with cancer (Shapiro, Lopez, Schwartz, Braden, & Kurker, 2001).
Thus, in order to account for a broader range of psychosocial factors that may
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have contributed to perceptions of distress in caregivers of individuals with head
and neck cancer, it is recommended that future inquiries assess a broader range
of psychological characteristics of the participants.
Lastly, in an effort to broaden the spectrum of time since diagnosis in
caregiver participants to include both newly diagnosed and long-term survivors, a
cross-sectional research design was employed for this study. However, crosssectional research designs do not permit causal analysis of factors that may
contribute to distress and perceived quality of life. Consequently, it is
recommended that future research into distress and quality of life in caregivers of
individuals with head and neck cancer employ research designs that are
prospective and longitudinal in nature. Such designs are appropriate in efforts
that seek to evaluate potential causal relationships between distress and the
factors which serve to induce and/or exacerbate it.
Conclusion
This study was designed to investigate and describe distress, quality of
life, and commonly reported problems in caregivers of individuals diagnosed with
head and neck cancer. Data indicated that distress was present in approximately
45% of all participants and that both caregiver sex and the treatment status of the
individual with head and neck cancer influenced perceptions of distress in
participants. Additionally, an inverse relationship between quality of life and
distress was evident, suggesting that as one’s level of distress increases,
perceived quality of life may consequently decrease. Perceived burden and the
level of disruptiveness to one’s life were significantly related to a caregiver’s
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reported level of distress. Emotional concerns were most frequently identified as
problematic by caregivers, followed closely by physical concerns that are closely
related to experiences of depression and grief (e.g., problems with sleeping,
fatigue, eating) (American Psychological Association, 2000; Miller & Massie,
2009). This study further revealed that being a female caregiver who provides
care for an individual who is either awaiting treatment or who has completed
treatment may contribute to elevated levels of perceived distress. In addition, the
Distress Thermometer proved to be a valuable screening tool for distress within
the present study.
Since data from the present investigation revealed that distress and the
problems associated with it, are indeed prevalent in caregivers of individuals with
head and neck cancer, and since caregivers often do not directly request
assistance for their distress and/or broader concerns (Zwahlen et al., 2011),
caregiver distress and the factors which serve to exacerbate it are often
overlooked by those most able to provide assistance (e.g., medical professionals,
psychologists, social workers, etc.). Ultimately, the goal of conducting research
into caregiver distress is to support caregivers’ ability to provide effective care
without sacrificing their own health and well-being (Northouse, Katapodi,
Schafenacker, & Weiss, 2012). Consequently, an important first step in the
process is to identify the factors that most significantly influence distress in
caregivers and thus inhibit their ability to deliver care. Therefore, if distress can
be identified early through efficient distress screening mechanisms and
addressed in a constructive manner, then perhaps the quality of life of caregivers
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– and by extension the experience of the individuals for whom they provide care
– may be enhanced.
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Chapter 4
General Discussion and Integration of Findings

The overarching purpose of this program of research sought to provide
insight into the experience of distress and quality of life in individuals with head
and neck cancer and that of their caregivers. The first study (Chapter 2)
examined both the presence and trajectory of distress in addition to quality of life
concerns and commonly reported problems among individuals with head and
neck cancer. This focus was also enhanced with the solicitation of information at
standardized three-month intervals throughout the first year following diagnosis.
The second study (Chapter 3) explored these same dimensions (e.g., distress,
quality of life, and commonly reported problems) from the perspective of
caregivers of individuals with head and neck cancer. Collectively, this program of
research sought to provide a multidimensional perspective on how living with
head and neck cancer – either as a person with the disease or as a caregiver –
may contribute to perceptions of distress and quality of life at various points
throughout the continuum of care. To this end, the integration of findings from
both the individual- and caregiver-based studies will be discussed in the following
sections; this will include interpretation in the context of both research and clinical
implications.
Distress in head and neck cancer
In general, findings from the present studies have demonstrated that
elevated distress can exist at any point along the continuum of care in both
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individuals with head and neck cancer and their caregivers. In particular, data
pertaining to individuals with head and neck cancer indicated that distress was
most prevalent at the point of diagnosis and that the length of time following
diagnosis had a large effect on the level of perceived distress. These findings
suggest that for some individuals, time may be an important factor in adapting to
the challenges associated with the diagnosis of head and neck cancer and its
treatment. However, the elevated rates of distress detected throughout the
continuum of care in individuals with head and neck cancer suggest that for
others, distress may remain an ongoing concern. Meanwhile, data from the
caregiver study indicated that distress was present in approximately 45 percent
of all caregiver participants. Further, both the sex of the caregiver and the
treatment status (i.e., awaiting treatment, undergoing treatment, completed
treatment) of the individual for whom they were providing care influenced
perceptions of distress in caregivers. Additionally, the level of perceived burden
and disruptiveness to one’s life were significantly related to a caregiver’s reported
level of distress. Despite these trends, it is important to acknowledge that
individualized responses and variability in data can be expected due to the
multidimensional subjective nature of distress.
Notably, an important finding from this program of research was that
analyses based on mean or frequency-related data alone may reveal only a
small fragment of the phenomenon of distress in oncology. To elaborate, when
individual trajectories of distress were analyzed longitudinally, distinct patterns
emerged (e.g., high-decreasing, low-increasing, consistently low, persistently
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high reports of distress). This finding provides clear evidence that perceptions of
distress are indeed individualized and heterogeneous in nature. Similar patterns
of distress have also been reported in caregiver populations (Choi et al., 2012).
Consequently, future work that centers on elucidating trajectories of distress (i.e.,
through growth mixture modeling) in both patient and caregiver populations may
be important for enhancing our understanding of persistent, or chronic distress in
these individuals. However, despite the potential benefits of trajectory-based
research, the sheer prevalence and perceived severity of distress observed in
the present studies suggests that better identification of distress is important in
order to facilitate the provision of support for those who require it most. As such,
the employment of routine distress screening represents a critical first step in the
identification of elevated distress in both those with head and neck cancer and
their caregivers.
Accordingly, use of the Distress Thermometer with its accompanying
Problem Checklist revealed that the potential sources of distress in participants
were often multifaceted. As such, data from the present studies suggest that not
everyone who experienced clinically significant distress would necessarily meet
the standard criteria for a diagnosis of major depression or an anxiety disorder
(American Psychological Association [APA], 2000). These findings are important
because they broaden our understanding regarding the range of factors (e.g.,
problems with partner, children, insurance, finances, work, housing,
concentration, etc.) that may contribute to elevated distress in both caregivers
and those with head and neck cancer. Currently, most of the commonly used
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distress assessment measures (e.g., Brief Symptom Inventory, Beck Depression
Inventory, Hospital Anxiety and Depression Scale, etc.) evaluate the construct of
distress according to the criteria for depression and/or anxiety disorders (Beck,
Steer, & Brown, 1993; Derogatis, 2001; Zigmond & Snaith, 1983). Granted,
distress is defined as an unpleasant emotional experience, but as noted in the
definition offered by the National Comprehensive Cancer Network (NCCN), it is
also a multifactorial and multidetermined experience (NCCN, 2013). That is,
distress emerges as a clinical entity due to the multiple domains that are
influenced by myriad factors that may change dramatically over time, even over
relatively short temporal periods. Consequently, it is important that assessments
of distress in oncology utilize an accompanying multidimensional Problem
Checklist (or similar multi-item measure) to ascertain specific information
regarding the myriad potential sources of distress in individuals with head and
neck cancer and their caregivers (e.g., problems with family, employment,
nutrition, spirituality, etc.). It is through the consideration of these perceived
problems and the subjective experience of them, that we may be able to better
target the sources of support that are required in order to alleviate or mitigate
elevated distress in these individuals.
Considerations of quality of life and commonly reported problems
It is apparent from the present studies that the concerns facing individuals
with head and neck cancer and their caregivers are diverse and multidimensional
in nature. Relative to the subjective experiences of participants, findings from the
present work suggest that numerous quality of life concerns exist for both
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individuals with head and neck cancer and caregivers at various stages
throughout the continuum of care. While the specific concerns cited by
participants were diverse and clearly based on each person’s experience as
either the individual with cancer or the caregiver, the common theme that
emerged from participants in both studies pertained to the perception of elevated
burden in three primary domains: role fulfillment, physical functioning, and
psychological well-being.
Specifically, concerns related to one’s ability to fulfill meaningful roles and
responsibilities were cited by both caregivers and individuals with cancer. Role
functioning was assessed according to an individual’s ability to meet work-related
obligations, engage in daily activities, and pursue hobbies and/or other leisure
time activities (Aaronson et al., 1993; Weitzner, Jacobsen, Wagner, Friedland, &
Cox, 1999). The ability to fulfill one’s “roles” in life (e.g., as an employee, spouse,
parent, etc.), or more importantly, the potential inability to fulfill roles due to
illness or the demands associated with caring for one who is ill, serves as a
critical barometer of perceived well-being and associated quality of life. Given
that previous research has determined that greater perceived disruption to an
individual’s daily routine resulted in poorer psychological health (Blood, Simpson,
Dineen, Kauffman, & Raimondi, 1994), the decreased role functioning observed
in both participant sets in the present studies suggests that these individuals may
be more susceptible to experiencing elevated distress. A recent investigation into
the relationship between role functioning and distress has reported similar
findings (Mols, Thong, de Poll-Franse, Roukema, & Denollet, 2012).
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Furthermore, existing data on factors that contribute to role functioning in
individuals with cancer and caregivers has determined that one’s level of
symptom burden (e.g., fatigue, appetite loss, insomnia, etc.) directly influences
one’s ability to fulfill role-based activities and obligations (Aaronson et al., 1993;
Bjordal et al., 2001; Given et al., 2004). Collectively, these data suggest that the
experience of head and neck cancer, whether as a patient or caregiver, is
marked by disruption to multiple interrelated domains of functioning, with an
emphasis on decrements to psychological, role and physical functioning (i.e.
symptom burden).
With regard to the issue of reported symptom burden in the present
studies, not unexpectedly, physical concerns were reported by most individuals
with head and neck cancer throughout the year following diagnosis. Clinically
significant increases in symptom burden were observed for several symptoms at
the three-month assessment (e.g., pain, trismus, xerostomia, sticky saliva, etc.).
While most symptoms had resolved by the one-year follow-up, clinically
significant problems related to xerostomia and decreased taste and smell
persisted. Given that several of the participants underwent radiation therapy as a
component of their treatment protocol, and since radiation therapy to the head
and neck region is known to cause these types of treatment-related problems
(Hunter & Jolly, 2013), these findings were consistent with previous research.
Additionally, while one might anticipate physical concerns to be prevalent for an
individual with head and neck cancer given that he or she must live with the
physical consequences of the disease and its treatment, results from the
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caregiver study suggest that caregivers also experience an increased level of
perceived physical burden while serving as a caregiver.
Interestingly, the most prominent physical concerns reported by caregivers
(e.g., problems with sleep, fatigue, appetite) were closely aligned with the
diagnostic criteria for depression (Miller & Massie, 2009). While a formal
assessment of depression was not conducted in the present study for the
caregivers, the presence of physical symptoms that have been established as
physical correlates of depression, suggests that this is an area worth
investigating further relative to the caregiver experience. While development of
depression is not believed to be a typical response in caregivers, it may be
characterized as a significant complication secondary to the increasing demands
of the caregiver role. As such, it may require individualized assessment and
treatment given its potential to compromise quality of life and functional status
(Miller & Massie, 2009).
With respect to elevated psychological burden, in several instances in the
present work both caregivers and those with head and neck cancer revealed the
highest proportion of concerns on the Problem Checklist as emotional problems
including worry, fears, sadness, nervousness, among others. While the Problem
Checklist does not assess the perceived severity of the problem experienced, the
fact that such a high proportion of participants in both studies reported multiple
emotional items as being problematic (and in the case of the patient study, these
concerns persisted over time) suggests that emotional problems are common. As
such, emotional concerns in those with head and neck cancer and those that
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emerge in caregivers likely warrant further investigation and subsequent action
towards the mitigation of these concerns where possible. Adding support to this
interpretation, previous researchers have also suggested that “the ideal
screening system would include a useful distress screening tool in combination
with a Problem Checklist” (Zabora & MacMurray, 2012, p.632). Ultimately, the
present findings support the notion that multidimensional concerns in caregivers
and individuals with head and neck cancer do in fact exist and that these issues
must be carefully considered and addressed as part of the comprehensive care
process. If such a consideration is avoided or disregarded, it is possible that
one’s level of distress (and the factors contributing to its exacerbation) would
increase in severity with consequent reductions to one’s perceived quality of life.
Ultimately, distress is a dynamic experience that can become increasingly
elevated and burdensome when significant concerns are not addressed in a
timely manner. As such, the early identification and management of clinically
significant distress is imperative.
Identifying and responding to psychological distress
In order to respond to the consequences of distress among individuals
with head and neck cancer and their caregivers, it is imperative to first recognize
its presence. Despite the fact that distress may be causing disruptions in daily
functioning, many individuals may actively conceal their distress from their
primary physician and healthcare team (Weisman, 1976; Zabora & MacMurray,
2012). Individuals displaying such behaviour may rationalize their secretive
response as an appropriate one because they believe that their physician and
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healthcare team members need to focus their energy on the treatment of the
disease (Zabora & MacMurray, 2012), or in the case of caregivers, of their loved
one’s disease (Zwahlen, Hagenbuch, Jenewein, Carley, & Buchi, 2011).
Additionally, individuals may not feel comfortable acknowledging that they are not
coping as well as they believe they should be and that, in fact, they require
assistance. Conversely, oncologists and healthcare team members may lack the
time or skills required to accurately identify and refer individuals exhibiting
significant distress to the appropriate psychological resources (Carlson & Bultz,
2004; Sollner, 2001; Zabora, Loscalzo, & Weber, 2003). The intersection
between these two areas of concern (i.e., the inability or unwillingness of either
the patient or clinician to address the problem) may have devastating
consequences. More specifically, the outcome of these combined elusive
approaches is the collective avoidance of the problem in both those with cancer
and their loved ones. Consequently, distress may remain undisclosed and only
become apparent when it has increased to a point where the individual is no
longer able to independently manage the situation. This in turn may then create a
cascade of psychosocial consequences that become increasingly problematic
throughout the post-diagnostic trajectory.
Undetected and untreated distress in individuals with cancer has been
associated with poorer medical outcomes, decreased compliance and patient
satisfaction, and increased healthcare costs (Carlson & Bultz, 2004; Zabora,
Loscalzo, & Smith, 2000). Furthermore, unidentified distress may manifest
physically as a variety of somatic complaints (e.g., pain, fatigue, etc.), which
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physicians may respond to by ordering diagnostic tests and treatments that may
be costly and unnecessary (Breslau, Curbow, Zabora, & Britzenhofeszoc, 2001;
Zabora & MacMurray, 2012). This manifestation of physical symptoms in
connection with one’s psychological state highlights an important observation
pertaining to the relationship between physical and psychological domains. That
is, while domains of functioning (e.g., physical, psychological, social, spiritual,
role, etc.) may appear to be discrete entities, in fact they are intrinsically dynamic
and deeply interrelated with one another. Furthermore, the biopsychosocial
consequences of this connection between functional domains are evident in not
only those with head and neck cancer, but also in their caregivers.
Research has indicated that untreated caregiver distress not only
compromises psychological well-being, but may also result in physical changes
to the immune system that can limit glucose control, promote flare-ups in
autoimmune diseases, and increase vulnerability to cardiovascular diseases
(Rohleder, Marin, Ma, & Miller, 2009). Thus, a pervasive consequence evident in
research related to unresolved distress, is that of elevated symptom burden both
in those with cancer (Aaronson et al., 1993; Bjordal et al., 2001; Given et al.,
2004) and their caregivers (Stenberg, Ruland, & Miaskowski, 2010). Interestingly,
quality of life data from the present study of individuals with head and neck
cancer found that all but one domain (i.e., role functioning) of the observed
clinically significant changes in quality of life scores to be symptom-related (e.g.,
pain, weight, appetite loss, eating, insomnia, trismus, xerostomia, sticky saliva,
decreased senses). Furthermore, the Problem Checklist data from the present

195
study of caregivers found a high proportion of participants reporting personal
physical concerns (e.g., problems with sleep, fatigue, eating, etc.) with equal or
similar frequency to the psychological concerns (e.g., worry, fears, sadness,
etc.). While these physical consequences were not directly assessed relative to
their relationship with distress, findings from the present studies seem to suggest
that elevated symptom burden represents a negative experience that can
compromise one’s perceived quality of life, and possibly level of distress. Future
research is required in order to verify these suggestions. Moreover, the ability to
identify key symptom-related factors that contribute to elevated distress (e.g.,
fatigue, poorly managed pain, inadequate nutritional intake, etc.) may permit
clinicians to offer simple, yet effective means of reducing distress-related
symptoms, thereby also potentially reducing the experience of elevated distress.
In order to ensure that problems such as distress and the factors
contributing to its development or exacerbation are identified in a timely manner,
researchers and clinicians alike have recommended the use of systematic
distress screening in order to identify those individuals who are experiencing
elevated distress (NCCN, 2013). Researchers and psychologists have noted the
importance of distress screening given that individuals who need psychosocial
support often do not seek out resources for themselves (Waller, Williams, Groff,
Bultz, & Carlson, 2011). Without screening and proper identification of distress
many problems may remain unresolved even after the first year following
diagnosis (Carlson, Waller, Groff, Giese-Davis, & Bultz, 2013). While the problem
of distress in oncology was first described in the mid 1970’s by Weisman
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(Weisman, 1976)13, the impetus for systematically identifying distress through
screening programs in oncology has only gained global momentum over the past
decade (Bultz & Johansen, 2011). In particular, relative to the acknowledgement
of distress from a research perspective, there has been a significant increase in
the number of research publications addressing the identification and
management of distress in oncology since 2006, with a marked increase
occurring in 2010 (Bultz & Johansen, 2011). However, despite this increased
level of research and scholarship on this topic, questions remain regarding how
to adequately address the problem of distress in oncology.
Research has indicated that distress screening can be performed through
a number of procedures including open interview, semi-structured interviews, or
more frequently and pragmatically, through utilization of self-report
questionnaires (Laraway & Rogers, 2012). Recently, standards for distress
screening procedures have been developed by national psychosocial oncology
organizations such as the Canadian Association for Psychosocial Oncology
(CAPO) (CAPO, 2010) and the NCCN (NCCN, 2013). These recommendations
have subsequently been endorsed by the American College of Surgeons (ACS)
(ACS, 2012) and Canadian cancer accreditation agencies (Bultz et al., 2011).
Further, several of these organizations (e.g., ACS, CAPO, NCCN) have
recommended the routine use of self-report questionnaires that are specifically
designed to screen for distress, such as the Distress Thermometer (NCCN,

13

Karnofsky and Burchenal (1949) also noted the important role of “mood” in their early
assessments of performance status in palliative care.
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2013) and an accompanying Problem Checklist, in order to facilitate the
identification of distress (ACS, 2012; CAPO, 2010; NCCN, 2013).
Distress screening provides a simple and reliable method of identifying
individuals who are experiencing problematic levels of distress. The use of selfreport surveys may be particularly useful for individuals who do not openly reveal
their distress when speaking with physicians and healthcare professionals
(Zabora et al., 2003; Zabora & MacMurray, 2012). That is, while some individuals
may not be comfortable verbalizing their concerns, they may have a willingness
to acknowledge a concern in this written, self-report format. By doing so, they
may then provide an opportunity for the problem to be recognized by the
healthcare team and, hopefully, provide the option to address the problem more
directly. It may also promote the opportunity for the practitioner and the patient
and/or caregiver to engage in a broader and more meaningful discussion relative
to how the patient or caregiver is really doing. Moreover, the use of distressscreening tools may communicate to individuals that the healthcare team is
concerned about their quality of life and psychological well-being (Zabora &
MacMurray, 2012). Based on its potential for quick scoring and interpretation, the
Distress Thermometer and an accompanying Problem Checklist may be an
appropriate distress-screening tool for clinical use. Additionally, the Distress
Thermometer is quick to use, efficient to administer, and most importantly (from a
research perspective) it is a statistically valid tool (Patrick-Miller, Broccoli, Much,
& Levine, 2004; Ransom, Jacobsen, & Booth-Jones, 2006; Zwahlen, Hagenbuch,
Carley, Recklitis, & Buchi, 2008). Ultimately the routine use of distress-screening
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tools may provide a cost-effective means of identifying clinically significant levels
of distress for individuals with head and neck cancer and their caregivers.
However, it is also imperative to note that while distress screening may provide
significant advantages towards the identification of problematic distress in those
with head and neck cancer and their caregivers, screening alone is insufficient.
Consequently, identification of distress is only the initial step in the clinical effort
to alleviate the areas of concern that contribute to elevated distress in both those
with head and neck cancer and their caregivers.
Management of distress
In essence, the process of distress screening involves determining the
level of risk presented by an individual’s psychosocial challenges and unmet
needs and subsequently, ascertaining the degree to which assistance is desired
or needed (Mitchell, 2011). Once the concerns have been identified and the
desire for assistance has been expressed, the process of distress management
may commence. Ideally, as soon as possible following the disclosure of clinically
significant distress, a healthcare team member should meet with the individual to
conduct a comprehensive assessment (Clark et al., 2012). This assessment
should seek to gather, analyze, and synthesize information regarding the
presence of psychosocial issues that may compromise the individual’s ability to
make healthcare-related decisions, manage their illness (or their loved one’s
illness), or maintain a desirable level of quality of life (Clark et al., 2012).
Specifically, the assessment should include a discussion regarding psychological
and behavioural symptoms (e.g., anxiety, worry, inability to experience pleasure
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from usually enjoyable activities, etc.), physical symptoms (e.g., appetite, sleep,
fatigue, etc.), the need for financial and/or spiritual support, concerns about body
image, sexuality, and suicidal ideation, in addition to an assessment of existing
coping mechanisms and social support networks (NCCN, 2013). Specific
strategies for the management of distress will likely vary based on the
information provided by the distressed individual. But it is clear that identification
of concerns provides the pivotal starting point from which problems identified can
be directly addressed as part of the cancer care process. Avoiding such
identification, or acquisition of incomplete information is likely to contribute
negatively to both short- and long-term cancer care outcomes.
Multiple studies have demonstrated that certain forms of psychosocial
intervention, including cognitive behavioural therapy and psycho-educational
interventions, can be beneficial towards the goal of reducing distress in oncology
(Chambers, Pinnock, Lepore, Hughes, & O’Connell, 2011; Fors et al., 2010;
Hammerlid et al., 1999; Newell, Sanson-Fisher, & Savolainen, 2002). For
instance, psychosocial interventions involving counseling (either structured or
unstructured) and guided imagery improved quality of life and the general
functioning of individuals with cancer (Newell et al., 2002), whereas psychoeducational interventions (i.e., support group information sessions), skills
training, and therapeutic counseling proved effective for caregivers (Northouse,
Katapodi, Song, Zhang, & Mood, 2010). Additionally, online counseling and
support groups have also been found to reduce distress in both caregivers and
individuals with cancer when moderated by a registered mental health
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professional (e.g., psychologist, social worker) (Ruland et al., 2013; Taylor &
Luce, 2003). The proliferation of internet-based resources such as support
groups that are conducted by registered health practitioners may provide another
useful resource for caregivers and individuals with head and neck cancer,
particularly if individuals live in a rural and remote setting or if they feel
uncomfortable disclosing personal issues in a face-to-face forum. Irrespective of
the specific type of intervention that is utilized, the key matter of importance is
that distress is treatable (Carlson, Waller, Groff, Zhong, & Bultz, 2012) and its
effective management has demonstrated worthwhile cost-benefit savings to the
healthcare system (Bultz & Carlson, 2005). Moreover, this economic perspective
provided by Bultz and Carlson (2005) suggests that if distress can be identified
early and managed effectively, then we may be able to not only improve the
overall functioning of those with cancer and their caregivers, but we may also
potentially reduce the economic burden on the healthcare system that arises as a
result of untreated or poorly managed distress. Therefore, a comprehensive
discussion of the problem of distress in oncology would be remiss without
acknowledgment of the economic implications of failing to address this problem.
Economic Implications
Despite acknowledgement by the medical community of the significant
psychological burden and distress associated with a cancer diagnosis and the
consequences of its treatment, there has been minimal effort to modify clinical
practice, increase relevant hospital budgets, or implement third-party coverage
for this key component of healthcare (Bultz & Carlson, 2005). Within Canada
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where the provision of healthcare is both publicly funded and delivered, a survey
of provincial cancer centers found that less than three percent of cancer agency
operating dollars were directed towards psychosocial care (Bultz, 2002; as cited
in, Bultz & Carlson, 2005). However, many forms of psychosocial intervention
such as peer-counseling or support groups place little to no economic burden on
the healthcare system and have been shown to be effective means of decreasing
distress (Blake-Mortimer, Gore-Felton, Kimerling, Turner-Cobb, & Spiegel, 1999;
Northouse et al., 2010; Ruland et al., 2013). The failure to identify and
appropriately manage distress in oncology results in increased costs – both
personal costs to the individual and financial costs to the healthcare system.
In terms of the financial impact of psychosocial support on the healthcare
system, a number of studies have noted benefits to individuals with either no
added cost to the system or even reductions in overall costs. For instance, a
meta-analysis of 90 studies established that psychosocial interventions were able
to offset health expenditures by an average of 20% (Chiles, Lambert, & Hatch,
1999), providing a considerable financial benefit to the system. Additionally, a
recent systematic review on the economic value of psychosocial interventions
determined that psychosocial interventions are inexpensive on a per patient
basis and have the potential to improve quality adjusted life years with minimal
financial input on the part of the healthcare system (Gordon, Beesley, &
Scuffham, 2011). Thus, through reduction of the emotional and personal burden
of cancer, it may also be possible to reduce its associated economic burden. Full
acknowledgment of the “human side” of cancer care and a family-based
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approach to the delivery of care are essential components of a compassionate
and well-managed oncology program.
Summary of contributions
This program of inquiry into distress represents a salient and timely
contribution to the literature. An important contribution of the first study (Chapter
2) was the inclusion of participants often excluded from head and neck
psychosocial oncology research; namely, those individuals who had received
“bad news”, were not receiving treatment for a curative intent, had previously
been diagnosed with depression, or those who had experienced a recurrence or
metastases of their disease. While we acknowledge that there may be instances
where inviting an individual to participate in a research protocol may be
inappropriate and/or insensitive to the circumstances they are facing, distressrelated research that purposely excludes individuals who are experiencing a
distressing life event, or those who may be prone to experiencing pathologic
distress, arguably fails to provide a comprehensive perspective on the very
factors which may both cause and exacerbate distress in these individuals. To
willingly exclude this data from such individuals runs contrary to the intent of
seeking to accurately understand the presence and impact that distress has
across the disease trajectory. Consequently, we believe that the purposeful
inclusion of individuals typically excluded from psychosocial oncology research in
head and neck cancer represents an important first step in encouraging a more
inclusive approach to psychosocial oncology research practices. As a result, we
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believe this inclusionary approach may serve to identify a more accurate
representation of distress that occurs in this unique clinical population.
To the authors’ knowledge, the second study (Chapter 3) is the first to
explore perceived distress and quality of life concerns in caregivers of individuals
with head and neck cancer who have been either recently diagnosed (e.g., less
than one week from diagnosis) or those who are long-term survivors (e.g. more
than 20 years from diagnosis). Furthermore, this study also represents the first
effort to utilize a single-item distress measure (e.g., Distress Thermometer) in
caregivers of individuals with head and neck cancer. Ultrashort measures such
as the Distress Thermometer have proven to be useful and effective for distress
screening in busy, clinical environments (Vodermaier, Linden, & Siu, 2009).
Consequently, use of the Distress Thermometer in head and neck cancer
caregiver populations may afford the opportunity to promote the regular
screening of distress, given its reliability and ease of use clinically (Vodermaier et
al., 2009). Finally, this study is the first to report that the level of perceived
distress in caregivers is related to the treatment status of the individuals with
head and neck cancer (e.g., awaiting treatment, undergoing treatment,
completed treatment) rather than the length of time since diagnosis, a suggestion
that has been a prevailing hypothesis within psychosocial oncology literature
(Hodges, Humphris, & Macfarlane, 2005). Further, we determined that this
difference represented a large effect, which suggests that one’s treatment stage
may have a sizeable and significant impact on perceptions of caregiver distress.
While additional work is certainly required in order to verify this relationship, the
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present findings suggest several specific recommendations for study.
Directions for future research
First, since data from the caregiver study (Chapter 3) revealed that the
treatment status of the individual with head and neck cancer (i.e., one’s position
relative to the progression of treatment – awaiting, undergoing, completed) was
significantly related to the distress level of the caregiver, additional research that
investigates perceived distress relative to treatment status is recommended. In
order to evaluate this potential relationship in a rigorous manner, the use of
prospective, longitudinal designs are advised. Longitudinal analysis that employs
regular follow-up with participants at each stage of treatment progression (e.g.,
awaiting, undergoing, completed) will likely elicit the most comprehensive data
relative to potential facets of the relationship between caregiver distress and an
individual’s treatment status.
Furthermore, the assessment of trajectories of distress in both individuals
with head and neck cancer and their caregivers is strongly recommended. To
date, research conducted using mixed growth modeling techniques has revealed
distinct patterns of distress that have challenged the accepted notion that
distress declines over time (Choi et al., 2012; Fielding & Lam, 2013; Helgeson,
Snyder, & Seltman, 2004; Lam, Ye, & Fielding, 2012; Lam et al., 2009; Lam et
al., 2011; Lam, Shing, Bonanno, Mancini, & Fielding, 2012). Further, since
research has suggested that between 5-20% of individuals with cancer
experience chronically high levels of distress throughout the duration of the
cancer trajectory (Lam et al., 2012; Lam et al., 2009; Lam et al., 2011; Lam et al.,
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2012), the ability to identify these chronically distressed individuals and
subsequently provide psychosocial support should be a key goal of future clinical
inquiry. Through this enhanced knowledge, we may be better able to understand
the process of distress in oncology with the goal of working towards its reduction
or alleviation.
Additionally, given the highly individualized and heterogeneous nature of
distress in both those with head and neck cancer and their caregivers, results of
the present investigation would seem to support the acknowledgement of
distress as the sixth vital sign, indicating that it should be monitored routinely.
Thus, it may be valuable to investigate the feasibility and utility of implementing a
standard distress screening program for both those with cancer and their
caregivers. Owing to the brief nature of its administration and scoring
procedures, an ultrashort instrument such as the Distress Thermometer has
been recommended for use in busy clinical environments (Vodermaier et al.,
2009). However, given that caregivers of individuals with head and neck cancer
may not be physically present at each clinical appointment, the ability to screen
caregivers in-person during clinical visits may not always be feasible. Similarly,
ongoing distress screening and management also may be challenging for
individuals who live in rural or remote settings. Consequently, research that
examines how health technology (e.g., Internet, Telehealth, smart phones, etc.)
can be effectively used to identify and manage distress in individuals with head
and neck cancer and their caregivers may be beneficial. The use of novel
sources of health-related technology to engage in distress screening and
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management may help to facilitate the routine and universal screening of distress
in those with cancer and their caregivers. Ultimately, future research that builds
on the insights gained within the present program of research could enhance the
understanding of distress in oncology, as well as improve efforts to both identify
and manage it in both individuals with head and neck cancer and their
caregivers. By doing so, the comprehensiveness of care may be enhanced and
long-term outcomes for both individuals with head and neck cancer and their
caregivers may be optimized.

207
References
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., .
. . Takeda, F. (1993). The European Organisation for Research and
Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in
international clinical trials in oncology. Journal of the National Cancer
Institute, 85, 365-376.
American Cancer Society (ACS). (2012). Cancer program standards 2012:
Ensuring patient-centered care (Vol. 1.1, pp. 1-140). Illinois: American
College of Surgeons.
American Psychological Association (APA). (2000). Diagnostic and statistical
manual of mental disorders - 4th edition text revision (DSM-IV-TR, 2000)
American Psychological Association (Ed.) Retrieved from
http://online.statref.com.proxy1.lib.uwo.ca/Document.aspx?docAddress=4
PNCnYvddqP04-isS3QEw%3d%3d&SessionId=1A9C4CBJVGMKQUIG&Scroll=1&goBestMat
ch=true&Index=10&searchContext=DSM-IV-TR|c0||10|0|0|0|0|0||c0
Beck, A. T., Steer, R. A., & Brown, G. K. (1993). Beck Depression Inventory-II
(BDI-II). Manual for Beck Depression Inventory-II.
Bjordal, K., Ahlner-Elmqvist, M., Hammerlid, E., Boysen, M., Evensen, J.,
Biorklund, A., . . . Kaasa, S. (2001). A prospective study of quality of life in
head and neck cancer patients. Part II: Longitudinal data. Laryngoscope,
111, 1440-1452.
Blake-Mortimer, J., Gore-Felton, C., Kimerling, R., Turner-Cobb, J. M., & Spiegel,
D. (1999). Improving the quality and quantity of life among patients with
cancer: A review of the effectiveness of group psychotherapy. European
Journal of Cancer, 35(11), 1581-1586.
Blood, G. W., Simpson, K. C., Dineen, M., Kauffman, S. M., & Raimondi, S. C.
(1994). Spouses of individuals with laryngeal cancer: Caregiver strain and
burden. Journal of Communication Disorders, 27, 19-35.
Breslau, E. S., Curbow, B., Zabora, J., & Britzenhofeszoc, K. (2001).
Psychological distress in post-surgical women with breast cancer. Paper
presented at the 2001 ASCO Annual Meeting.
Bultz, B. D. (2002). Changing the face of cancer care for patients, community
and the healthcare system. Report to the Romanow Commission on the
Future of Healthcare in Canada.: Canadian Association of Psychosocial
Oncology.
Bultz, B. D., & Carlson, L. (2005). Emotional distress: The sixth vital sign in
cancer care. [Correspondence]. Journal of Clinical Oncology, 23(26),
6440-6441. doi: 10.1200/JCO.2005.01.9232
Bultz, B. D., Groff, S. L., Fitch, M., Blais, M. C., Howes, J., Levy, K., & Mayer, C.
(2011). Implementing screening for distress, the 6th vital sign: A Canadian
strategy for changing practice. Psycho-Oncology, 20(5), 463-469. doi:
10.1002/pon.1932

208
Bultz, B. D., & Johansen, C. (2011). Screening for distress, the 6th vital sign:
Where are we, and where are we going? Psycho-Oncology, 20(6), 569571. doi: 10.1002/pon.1986
Canadian Association of Psychosocial Oncology (CAPO). (2010). Standards of
psychosocial health services for persons with cancer and their families.
Retrieved from: http://www.capo.ca/pdf/CAPOstandards.pdf
Carlson, L., & Bultz, B. (2004). Efficacy and medical cost offset of psychosocial
interventions in cancer care: Making the case for economic analyses.
Psycho-Oncology, 13(12), 837-849. doi: 10.1002/pon.832
Carlson, L. E., Waller, A., Groff, S. L., Giese-Davis, J., & Bultz, B. D. (2013).
What goes up does not always come down: Patterns of distress, physical
and psychosocial morbidity in people with cancer over a one year period.
Psycho-Oncology, 22(1), 168-176. doi: 10.1002/pon.2068
Carlson, L. E., Waller, A., Groff, S. L., Zhong, L., & Bultz, B. D. (2012). Online
screening for distress, the 6th vital sign, in newly diagnosed oncology
outpatients: Randomised controlled trial of computerised vs personalised
triage. British Journal of Cancer, 107(4), 617-625. doi:
10.1038/bjc.2012.309
Carlson, L. E., Waller, A., Groff, S. L., Zhong, L., & Bultz, B. D. (2013). Reply:
Benefits of screening for distress still not demonstrated. British Journal of
Cancer, 108, 738-739. doi: 10.1038/bjc.2013.17
Chambers, S. K., Pinnock, C., Lepore, S. J., Hughes, S., & O’Connell, D. L.
(2011). A systematic review of psychosocial interventions for men with
prostate cancer and their partners. Patient Education and Counseling,
85(2), e75-e88. doi: 10.1016/j.pec.2011.01.027
Chiles, J. A., Lambert, M. J., & Hatch, A. L. (1999). The impact of psychological
interventions on medical cost offset: A meta-analytic review. Clinical
Psychology: Science and Practice, 6(2), 204-220.
Choi, C.-W. J., Stone, R. A., Kim, K. H., Ren, D., Schulz, R., Given, C. W., . . .
Sherwood, P. R. (2012). Group-based trajectory modeling of caregiver
psychological distress over time. Annals of Behavioral Medicine, 44(1),
73-84. doi: 10.1007/s12160-012-9371-8
Clark, P. G., Bolte, S., Buzaglo, J., Golant, M., Daratsos, L., & Loscalzo, M.
(2012). From distress guidelines to developing models of psychosocial
care: Current best practices. Journal of Psychosocial Oncology, 30(6),
694-714. doi: 10.1080/07347332.2012.721488
Clover, K., Carter, G. L., Mackinnon, A., & Adams, C. (2009). Is my patient
suffering clinically significant emotional distress? Demonstration of a
probabilities approach to evaluating algorithms for screening for distress.
Supportive Care in Cancer, 17(12), 1455-1462. doi: 10.1007/s00520-0090606-6
Derogatis, L. (2001). BSI 18, Brief Symptom Inventory 18: Administration, scoring
and procedures manual: NCS Pearson, Inc.
Fielding, R., & Lam, W. W. T. (2013). Unresolved problems with distress
screening. British Journal of Cancer, 118, 1922-1923. doi:
10.1038/bjc.2013.137

209
Fors, E. A., Bertheussen, G. F., Thune, I., Juvet, L. K., Elvsaas, I.-K. Ø.,
Oldervoll, L., . . . Leivseth, G. (2010). Psychosocial interventions as part of
breast cancer rehabilitation programs? Results from a systematic review.
Psycho-Oncology. doi: 10.1002/pon.1844
Given, B., Wyatt, G., Given, C., Sherwood, P., Gift, A., DeVoss, D., & Rahbar, M.
(2004). Burden and depression among caregivers of patients with cancer
at the end of life. Paper presented at the Oncology Nursing Forum.
Gordon, L. G., Beesley, V. L., & Scuffham, P. A. (2011). Evidence on the
economic value of psychosocial interventions to alleviate anxiety and
depression among cancer survivors: A systematic review. Asia-Pacific
Journal of Clinical Oncology, 7(2), 96-105. doi: 10.1111/j.17437563.2011.01395.x
Hammerlid, E., Ahlner-Elmqvist, M., Bjordal, K., Biorklund, A., Evensen, J.,
Boysen, M., . . . Westin, T. (1999). A prospective multicentre study in
sweden and norway of mental distress and psychiatric morbidity in head
and neck cancer patients. British Journal of Cancer, 80(5-6), 766-774. doi:
10.1038/sj.bjc.6690420
Helgeson, V., Snyder, P., & Seltman, H. (2004). Psychological and physical
adjustment to breast cancer over 4 years: Identifying distinct trajectories of
change. . Health Psychology, 23(1), 3-15. doi: 10.1037/0278-6133.23.1.3
Hodges, L. J., Humphris, G. M., & Macfarlane, G. (2005). A meta-analytic
investigation of the relationship between the psychological distress of
cancer patients and their carers. Social Science & Medicine, 60(1), 1-12.
doi: 10.1016/j.socscimed.2004.04.018
Hunter, K. U., & Jolly, S. (2013). Clinical review of physical activity and functional
considerations in head and neck cancer patients. Supportive Care in
Cancer, 21(5), 1475-1479. doi: 10.1007/s00520-013-1736-4
Karnofsky, D., & Burchenal, J. (1949). The clinical evaluation of
chemotherapeutic agents in cancer. In C. MacLeod (Ed.), Evaluation of
chemotherapeutic agents: Columbia University Press.
Lam, W., Ye, M., & Fielding, R. (2012). Trajectories of quality of life among
chinese patients diagnosed with nasopharyngeal cancer. . PLoS One 7(9):
e44022., 7(9), e44022. doi: 10.1371/journal.pone.0044022
Lam, W. W. T., Bonanno, G. A., Mancini, A. D., Ho, S., Chan, M., Hung, W. K., . .
. Fielding, R. (2009). Trajectories of psychological distress among chinese
women diagnosed with breast cancer. Psycho-Oncology, 19(10), 10441051. doi: 10.1002/pon.1658
Lam, W. W. T., Li, W. W. Y., Bonanno, G. A., Mancini, A. D., Chan, M., Or, A., &
Fielding, R. (2011). Trajectories of body image and sexuality during the
first year following diagnosis of breast cancer and their relationship to
6 years psychosocial outcomes. Breast Cancer Research and Treatment,
131(3), 957-967. doi: 10.1007/s10549-011-1798-2
Lam, W. W. T., Shing, Y. T., Bonanno, G. A., Mancini, A. D., & Fielding, R.
(2012). Distress trajectories at the first year diagnosis of breast cancer in
relation to 6 years survivorship. Psycho-Oncology, 21(1), 90-99. doi:
10.1002/pon.1876

210
Laraway, D. C., & Rogers, S. N. (2012). A structured review of journal articles
reporting outcomes using the university of washington quality of life scale.
British Journal of Oral and Maxillofacial Surgery, 50(2), 122-131. doi:
10.1016/j.bjoms.2010.12.005
Miller, K., & Massie, M. J. (2009). Depressive disorders. In J. C. Holland, W. S.
Breitbart, P. B. Jacobsen, M. S. Ledeberg & M. J. Loscalzo (Eds.),
Psycho-oncology (pp. 311-318). New York: Oxford University Press.
Mitchell, A. J. (2011). Detecting and managing psychological distress in women
with cancer: An update of recent evidence. The Obstetrician &
Gynaecologist, 13(1), 22-28.
Mols, F., Thong, M. S. Y., de Poll-Franse, L. V. v., Roukema, J. A., & Denollet, J.
(2012). Type d (distressed) personality is associated with poor quality of
life and mental health among 3080 cancer survivors. Journal of Affective
Disorders, 136(1-2), 26-34. doi: 10.1016/j.jad.2011.08.034
National Comprehensive Cancer Network (NCCN). (2013). NCCN clinical
practice guidelines in oncology: Distress management. 2.2013. Retrieved
from http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf
Newell, S. A., Sanson-Fisher, R. W., & Savolainen, N. J. (2002). Systematic
review of psychological therapies for cancer patients: Overview and
recommendations for future research. Journal of the National Cancer
Institute, 94(8), 559-584.
Northouse, L. L., Katapodi, M. C., Song, L., Zhang, L., & Mood, D. W. (2010).
Interventions with family caregivers of cancer patients: Meta-analysis of
randomized trials. Ca: A Cancer Journal for Clinicians. doi:
10.3322/caac.20081
Patrick-Miller, L. J., Broccoli, T. L., Much, J. K., & Levine, E. (2004). Validation of
the distress thermometer: A single item screen to detect clinically
significant psychological distress in ambulatory oncology patients. Paper
presented at the 2004 American Society of Clinical Oncology Annual
Meeting Proceedings (Post-Meeting Edition).
Ransom, S., Jacobsen, P. B., & Booth-Jones, M. (2006). Validation of the
distress thermometer with bone marrow transplant patients. PsychoOncology, 15(7), 604-612. doi: 10.1002/pon.993
Rohleder, N., Marin, T. J., Ma, R., & Miller, G. E. (2009). Biologic cost of caring
for a cancer patient: Dysregulation of pro- and anti-inflammatory signaling
pathways. Journal of Clinical Oncology, 27(18), 2909-2915. doi:
10.1200/jco.2008.18.7435
Ruland, C. M., Andersen, T., Jeneson, A., Moore, S., Grimsbø, G. H., Børøsund,
E., & Ellison, M. C. (2013). Effects of an internet support system to assist
cancer patients in reducing symptom distress. Cancer Nursing, 36(1), 617. doi: 10.1097/NCC.0b013e31824d90d4
Sollner, W., De Vries, A., Steixner, E., Sprinzi, G., Rumpold, G., Maislinger, S.
(2001). How successful are oncologists in identifying patient distress,
perceived social support, and need for psychosocial counselling? British
Journal of Cancer, 84(2), 179-185. doi: 10.1054/

211
Stenberg, U., Ruland, C. M., & Miaskowski, C. (2010). Review of the literature on
the effects of caring for a patient with cancer. Psycho-Oncology, 19(10),
1013-1025. doi: 10.1002/pon.1670
Taylor, C. B., & Luce, K. H. (2003). Computer-and internet-based psychotherapy
interventions. Current Directions in Psychological Science, 12(1), 18-22.
Vodermaier, A., Linden, W., & Siu, C. (2009). Screening for emotional distress in
cancer patients: A systematic review of assessment instruments. JNCI
Journal of the National Cancer Institute, 101(21), 1464-1488. doi:
10.1093/jnci/djp336
Waller, A., Williams, A., Groff, S. L., Bultz, B. D., & Carlson, L. E. (2011).
Screening for distress, the sixth vital sign: Examining self-referral in
people with cancer over a one-year period. Psycho-Oncology. doi:
10.1002/pon.2102
Weisman, A. (1976). Early diagnosis of vulnerability in cancer patients. American
Journal of Medical Science, 271, 187-196.
Weitzner, M. A., Jacobsen, P. B., Wagner, J. H., Friedland, J., & Cox, C. (1999).
The Caregiver Quality of Life Index - Cancer (CQOLC) scale:
Development and validation of an instrument to measure quality of life of
the family caregiver of patients with cancer. Quality of Life Research, 8,
55-63.
Zabora, J., Loscalzo, M., & Smith, E. (2000). Psychosocial Rehabilitation. New
York: Churchill Livingstone.
Zabora, J. R., Loscalzo, M. J., & Weber, J. (2003). Managing complications in
cancer: Responding to the patient's perspective. Seminars in Oncology
Nursing, 19(4, Suppl 2), 1-9. doi: 10.1016/S0749-2081(03)00113-X
Zabora, J. R., & MacMurray, L. (2012). The history of psychosocial screening
among cancer patients. Journal of Psychosocial Oncology, 30(6), 625635. doi: 10.1080/07347332.2012.721491
Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression
Scale. Acta Psychiatrica Scandinavica, 67(6), 361-370. doi:
10.1111/j.1600-0447.1983.tb09716.x
Zwahlen, D., Hagenbuch, N., Carley, M. I., Recklitis, C. J., & Buchi, S. (2008).
Screening cancer patients' families with the Distress Thermometer (DT): A
validation study. Psycho-Oncology, 17(10), 959-966. doi:
10.1002/pon.1320
Zwahlen, D., Hagenbuch, N., Jenewein, J., Carley, M. I., & Buchi, S. (2011).
Adopting a family approach to theory and practice: Measuring distress in
cancer patient-partner dyads with the distress thermometer. PsychoOncology, 20(4), 394-403. doi: 10.1002/pon.1744

212
Appendix A

213
Appendix B

214
Appendix C

215

216

217
Appendix D

218

219

220
Appendix E

221

222

223
Appendix F

224

225
Appendix G

EORTC-QLQ-C30 images removed due to copyright restrictions

226
Appendix H

EORTC-QLQ-H&N35 images removed due to copyright restrictions

227
Appendix I

Distress Thermometer image removed due to copyright restrictions

228
Appendix J

CQOLC images removed due to copyright restrictions

229
Appendix K

230
Appendix L
Histograms for Longitudinal Distress Thermometer Findings (Chapter 2)

231

232

233
Curriculum Vitae
a)

Name:

Catherine Bornbaum

Status:

Doctoral Candidate – Year 4

Full-time or part-time status: Full-time

b)

c)

Degree

University

Ph.D.

Western University

M.Sc.

Western University

B.H.Sc.

Western University

Department
Health & Rehabilitation
Sciences
Health & Rehabilitation
Sciences
Health Sciences

Year
2010-2013
2008-2009
2004-2008

Employment History:
Date

Rank & Position

Sept 2013
- Present
Oct 2013 Present

Senior Research Coordinator,
Knowledge Broker
Research Consultant

Jan 2010
– Oct
2013
Oct 2008
– Aug
2013

Senior Research Associate

Sept 2010
– Dec
2010
Apr 2010
– Sept
2010
Sept 2009
– Dec
2009
Sept 2008
– Dec
2008
Jan 2008
– Apr
2008

Teaching Assistant
HS3500 – Health Related
Quality of Life
Research Assistant

Research Assistant

Teaching Assistant
HS1000 – Introduction to
Health Sciences
Teaching Assistant
HS2800 – Measurement and
Methods
Class Assistant
(Undergraduate Teaching
Assistant)
HS345b – Health and Aging

Department
Public Health
Sciences
Laboratory for WellBeing and Quality of
Life in Oncology
Laboratory for WellBeing and Quality of
Life in Oncology
Department of
Otolaryngology Head
& Neck Surgery
School of Health
Studies

Institution
Public Health
Ontario
University of
Western Ontario
University of
Western Ontario
London Health
Sciences Centre –
Victoria Hospital,
London, Ontario
University of
Western Ontario

School of Health
Studies – Knowledge
Translation Laboratory
School of Health
Studies

University of
Western Ontario

School of Health
Studies

University of
Western Ontario

School of Health
Studies

University of
Western Ontario

University of
Western Ontario

234
d)

Academic Honours: (not research grants)
2013 – Faculty of Health Sciences Travel Award
2013 – Faculty of Health Sciences Graduate Student Conference Travel Award
2013 – Health & Rehabilitation Sciences Graduate Research Forum
st
Oral Presentation Award (1 place)
2012 – Faculty of Health Sciences Thesis Research Award
2011 – Western Fund Ontario Graduate Scholarship
2011 – Graduate Student Teaching Award Nominee
2011 – Faculty of Health Sciences Travel Award
2011 – Alumni Western Multidisciplinary Poster Competition (First place)
2011 – Faculty of Health Sciences Graduate Student Conference Travel Award
2010 – Faculty of Health Sciences Travel Award
2009 – Graduate Student Teaching Award Nominee
2008 – Bachelor of Health Sciences Award of Recognition
2008 – Faculty of Health Sciences Dean’s Honor List
2007 – McGraw-Hill Ryerson Student Scholarship Award Nominee

e)

Scholarly and Professional Activities: (from 2008 to present)
2012 – 2013
2008 – 2013
2011 – 2012
2010 – 2011
2009 – 2011
2008 – 2010

Senate Review Board Academic, Graduate Student Member
Rehabilitation Sciences Journal Club, Student Member
University Research Board, Graduate Student Member
Rehabilitation Sciences Journal Club, Coordinator
Faculty of Health Sciences Faculty Council, Graduate Student
Representative
Health & Rehabilitation Sciences Graduate Student Society, Executive
Member

Journal Referee:
2010 – Present Disability & Rehabilitation (9 manuscripts reviewed to date)
2012 – Present Supportive Care in Cancer (5 manuscripts reviewed to date)
2012 – Present Oral Oncology (1 manuscript reviewed to date)

h)

Research Funding: (from 2008 to present)
Start
Date
2012

End
Date
2013

Principal
Investigator
Bornbaum,
C.

2012

2013

Bornbaum,
C.

Funding Agency

Project Title

Canadian
Institutes of
Health Research
(Priority Area:
Patient-Oriented
Research)
Ontario Graduate
Scholarship

Measuring the sixth vital
sign: A prospective,
longitudinal analysis of
distress in head and neck
cancer (Doctoral
research)
Measuring the sixth vital
sign: A prospective,
longitudinal analysis of
distress in head and neck
cancer (Doctoral
research)

Total
Amount
$55,417

$15,000
offered &
declined

235

i)

2012

2013

Bornbaum,
C.

2011

2012

Bornbaum,
C.

2011

2012

Bornbaum,
C.

2010

2011

Bornbaum,
C.

2010

2010

Bornbaum,
C.

2009

2009

Bornbaum,
C.

2008

2009

Bornbaum,
C.

The University of
Western Ontario
– Western
Graduate
Research
Scholarship
Ontario Graduate
Scholarship

The University of
Western Ontario
– Western
Graduate
Research
Scholarship
Ontario Graduate
Scholarship in
Science and
Technology

The University of
Western Ontario
– Western
Graduate
Research
Scholarship
The University of
Western Ontario
– Western
Graduate
Research
Scholarship
The University of
Western Ontario
– Western
Graduate
Research
Scholarship

Measuring the sixth vital
sign: A prospective,
longitudinal analysis of
distress in head and neck
cancer (Doctoral
research)
Measuring the sixth vital
sign: A prospective,
longitudinal analysis of
distress in head and neck
cancer (Doctoral
research)
Measuring the sixth vital
sign: A prospective,
longitudinal analysis of
distress in head and neck
cancer (Doctoral
research)
Measuring the sixth vital
sign: A prospective,
longitudinal analysis of
distress in head and neck
cancer (Doctoral
research)
Measuring the sixth vital
sign: A prospective,
longitudinal analysis of
distress in head and neck
cancer (Doctoral
research)
A cross-sectional analysis
of distress and quality of
life concerns in
individuals diagnosed
with head and neck
cancer
A cross-sectional analysis
of distress and quality of
life concerns in
individuals diagnosed
with head and neck
cancer

PUBLICATIONS
1)

Life-time summary (count) according to the following categories:
Books authored: 0
Books edited: 0
Chapters in books: 0
Papers in refereed journals: 4
Papers in refereed conference proceedings: 0
Technical reports: 0
Abstracts and/or papers read: 1
Presentations at professional meetings/workshops and others: 41

$8,000

$15,000

$8,000

$10,000

$19,000

$10,000

$10,000

236

Papers in refereed journals:
4. Bornbaum, C.C., Day, A.M.B., & Doyle, P.C. (2013). Examining the construct validity of the
Voice-Related Quality of Life (V-RQOL) measure in alaryngeal speakers. American Journal of
Speech-Language Pathology, [In Press].
3. Bornbaum C.C., Doyle, P.C., Skarakis-Doyle, E., & Theurer, J.A. (2013). A critical exploration
of the International Classification of Functioning, Disability and Health (ICF) framework from the
perspective of cancer care: Recommendations for revision. Journal of Multidisciplinary
Healthcare, 6, 75-86.
2. Bornbaum, C.C., Fung, K., Franklin, J.H., Nichols, A., Yoo, J., & Doyle, P.C. (2012). A
descriptive analysis of the relationship between quality of life and distress in individuals with head
and neck cancer. Supportive Care in Cancer, 20(9), 2157-2165. doi: 10.1007/s00520-011-13262.
1. Yeung, J.C., Fung, K., Bornbaum, C.C., Day, A.M.B., Dziboa, A., Parsa, V., Levee, T. &
Doyle, P.C. (2011). A clinical approach to monitoring variability associated with adductor
spasmodic dysphonia. Journal of Otolaryngology Head and Neck Surgery, 40(4), 343-349.
Abstracts and/or papers read:
1. Bornbaum, C.C., Fung, K., & Doyle, P.C. (2010). Heightened distress and quality of life
concerns in individuals with head and neck cancer. Psycho-Oncology, 19(S2), S100-S101.
Presentations at professional meetings/workshops:
41. Bornbaum, C.C., Doyle, P.C., Fung, K., Franklin, J., Nichols, A. & Yoo, J. Factors
contributing to elevated distress in caregivers of individuals with head and neck cancer. To be
presented at the Multinational Association of Supportive Care in Cancer conference, Berlin,
Germany, June 27-29, 2013.
40. Bornbaum, C.C. A prospective, longitudinal analysis of distress in individuals diagnosed with
head and neck cancer. Invited presentation at the Department of Otolaryngology – Head and
Neck Surgery Grand Rounds, London, ON, May 22, 2013.
39. Bornbaum, C.C., Doyle, P.C., Fung, K., Franklin, J., Nichols, A. & Yoo, J. Caregiver distress
and quality of life in head and neck cancer: A comparison of new (<12 months post-diagnosis)
and longer-term caregivers (≥12 months post-diagnosis). Presented at the Canadian Association
for Psychosocial Oncology conference, Ottawa, ON, April 24-26, 2013.
38. Bornbaum, C.C. Reflections on the graduate school process: Tips and tricks for success and
sanity. Invited presentation at the University of Western Ontario, London, ON, March 1, 2013.
37. Doyle, P.C., Scott, G.M., Bornbaum, C.C., & Day, A.M.B. Listener comfort as a clinical metric
for tracheoesophageal voice. Presented at the XXI Pacific Voice and Speech Foundation/ECLA
Voice Conference: Neoplastic Lesions of the Larynx + Voice & Deglutition – Update in Diagnosis
and Treatment, Ronald Reagan Hospital, UCLA Medical Center, Los Angeles, CA, February 2223, 2013.
36. Bornbaum, C.C., Doyle, P.C., Fung, K., Franklin, J., Nichols, A. & Yoo, J. Factors
contributing to elevated distress in caregivers of individuals with head and neck cancer: A
preliminary examination. Presented at the Health and Rehabilitation Sciences Research Forum,
London, ON, February 6, 2013.

237

35. Bornbaum, C.C. An introduction to caregiver distress and concerns among family members
of individuals diagnosed with cancer. Invited presentation at the University of Western Ontario,
London, ON, November 27, 2012.
34. Cox, S., Day, A.M.B., Bornbaum, C.C. & Doyle, P.C. The impact of the electrolarynx on
voice-related quality of life. Paper presented at the Annual American Speech-Language Hearing
Association convention, Atlanta, GA, November 15, 2012.
33. Bornbaum, C.C. A practical guide to identifying and managing distress in clinical settings.
Invited presentation at the Annual Meeting of The International Association of Laryngectomees
(Voice Institute), Raleigh, North Carolina, USA, June 2012.
32. Kahlili, S., Doyle, P.C., Franklin, J., Nichols, A., Yoo, J., Sleeth, L., Bornbaum, C.C., & Fung,
K. Tracheoesophageal puncture: An initial exploration of factors affecting voice quality. Paper
th
presented at the 66 Annual Canadian Society of Otolaryngology – Head & Neck Surgery
conference, Toronto, ON, May 2012.
31. Bornbaum, C.C., & Doyle, P.C. Is the Voice-Related Quality of Life (V-RQOL) valid for
postlaryngectomy speakers? Examining the construct validity of the V-RQOL. Paper presented at
th
the 66 Annual Canadian Society of Otolaryngology – Head & Neck Surgery conference,
Toronto, ON, May 2012.
30. Bornbaum, C.C., Doyle, P.C., Fung, K., Franklin, J., Nichols, A & Yoo, J. Perceptions of
distress and quality of life among caregivers of individuals diagnosed with head and neck cancer.
Presented at the Annual Meeting of the Canadian Association for Psychosocial Oncology,
Vancouver, BC, April 26, 2012.
29. Bornbaum, C.C. & Doyle, P.C. Understanding the benefits of quality of life measures in the
alaryngeal population. Presented at the Health and Rehabilitation Sciences Research Forum,
London, ON, February 2012.
28. Cox, S.R., Day, A.M.B., Bornbaum, C.C., Sleeth, L., Dzioba, A. & Doyle, P.C.
Electrolaryngeal use on Voice-Related Quality of Life (V-RQOL): Understanding the potential for
th
voice-related disability following total laryngectomy. Presented at the 5 annual Aging,
Rehabilitation & Geriatric Care Research Conference, London, ON, February 2012.
27. Cox, S.R., Day, A.M.B., Bornbaum, C.C., Sleeth, L., Dzioba, A. & Doyle, P.C. Voice-related
disability: Uncovering the impact of the electrolarynx (EL) on Voice-Related Quality of Life (VRQOL). Presented at the Health and Rehabilitation Sciences Research Forum, London, ON,
February 8, 2012.
26. Bornbaum, C.C., Day, A.M.B., & Doyle, P.C. Evaluating the validity of the Voice-Related
Quality of Life measure: Is it an appropriate measure for the laryngeal cancer population?
Presented at the Health and Rehabilitation Sciences Research Forum, London, ON, February 8,
2012.
25. Bornbaum, C.C., Doyle, P.C., Fung, K., Franklin, J., Nichols, A. & Yoo, J. Factors
contributing to elevated distress in caregivers of individuals with head and neck cancer: A
preliminary examination. Presented at the Health and Rehabilitation Sciences Research Forum,
London, ON, February 8, 2012.
24. Bornbaum, C.C., Doyle, P.C., Day, A.M.B., Dzioba, A., Sleeth, L. & Fung, K. Construct
validation of the V-RQOL in alaryngeal speakers. Paper presented at the Annual American
Speech-Language Hearing Association convention, San Diego, CA, November 2011.

238
23. Bornbaum, C.C., Doyle, P.C., Day, A.M.B., Dzioba, A. & Sleeth, L. Relationships between
listener comfort & voice severity in tracheoesophageal speech. Paper presented at the Annual
American Speech-Language Hearing Association convention, San Diego, CA, November 2011.
22. Bornbaum, C.C. An introduction to the issue of distress in considerations of health-related
quality of life. Invited presentation at the University of Western Ontario, London, ON, November
2011.
21. Bornbaum, C.C., Doyle, P.C., Fung, K., Franklin, J.H., Nichols, A., & Yoo, J. Identifying and
th
managing distress in head and neck cancer. Paper presented at the 65 Annual Canadian
Society of Otolaryngology – Head & Neck Surgery conference, Victoria, BC, May 2011.
20. Yeung, J., Fung, K., Dzioba, A., Day, A., Bornbaum, C.C., Sleeth, L., Doyle, P.C. Influence of
listener experience on perceptual judgments of adductor spasmodic dysphonia. Paper presented
th
at the 65 Annual Canadian Society of Otolaryngology – Head & Neck Surgery conference,
Victoria, BC, May 2011.
19. Bornbaum, C.C., Fung, K., & Doyle, P.C. The Influence of Treatment Modality on Reported
Distress Levels and Quality of Life Concerns in Individuals with Head and Neck Cancer. Paper
presented at the Canadian Association of Psychosocial Oncology conference, Toronto, ON, May
2011.
18. Bornbaum, C.C., Fung, K. & Doyle, P.C. Evaluating psychosocial well-being in individuals
with head and neck cancer. Poster presentation at Faculty of Health Sciences Research Day,
London ON, March 25, 2011.
17. Bornbaum, C.C., Fung, K., & Doyle, P.C. Assessing the impact of treatment modality on
perceived levels of distress and quality of life in individuals diagnosed with head and neck cancer.
th
Poster presented at the 4 annual Aging, Rehabilitation & Geriatric Care Research conference,
London, ON, February 2011.
16. Sleeth, L., Skidmore, E., Elliot, H.C., Bornbaum, C.C., & Doyle, P.C. Comprehensive
evaluation of voice severity and listener comfort in postlaryngectomy tracheoesophageal
th
speakers. Poster presented at the 4 annual Aging, Rehabilitation & Geriatric Care Research
conference, London, ON, February 2011.
15. Bornbaum, C.C. & Doyle, P.C. Distress in head and neck cancer: An important factor
influencing perceived quality of life. Presented at the Health and Rehabilitation Sciences
Research Forum, London, ON, February 2011.
14. Sleeth, L., Skidmore, E., Elliot, H.C., Bornbaum, C.C., & Doyle, P.C. Auditory-perceptual
assessments of voice severity and listener comfort in postlaryngectomy tracheoesophageal
rd
speakers. Presented at the 23 annual Western Research Forum, London, ON, February 2011.
13. Bornbaum, C.C. & Doyle, P.C. Multidimensional concerns in individuals with head and neck
rd
cancer. Presented at the 23 annual Western Research Forum, London, ON, February 2011.
12. Doyle, P.C., Skidmore, E., Seuchuk, C., Bornbaum, C.C., Day, A.M.B., Caty, M.-E., & Levee,
T. Evaluation of Listener Comfort and Voice Severity in Tracheoesophageal Speech. Paper
presented at the annual American Speech Language & Hearing Association conference,
Philadelphia, USA, November, 2010.
11. Bornbaum, C.C., Fung, K., & Doyle, P.C. Heightened distress and quality of life concerns in
th
individuals with head and neck cancer. Paper presented at the 12 world congress of psychosocial oncology hosted jointly by the International Psycho-Oncology Society and the Canadian
Association of Psychosocial Oncology, Quebec City, QC, May 2010.

239

10. Bornbaum, C.C., Doyle, P.C., Fung, K., Franklin, J.H., Nichols, A., & Yoo, J. Distress and
th
quality of life in head and neck cancer. Poster presented at the 64 Annual Canadian Society of
Otolaryngology – Head & Neck Surgery conference, Niagara Falls, ON, May 2010.
9. Yeung, J.C., Fung, K., Day, A.M.B., Dzioba, A., Bornbaum, C.C., Levee, T., & Doyle, P.C.
(2010). Longitudinal evaluations of laryngeal overpressure and Voice-Related Quality of Life in
th
adductor spasmodic dysphonia. Paper presented at the 64 Annual Canadian Society of
Otolaryngology – Head & Neck Surgery conference, Niagara Falls, ON, May 2010.
8. Bornbaum, C.C. & Doyle, P.C. Relationships between distress and quality of life in individuals
with head and neck cancer. Invited presentation at Wellspring-Sunnybrook Cancer Centre,
Toronto, ON. April 1, 2010.
7. Bornbaum, C.C. & Doyle, P.C. The role of distress screening in assessments of quality of life
among individuals with head and neck cancer. Poster presentation at Faculty of Health Sciences
Research Day, London ON, March 22, 2010.
6. Bornbaum, C.C., Fung, K., & Doyle, P.C. Identification of distress in individuals with head and
rd
neck cancer in the early post-diagnostic period. Poster presented at the 3 annual Aging,
Rehabilitation & Geriatric Care Research conference, London, ON, February 2010.
5. Eadie, T.L., Nevdahl, M.T., Bornbaum, C.C., Day, A.M.B., & Doyle, P.C. Voice Disability in
Laryngectomized Women: Esophageal, Tracheoesophageal, & Electrolaryngeal Speech. Paper
presented at the annual American Speech Language & Hearing Association conference, New
Orleans, USA, November 2009.
4. Bornbaum, C.C. Understanding personal determinants of health: A comprehensive
perspective. Invited presentation at Six Nations Polytechnic Institute, Brantford, ON. November 5,
2009.
3. Bornbaum, C.C., Sillick, J., & Doyle, P.C. Vocal communication disability among
nd
electrolaryngeal speakers. Poster presented at the 2 annual Aging, Rehabilitation & Geriatric
Care Research conference, London, ON, February 2009. *First two authors had equal
contribution.
2. Bornbaum, C.C. & Doyle, P.C. The impact of stigmatization and judgments of responsibility on
individuals diagnosed with lung cancer. Presented at the Health and Rehabilitation Sciences
Research Forum, London, ON, February 2009.
1. Bornbaum, C.C. & Doyle, P.C. Stigma, shame, and judgments of responsibility: Factors
st
influencing quality of life in individuals diagnosed with lung cancer. Presented at the 21 annual
Western Research Forum, London, ON, February 2009.
Manuscripts under review
2. Bornbaum, C.C., Day, A.M.B., Izaryk, K., Morrison, S., Ravenek, M., Skarakis-Doyle, E., &
Sleeth, L. (2013). Exploring the use of the ICF in education: A scoping review. Manuscript
submitted to Disability & Rehabilitation.
1. Brandt, M.G., Rotenberg, B.W., Moore, C.C., Bornbaum, C.C., & Doyle, P.C. (2013). A
prospective evaluation of the impact of nasal surgery on voice. Manuscript submitted to Journal of
Voice.

